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A B S T R A C T
Background
Cardiovascular disease is the most common cause of death globally. Traditionally, centre-based cardiac rehabilitation programmes
are offered to individuals after cardiac events to aid recovery and prevent further cardiac illness. Home-based cardiac rehabilitation
programmes have been introduced in an attempt to widen access and participation. This is an update of a review previously published
in 2009 and 2015.
Objectives
To compare the effect of home-based and supervised centre-based cardiac rehabilitation on mortality and morbidity, exercise-capacity,
health-related quality of life, and modifiable cardiac risk factors in patients with heart disease.
Search methods
Weupdated searches from the previous Cochrane Review by searching theCochrane Central Register of Controlled Trials (CENTRAL),
MEDLINE (Ovid), Embase (Ovid), PsycINFO (Ovid) and CINAHL (EBSCO) on 21 September 2016. We also searched two clinical
trials registers as well as previous systematic reviews and reference lists of included studies. No language restrictions were applied.
Selection criteria
We included randomised controlled trials, including parallel group, cross-over or quasi-randomised designs) that compared centre-based
cardiac rehabilitation (e.g. hospital, gymnasium, sports centre) with home-based programmes in adults with myocardial infarction,
angina, heart failure or who had undergone revascularisation.
Data collection and analysis
Two review authors independently screened all identified references for inclusion based on pre-defined inclusion criteria. Disagreements
were resolved through discussion or by involving a third review author. Two authors independently extracted outcome data and study
characteristics and assessed risk of bias. Quality of evidence was assessed using GRADE principles and a Summary of findings table was
created.
1Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We included six new studies (624 participants) for this update, which now includes a total of 23 trials that randomised a total of
2890 participants undergoing cardiac rehabilitation. Participants had an acute myocardial infarction, revascularisation or heart failure.
A number of studies provided insufficient detail to enable assessment of potential risk of bias, in particular, details of generation and
concealment of random allocation sequencing and blinding of outcome assessment were poorly reported.
No evidence of a difference was seen between home- and centre-based cardiac rehabilitation in clinical primary outcomes up to 12
months of follow up: total mortality (relative risk (RR) = 1.19, 95% CI 0.65 to 2.16; participants = 1505; studies = 11/comparisons
= 13; very low quality evidence), exercise capacity (standardised mean difference (SMD) = -0.13, 95% CI -0.28 to 0.02; participants
= 2255; studies = 22/comparisons = 26; low quality evidence), or health-related quality of life up to 24 months (not estimable). Trials
were generally of short duration, with only three studies reporting outcomes beyond 12 months (exercise capacity: SMD 0.11, 95%
CI -0.01 to 0.23; participants = 1074; studies = 3; moderate quality evidence). However, there was evidence of marginally higher levels
of programme completion (RR 1.04, 95% CI 1.00 to 1.08; participants = 2615; studies = 22/comparisons = 26; low quality evidence)
by home-based participants.
Authors’ conclusions
This update supports previous conclusions that home- and centre-based forms of cardiac rehabilitation seem to be similarly effective
in improving clinical and health-related quality of life outcomes in patients after myocardial infarction or revascularisation, or with
heart failure. This finding supports the continued expansion of evidence-based, home-based cardiac rehabilitation programmes. The
choice of participating in a more traditional and supervised centre-based programme or a home-based programme may reflect local
availability and consider the preference of the individual patient. Further data are needed to determine whether the effects of home-
and centre-based cardiac rehabilitation reported in the included short-term trials can be confirmed in the longer term and need to
consider adequately powered non-inferiority or equivalence study designs.
P L A I N L A N G U A G E S U M M A R Y
Home-based versus supervised centre-based cardiac rehabilitation
Review question
We compared home-based cardiac rehabilitation programmes with supervised centre-based cardiac rehabilitation for adults with my-
ocardial infarction (blood flow to the heart has stopped), angina (chest pain), heart failure or who had undergone revascularisation.
Background
Cardiac rehabilitation aims to restore people with heart disease to health, through a combination of exercise, education and psychological
support. Traditionally, centre-based cardiac rehabilitation programmes (e.g. based at a hospital, gymnasium or in sport centre) are
offered to people after cardiac events. Home-based cardiac rehabilitation programmes have been introduced to increase access and
participation.
Search date
We searched up to September 2016.
Study characteristics
We searched for randomised controlled trials (trials that randomly allocate participants to one of two or more treatment groups) looking
at the effectiveness of home-based versus supervised centre-based cardiac rehabilitation programmes, in adults with heart disease.
We included 23 trials (2890 participants). Most trials were relatively small (median 104 participants, range: 20 to 525). The average
age of trial participants ranged from 51.6 to 69 years. Women accounted for only 19% of recruited participants; four trials did not
include women.
The mix of people recruited to the trials varied; 10 studies included a mixed population of people with coronary heart disease, five
studies included people who had had a heart attack, and four studies each recruited people following revascularisation or who had heart
failure.
Study funding sources
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Sixteen studies reported sources of funding; seven did not. No study reported funding from an agency with commercial interest in the
results.
Key results
We found that home- and centre-based cardiac rehabilitation programmes are similar in benefits measured in terms of numbers of
deaths, exercise capacity and health-related quality of life. Further data are needed to confirm if these short-term effects of home- and
centre-based cardiac rehabilitation can be sustained over time.
Quality of the evidence
Poor reporting made it difficult to assess methodological quality of the included studies and their risk of bias. Evidence quality ranged
from very low (total mortality), to moderate (exercise capacity over 12 months and health-related quality of life). The main reasons for
the low assessment of quality was poor reporting in the included studies.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Home-based versus supervised centre-based cardiac rehabilitat ion for heart disease
Patient or population: Patients with heart disease
Settings: Home and rehabilitat ion centres
Intervention: Home-based cardiac rehabilitat ion
Comparison: Centre-based cardiac rehabilitat ion
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with centre-based Risk with home-base
Total mortality
Number of deaths
Follow-up: up to 12
months
Study populat ion RR 1.19
(0.65 to 2.16)
1505
(11 studies/ 13 com-
parisons)
⊕©©©
VERY LOW 12
22 per 1,000 26 per 1,000
(14 to 47)
Exercise capacity ≤ 12
months
Validated out-
come measure (e.g. VO
peak, 6 minute walk
test)
Follow-up: 2 to 12
months
The mean exercise ca-
pacity ≤ 12 months
ranged f rom -2 to 3,509.
33
SMD 0.13 lower
(0.28 lower to 0.02
higher)
- 2255
(22 studies / 26 com-
parisons)
⊕⊕©©
LOW 13
Higher score indicates
improved act ivity.
A rule of thumb for in-
terpret ing SMD is that
0.2 represents a small
ef fect, 0.5 a moderate
ef fect and 0.8 a large
ef fect (Cohen 1988)
Withdrawal from the in-
tervention group
Number of completers
(part icipants with data
at follow-up)
Follow-up: 2 to 72
months
Study populat ion RR 1.04
(1.00 to 1.08)
2615
(22 studies/
26 comparisons)
⊕⊕©©
LOW 13
816 per 1,000 848 per 1,000
(816 to 881)
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HRQoL
Validated measures of
HRQoL (e.g. Short Form
Health Survey (SF-36)
, Sickness Impact Pro-
f ile, Nott ingham Health
Prof ile)
Follow-up: 2 to 24
months
HRQoL in home-based cardiac rehabilitat ion =
HRQoL in centre-based cardiac rehabilitat ion, in
61/ 67 domains
Not est imable 2079
(14 studies/ 15 com-
parison)
⊕⊕⊕©
MODERATE1
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Random sequence generat ion, allocat ion concealment or blinding of outcome assessors were poorly described in over 50%
of included studies; bias likely, therefore quality of evidence downgraded by one level.
2 The 95% CIs includes both no ef fect, appreciate benef it and appreciable harm (i.e. CI < 0.75 and > 1.25), therefore quality of
evidence downgraded by two levels.
3 I² > 50%; heterogeneity may be important and therefore quality of evidence downgraded by one level
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B A C K G R O U N D
Description of the condition
Cardiovascular disease (CVD) is the leading cause of death glob-
ally: in 2015 an estimated 17.7 million people died from CVD,
representing 31% of all global deaths (WHO 2016). Of these
deaths, an estimated 7.4millionwere due to coronary heart disease
(CHD) and 6.7 million were due to stroke (WHO 2016). Over
three quarters of CVD deaths occur in low- and middle-income
countries (WHO 2016).
Coronary heart disease is caused by the build-up of plaque inside
the coronary arteries (atherosclerosis), causing arterial narrowing
and reducing the flow of oxygen-rich blood to the heart. The main
manifestations of CHD are angina pectoris (chest pain), myocar-
dial infarction (MI), and heart failure. Myocardial infarction oc-
curs when blood flow to the heart muscle is abruptly cut off as the
result of a blockage in one or more of the coronary arteries, caus-
ing tissue damage. Over time, CHD can weaken the heart muscle
and lead to arrhythmias or heart failure. Coronary heart disease
causes significant morbidity and mortality, and as a long term con-
dition it contributes greatly to disability in developed countries,
accounting for 19% of total disability adjusted life years lost in
European countries (European Cardiovascular Disease Statistics
2017). Coronary heart disease can result in difficulties in func-
tionality and performing everyday activities, and impairs sexual
function (Racca 2010), all contributing to a reduction in health-
related quality of life (HRQoL) (Gravely-Witte 2007).
In the United Kingdom (UK), an estimated 2.3 million people
live with CHD and the condition accounts for one in five deaths
in men and one in 10 deaths in women (Nicholls 2012; Townsend
2012). However, with more people surviving MI (WHO 2008)
and heart failure (Kostis 1997), an increasing number of people
are now living with CHD and may need support to manage their
symptoms and improve their prognosis.
Description of the intervention
Although there are many definitions of cardiac rehabilitation, the
following describes their combined key elements: “The coordi-
nated sum of activities required to influence favourably the un-
derlying cause of cardiovascular disease, as well as to provide the
best possible physical, mental, and social conditions, so that the
patients may, by their own efforts, preserve or resume optimal
functioning in their community and through improved health be-
haviour, slow or reverse progression of disease” (BACPR 2012;
Buckley 2013). A central component of cardiac rehabilitation is
exercise training (Piepoli 1998; Piepoli 2010). However, in ad-
dition to exercise, it is recommended that programmes provide
lifestyle education on CHD risk factor management plus coun-
selling and psychological support - so-called ‘comprehensive car-
diac rehabilitation’ (Corrà 2005).
Cardiac rehabilitation is a complex intervention that involves a
variety of therapies, including exercise, risk factor education, be-
haviour change, psychological support, and strategies that are
aimed at targeting traditional risk factors for cardiovascular dis-
ease. Cardiac rehabilitation should be considered an essential part
of the contemporary treatment of heart disease and is consid-
ered a priority in countries with a high prevalence of CHD. Car-
diac rehabilitation has been shown to improve health-related qual-
ity of life and reduce future morbidity (Anderson 2016; Taylor
2014; Davies 2014). Based on evidence from previous meta-anal-
yses and systematic reviews, exercise-based cardiac rehabilitation
following a cardiac event, or for patients with heart failure, is
a Class I recommendation from the American College of Car-
diology/American Heart Association (Balady 2011; Kulik 2015;
Smith 2011; Yancy 2013) and the European Society of Cardi-
ology, (McMurray 2012; Roffi 2015; Steg 2012) and is recom-
mended by the National Institute for Health and Care Excellence
(NICE 2010; NICE 2013). Service provision, though predomi-
nantly centre-based, varies markedly, and referral, enrolment and
completion are sub-optimal, especially among women and older
people (Beswick 2004; Clark 2012). Home-based cardiac rehabil-
itation programmes have been increasingly introduced to widen
access and participation (Taylor 2009), and interventions aimed at
improving patient uptake and adherence to cardiac rehabilitation
programmes have been adopted (Karmali 2014).
How the intervention might work
There are a number of mechanisms by which exercise training
benefits patients dependent on the cause of their heart disease. For
peoplewithCHD, approximately half of the 28%reduction in car-
diac mortality achieved with exercise-based cardiac rehabilitation
has been attributed to reductions in major risk factors (e.g. lipids,
smoking) (Taylor 2006). For patients with ischaemic causes of
heart failure, exercise training appears to improve myocardial per-
fusionby alleviating endothelial dysfunction thereby dilating coro-
nary vessels, and by stimulating new vessel formation by way of
intermittent ischaemia (ExTraMatch 2004). Indeed, Haykowsky
2007 demonstrated that aerobic training in people with heart fail-
ure patients improvesmyocardial contractility and diastolic filling.
In their meta-analysis Haykowsky 2007 demonstrated the benefits
of exercise training in people with heart failure in terms of cardiac
remodelling as measured by ejection fraction, end-diastolic vol-
ume, and end-systolic volume. Skeletal muscle dysfunction and
wasting may also respond to exercise training (Haykowsky 2007).
Regular physical activity by people with heart failure also stimu-
lates vasodilation in the skeletal muscle vasculature and improves
oxidative capacity (Hambrecht 1998).The inclusion of psycho-ed-
ucational interventions may improve patients’ knowledge and risk
factor behaviour (Brown 2013; Dickens 2013) and psychological
well-being, including levels of depression and anxiety.
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Why it is important to do this review
Although the beneficial effects of cardiac rehabilitation have been
shown, participation remains sub-optimal (Dalal 2012), particu-
larly so by heart failure patients (Dalal 2012; Piepoli 2015). Two
of the main reasons people give for not accepting the invitation to
attend cardiac rehabilitation are difficulty with regularly attend-
ing sessions at their local hospital and reluctance to take part in
group-based classes (Beswick 2004). Home-based cardiac reha-
bilitation programmes have therefore been introduced in an at-
tempt to improve rates of participation. In the UK, home-based
cardiac rehabilitation with a self-help manual - the Heart Manual
- supported by a nurse facilitator is a programme of rehabilita-
tion that has been available for over two decades (Lewin 1992).
Home-based cardiac rehabilitation programmes can include su-
pervised and unsupervised elements and increasingly use technol-
ogy or “telehealth” interventions to support or encourage exercise
or behaviour change (Artinian 2007; Neubeck 2009) or to over-
come barriers of time and distance (Huang 2015). Figures from the
National Audit for Cardiac Rehabilitation (NACR) indicate that
approximately 5% of UK sites are currently providing the Heart
Manual (NACR 2013), with some 14,000 copies given to patients
in UK and abroad each year (Heart Manual 2016). The Heart
Manual has also been used in many countries across the world,
including Singapore, Italy, Canada, China, Ireland and Cayman
(Heart Manual 2016), yet facilitated home-based options such as
the Heart Manual have not increased their share of cardiac reha-
bilitation provision in the UK in recent years (NACR 2016).
In the previous version of this Cochrane Review, the authors iden-
tified five new head-to-head randomised controlled trials (345
participants) of home- versus centre-based cardiac rehabilitation
(Taylor 2015). Unlike most studies in the original version of the
review (Dalal 2010; Taylor 2009), these new studies included
patients with heart failure. The authors found the two methods
of delivery to be equally effective for improving the clinical and
health-related quality of life outcomes in low risk patients after
MI or revascularisation, or with heart failure (Buckingham 2016;
Taylor 2015). On the basis of this evidence, together with the
absence of evidence of important differences in healthcare costs
between the two approaches, the authors concluded that the ex-
pansion of home-based cardiac rehabilitation programmes should
continue and that the choice of participating in a more tradi-
tional and supervised centre-based programme or a home-based
programme should reflect the preference of the individual patient
(Taylor 2015). More recently, a systematic review was conducted
to assess the effectiveness of home-based cardiac rehabilitation for
heart failure compared to either usual medical care (i.e. no cardiac
rehabilitation) or centre-based cardiac rehabilitation on mortal-
ity, morbidity, exercise capacity, health-related quality of life, drop
out, adherence rates, and costs (Zwisler 2016). This review found
that home-based cardiac rehabilitation led to short-term improve-
ments in exercise capacity and health-related quality of life of heart
failure patients compared to usual care, and the magnitude of out-
come improvements were similar to those achieved with centre-
based cardiac rehabilitation (Zwisler 2016).
O B J E C T I V E S
To compare the effect of home-based and supervised centre-based
cardiac rehabilitation on mortality and morbidity, exercise-capac-
ity, health-related quality of life, and modifiable cardiac risk fac-
tors in patients with heart disease.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs; individual or cluster level),
including parallel group, cross-over or quasi-randomised designs,
were eligible for inclusion. Systematic reviews and meta-analyses
were identified as a means to identify additional RCTs.
Types of participants
The study population included adults (≥18 years) who were post
myocardial infarction (MI), have angina, or had undergone revas-
cularisation (coronary artery bypass grafting (CABG), percuta-
neous transluminal coronary angioplasty or coronary artery stent)
or who have had heart failure, who have taken part, or been invited
to take part, in cardiac rehabilitation.
Studies were excluded if they included participants with heart
transplants, those implanted with either cardiac resynchronisation
therapy or implantable defibrillators, or those who had previously
received cardiac rehabilitation.
Types of interventions
Home-based cardiac rehabilitation is defined as a structured pro-
gramme (that includes exercise training) with clear objectives for
the participants, including monitoring, follow up visits, letters or
telephone calls from staff or at least self-monitoring diaries (Jolly
2006). The comparison group was centre-based cardiac rehabilita-
tion based in a variety of settings (e.g. hospital physiotherapy de-
partment, university gymnasium, community sports centre). We
included cardiac rehabilitation programmes whether they were
based solely on exercise or included other intervention elements
(comprehensive cardiac rehabilitation).
7Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Types of outcome measures
Primary outcomes
• Total mortality.
• Cardiac events:
◦ Re-infarction;
◦ Total revascularisations (including CABG and
percutaneous coronary intervention (PCI)); and
◦ Cardiac associated hospitalisation.
• Exercise capacity assessed by validated outcome measure
(e.g. VO peak, 6 minute walk test).
• Validated measures of health-related quality of life
(HRQoL) (e.g. Short Form Health Survey (SF-36), Sickness
Impact Profile, Nottingham Health Profile).
• Withdrawal from the exercise programme.
Secondary outcomes
• Modifiable coronary risk factors (i.e. blood lipid levels,
blood pressure, smoking behaviour).
• Adherence to cardiac rehabilitation.
• Costs and health service use (e.g. use of medication,
primary care contacts).
Reporting of outcomes was not an inclusion or exclusion criterion
for this update.
Search methods for identification of studies
Electronic searches
The search from the previously publishedCochrane review (Taylor
2015) was updated by searching the following bibliographic
databases on 21 September 2016:
• CENTRAL Issue 8, 2016 in the Cochrane Library.
• Epub Ahead of Print, In-Process & Other Non-Indexed
Citations, MEDLINE Daily and MEDLINE (Ovid, 1946 to 21
September 2016).
• Embase (Ovid, 1980 to 2016 Week 38).
• PsycINFO (Ovid, 1806 to July Week 4 2016).
• CINAHL Plus (EBSCO, 1937 to 21 September 2016).
The searches were run twice for this update; once in August
2016 using the search strategies from the last update and again
in September 2016 with additional terms added to the strategies.
Date limits were applied to the old terms to only retrieve results
added since the last search, but not to the newly added terms.
The search strategies were designed with reference to those of the
previous version of this review (Taylor 2015). We searched the
databases using a strategy combining selected MeSH terms and
free text terms relating to patient education and coronary heart
disease (CHD), with filters applied to limit to RCTs. We used
the Cochrane sensitivity-maximising RCT filter for MEDLINE,
and for Embase, terms recommended in the Cochrane Hand-
book for Systematic Reviews of Interventions were applied (Lefebvre
2011). Adaptations of this filter were applied to CINAHL and
PsycINFO. We translated the MEDLINE search strategy into the
other databases using the appropriate controlled vocabulary as ap-
plicable. We imposed no language or other limitations and gave
consideration to variations in terms used and spellings of terms
in different countries so that studies would not be missed by the
search strategy because of such variations. See Appendix 1 for de-
tails of the search strategies used.
The reporting of search results was conducted in accordance with
PRISMA (Moher 2009). Information about the number of studies
identified, included and excluded, and the reasons for exclusion is
summarised using a flow diagram (Figure 1).
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Figure 1. PRISMA Flow Diagram
Searching other resources
Wehandsearched reference lists of retrieved articles and systematic
reviews for any studies not identified by the electronic searches.We
also searched clinical trial registers on 7 November 2016; World
Health Organization International Clinical Trials Registry Plat-
form (WHO ICTRP; http://www.who.int/ictrp/en) and Clini-
calTrials.gov (https://clinicaltrials.gov)) for ongoing clinical trials
and sought expert advice. Attempts were made to contact all study
authors to obtain relevant information not available in the pub-
lished manuscript.
Data collection and analysis
Selection of studies
We screened (LA and GAS) the titles and abstracts of identified
studies, and discarded clearly irrelevant ones. Two review authors
(LA and GAS) then obtained and independently assessed the full-
text reports of all potentially relevant randomised trials for eligi-
bility, based on the defined inclusion criteria. Any disagreement
was resolved by discussion and where uncertainty remained, the
opinion of a further author (RST) was taken. Excluded studies and
reasons for exclusion are detailed in Characteristics of excluded
studies. Where necessary, authors of included studies were con-
tacted for missing information.
Data extraction and management
Two independent review authors (LA and GAS) extracted study
characteristics of included RCTs using a standardised data collec-
tion form which had been piloted on two RCTs included in the
review. Data on participant characteristics (e.g. age, sex, CHD di-
agnosis) details of the intervention (including duration, frequency
and delivery), description of usual care and length of follow-up
were extracted. Two independent review authors (LA and GAS)
extracted outcome data onto a standardised collection form. If
data were presented numerically (in tables or text) and graphi-
cally (in figures), the numeric data were used because of possible
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measurement error when estimating from graphs. Any discrepan-
cies were resolved by arbitration. One review author (LA) trans-
ferred extracted data into Review Manager 5.3 (RevMan 2014),
and checked data for accuracy against the data collection forms.
If there were multiple reports of the same study, we assessed the
duplicate publications for additional data. We extracted outcome
results at all follow-up points post-randomisation. We contacted
study authors where necessary to provide additional information.
Assessment of risk of bias in included studies
Factors considered included the reporting of random sequence
generation and allocation concealment, the description of drop-
outs and withdrawals (high risk if >20% loss), consideration of
blinding of outcome assessors, and degree of selective outcome
reporting. In addition, evidence was sought that the groups were
balanced at baseline and whether co-interventions were delivered
equally across the groups. The risk of bias in eligible trials was
assessed by two reviewers independently (LA and GAS).
Measures of treatment effect
We extracted outcome results at follow-up and the focus of this
review was the between-group difference in home- versus centre-
based groups. Primary outcomes relating to clinical event datawere
extracted as dichotomous outcomes for each study. Event datawere
expressed as risk ratios (RR) with associated 95% confidence in-
tervals (CI), and study sample sizes were based on the number ran-
domised to treatment conditions. For continuous variables, mean
differences (MD) and 95% CI were calculated for each outcome,
with sample sizes based on number completing assessments at each
time-point.When the results at follow-up and differences between
groups of the individual trials were not reported in the original
publication, we calculated P values for the differences using the
reported mean and standard deviation with the t-test command
in STATA (StataCorp 2013).
Given the variety of exercise capacity measures reported, results
for this outcome were expressed as a standardised mean difference
(SMD). Where a trial reported more than one exercise capacity
endpoint we used the first one reported in the publication. Other
continuous outcomes were pooled as weighted mean differences
(WMD).
Unit of analysis issues
In accordance with Section 9.3.1 of the Cochrane Handbook for
Systematic Reviews of Intervention (Higgins 2011), we ensured that
the analysis was appropriate to the level at which randomisation
occurred. All studies included in this review were simple parallel
groupRCTs, and so there were no issues relating to unit of analysis.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and obtain missing numerical outcome data where
possible (for example when a study was identified as abstract only).
For this update, we contacted Grace to request absolute values
for adherence data which were presented graphically in the pub-
lication (Grace 2016 Mixed). We also contacted Varnfield to ob-
tain six month follow-up data which were presented graphically
(Varnfield 2014). Finally, we contacted Hadadzadeh for further
details on study which had been identified as an abstract. This
communication also led to the identification of a second study by
the same authors which also met our inclusion criteria, but was
not yet published (Hadadzadeh 2013; Hadadzadeh 2015).
Assessment of heterogeneity
Heterogeneity amongst included studieswas explored qualitatively
(by comparing the characteristics of included studies) and quan-
titatively (using the Chi² test of homogeneity and I² statistic).
Where appropriate, the results from included studies were com-
bined for each outcome to give an overall estimate of treatment
effect. A fixed-effect meta-analysis was used except where statisti-
cal heterogeneity was indicated by a I² of ≥ 50%, in which case a
random-effects model was used.
Assessment of reporting biases
The funnel plot and the Egger test (Egger 1997) were used to
examine small study bias for outcomes where there were 10 or
more studies contributing data to the analysis.
Data synthesis
We processed data in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). Where appro-
priate and possible, results from included studies were combined
for each outcome to give an overall estimate of treatment effect,
using either a fixed-effect or random-effects model.
Summary of findings table
Two independent review authors (LA andGS) employed theGrad-
ing of Recommendations Assessment, Development and Evalu-
ation (GRADE) approach to interpret result findings and used
GRADEpro GDT 2015 to import data from Review Manager to
create a ’Summary of findings table’. We created a ’Summary of
findings’ table using the following outcomes: total mortality, exer-
cise capacity, withdrawal and HRQoL. We used the five GRADE
considerations (study limitations, consistency of effect, impreci-
sion, indirectness, and publication bias) to assess the quality of a
body of evidence as it relates to the studies that contribute data to
themeta-analyses for the prespecified outcomes.We usedmethods
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and recommendations described in Section 8.5 and Chapter 12
of the Cochrane Handbook for Systematic Reviews of Interventions
using GRADEpro software (Higgins 2011). We have justified all
decisions to downgrade the quality of studies using footnotes, and
have made comments to aid readers’ understanding of the review
where necessary.
Subgroup analysis and investigation of heterogeneity
We undertook subgroup analysis using meta-regression to exam-
ine potential treatment effect modifiers. We tested the following
a priori hypotheses that there may be differences in the effect of
home- and centre-based cardiac rehabilitation programmes on to-
tal mortality, exercise capacity ≤ 12 months, withdrawal, total
cholesterol and blood pressure, across the following subgroups:
• case mix (% MI);
• type of cardiac rehabilitation (exercise-only cardiac
rehabilitation versus comprehensive cardiac rehabilitation);
• ’dose’ of exercise intervention (dose = number of weeks of
exercise training x average number of sessions/week x average
duration of session in minutes) (dose ≥ 1000 units versus dose <
1000 units);
• follow-up period;
• year of publication;
• sample size;
• risk of bias (low risk in ≥ 4 items versus < 4 items); and
• study location (continent).
Given the relatively small ratio of trials to covariates, multivariable
meta-regression was not appropriate, and instead, limited to a uni-
variate analysis (Deeks 2011). The permute option in STATA was
used to allow for multiple testing in meta-regression (StataCorp
2013).
R E S U L T S
Description of studies
No cluster RCTs were identified in our searches and therefore only
individual RCTs were included in this review.
Results of the search
The original 2009 version of this Cochrane Review contributed
12 trials to this latest analysis (Arthur 2002; Bell 1998; Carlson
2000; Dalal 2007; Daskapan 2005; Gordon 2002 Community;
Gordon 2002 Supervised; Jolly 2007; Kassaian 2000;Marchionni
2003;Miller 1984 Brief;Miller 1984 Expanded; Sparks 1993;Wu
2006). The 2015 update identified one previously included trial
with longer follow up (Arthur 2002) and five new trials (Cowie
2012; Karapolat 2009; Moholdt 2012; Oerkild 2011; Piotrowicz
2010) and included a total of 17 trials (28 reports).
For this update, 18,255 records were identified through database
searches and 10,482 records were screened following de-duplica-
tion. An additional 10 records were identified from other sources.
We assessed a total of 62 full text records. We identified one pre-
viously included trial with further health-related quality of life
(HRQoL) data (Piotrowicz 2010) and six new trials (Aamot 2014
Treadmill; Grace 2016 Mixed; Hadadzadeh 2013; Hadadzadeh
2015; Kraal 2014; Varnfield 2014). Two of these trials compared
a home-based programme with two supervised centre-based ex-
ercise programmes (Aamot 2014 Treadmill; Grace 2016 Mixed)
and this update therefore includes eight additional home- versus
centre-based cardiac rehabilitation comparisons.
Two of the studies identified in this update have not yet been pub-
lished in peer-reviewed journals (Hadadzadeh 2013; Hadadzadeh
2015). Study and outcome data have been provided by the author
of these trials, but in the absence of full study details, it was not
possible to assess methodological quality using all domains of the
Cochrane risk of bias tool, for these studies.
The study selection process is summarised in the PRISMA flow
diagram (Figure 1).
Included studies
The 23 trials (27home- versus centre-based comparisons) included
a total of 2890 participants and all used an individual patient
randomisation method (there were no quasi-randomised studies).
Most trials were relatively small in sample size (median 104 partic-
ipants, range: 20 to 525). The average age of patients in the trials
ranged from 51.6 to 69.0 years. With the exception of four trials
(Kassaian 2000; Miller 1984 Brief; Sparks 1993; Wu 2006), all
included women. However, women accounted for only 19% of all
participants who were recruited in the included studies. The mix
of participants recruited to included trials varied, with 10 studies
including a mixed population of people with coronary heart dis-
ease (CHD) (Aamot 2014 Treadmill; Carlson 2000;Gordon 2002
Community; Grace 2016 Mixed; Hadadzadeh 2015; Jolly 2007;
Kassaian 2000; Kraal 2014; Oerkild 2011; Piotrowicz 2010), five
studies included patients post-myocardial infarction (MI) (Bell
1998; Dalal 2007;Marchionni 2003; Miller 1984 Brief; Varnfield
2014), four recruited patients following revascularisation (Arthur
2002; Hadadzadeh 2013; Moholdt 2012; Wu 2006), and four
studies included participants with heart failure (Cowie 2012;
Daskapan 2005; Karapolat 2009; Piotrowicz 2010).
All trials used an individual patient level method for randomisa-
tion. Four studies were UK-based (Bell 1998; Cowie 2012; Dalal
2007; Jolly 2007); four were based in the USA (Carlson 2000;
Gordon 2002 Community; Miller 1984 Brief; Sparks 1993);
two studies each were from Turkey (Daskapan 2005; Karapolat
2009), Norway (Aamot 2014 Treadmill; Moholdt 2012) and
Canada (Arthur 2002; Grace 2016 Mixed); and one each from
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Denmark (Oerkild 2011), Italy (Marchionni 2003), Netherlands
(Kraal 2014); Poland (Piotrowicz 2010), China (Wu 2006), Iran
(Kassaian 2000), India (Hadadzadeh 2013), Australia (Varnfield
2014), India and Iran (Hadadzadeh 2015). Most studies reported
outcomes up to six months post-randomisation. Only three stud-
ies reported longer-term follow-up at 14 months (Marchionni
2003), 18 months (Arthur 2002) and 24 months (Jolly 2007).
Sixteen studies compared comprehensive programmes (i.e. exer-
cise plus education and/or psychological management) and the
remainder reported only an exercise intervention (Aamot 2014
Treadmill;Daskapan 2005;Karapolat 2009;Kassaian 2000;Miller
1984 Brief; Wu 2006). Three studies compared a comprehensive
home-based programme with an exercise-only centre-based pro-
gramme (Hadadzadeh 2013;Hadadzadeh 2015; Kraal 2014). The
cardiac rehabilitation programmes differed considerably in dura-
tion (range: 1 to 6 months), frequency (1 to 5 sessions per week)
and session length (20 minutes to 60 minutes per session). Most
programmes used individually tailored exercise prescription which
makes it difficult to precisely quantify the amount of exercise un-
dertaken. Centre-based programmes typically provided supervised
cycle and treadmill exercise, while virtually all home programmes
were based onwalking, with some level of intermittent nurse or ex-
ercise specialist telephone support. Two studies used web-based or
smart phone applications to upload recorded exercise data (Kraal
2014) or to monitor health and exercise, and deliver motivational
and educational materials (Varnfield 2014).Most studies recruited
lower-risk patients following an acute MI or revascularisation, and
excluded those with significant arrhythmias, ischaemia, or heart
failure. Four studies included individuals (315 participants) with
New York Heart Association (NYHA) class II or III heart failure
(Cowie 2012; Daskapan 2005; Karapolat 2009; Piotrowicz 2010).
Most studies reported sources of trial funding; seven did not (Bell
1998; Carlson 2000; Daskapan 2005; Gordon 2002 Community;
Kassaian 2000; Sparks 1993; Wu 2006); and two studies are yet
to be published (Hadadzadeh 2013; Hadadzadeh 2015). None of
the studies reported that they were funded by an agency with a
commercial interest in the results of the study.
Marchionni 2003 reported outcomes for home- versus centre-
based care according to three patient age subgroups (i.e. 45 to 65,
66 to 75, > 75 years). Given the data reporting, we pooled these
data to obtain single overall outcome results for home- and centre-
based groups.
For three studies that report more than one comparator, we
reported outcome results separately for each comparison. Gor-
don et al compared two home-based exercise groups: a physi-
cian-supervised nurse-case-managed programme and a commu-
nity-based programme (Gordon 2002 Supervised; Gordon 2002
Community, respectively), versus a centre-based cardiac rehabil-
itation programme. The study by Miller et al compared home-
versus centre-based cardiac rehabilitation programmes that were
either 11 weeks long or 26 weeks long (Miller 1984 Brief; Miller
1984 Expanded, respectively). Grace et al compared a home-based
programme with a supervised mixed-sex and a supervised women-
only programme (Grace 2016 Mixed), and Aamot et al com-
pared a home-based programme with a supervised group exer-
cise programme and a treadmill exercise programme (Aamot 2014
Treadmill). We used the method for splitting sample size of shared
comparator studies in accordance with theCochrane Handbook for
Systematic Reviews of Interventions (chapter 16.5; Higgins 2011).
Details of included studies are listed in Characteristics of included
studies.
Excluded studies
We excluded 36 reports (29 studies): 17 studies included a com-
parator group which did not receive exercise-based cardiac reha-
bilitation or did not compare home- versus centre-based cardiac
rehabilitation; nine studies included an intervention which was
not exercise-based; two studies were not RCTs and one study in-
cluded an inappropriate population. Details of excluded studies
are listed in Characteristics of excluded studies.
Risk of bias in included studies
Anumber of study reports did not contain sufficient detail to assess
their potential risk of bias (Figure 2; Figure 3).
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study
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Figure 3. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies
Allocation
Details of generation and concealment of random allocation se-
quence were particularly poorly reported, with only nine studies
adequately describing random sequence generation (Aamot 2014
Treadmill; Aamot 2014 Group; Dalal 2007; Grace 2016 Mixed;
Grace 2016 Women; Hadadzadeh 2013; Hadadzadeh 2015; Jolly
2007;Moholdt 2012; Oerkild 2011; Varnfield 2014) and 11 stud-
ies adequately reporting random sequence concealment (Arthur
2002; Bell 1998; Cowie 2012; Dalal 2007; Grace 2016 Mixed;
Grace 2016 Women; Hadadzadeh 2013; Hadadzadeh 2015; Jolly
2007; Karapolat 2009; Moholdt 2012; Oerkild 2011).
Blinding
Given the nature of these trials, it is not possible to blind par-
ticipants or carers to group allocation; in such situations, blind-
ing outcome assessors to knowledge of allocation is probably of
greater importance. However, only 10 studies stated that they took
measures to blind outcome assessment (Arthur 2002; Bell 1998;
Cowie 2012;Dalal 2007;Grace 2016Mixed;Grace 2016Women;
Hadadzadeh 2013; Hadadzadeh 2015; Jolly 2007; Marchionni
2003; Wu 2006).
Incomplete outcome data
Loss to follow-up varied considerably among studies and was often
asymmetric across home- and centre-based cardiac rehabilitation
groups. Only a few trials examined the impact of losses to follow-
up or drop out. Five studies were judged to have an unclear risk of
attrition bias (Bell 1998; Daskapan 2005; Kassaian 2000; Miller
1984 Brief; Miller 1984 Expanded; Piotrowicz 2010); a further
four studies were judged as having a high risk of attrition bias
(Carlson 2000; Grace 2016 Mixed; Grace 2016 Women; Kraal
2014; Varnfield 2014).
Selective reporting
We compared the reported outcomes in the results sections to the
outcomes described in the methods of the published papers, Most
of the included studies fully reported on all the specified outcomes
listed in theirmethods sections; three studieswere judged as having
an unclear risk of reporting bias (Hadadzadeh 2013; Hadadzadeh
2015; Kassaian 2000). However, the two studies by Hadadzadeh
et al have not yet been published and we do not have access to
a published protocol or description of the methods, which made
reporting bias impossible to assess.
Groups balanced at baseline?
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There was generally good evidence of balance in baseline char-
acteristics between groups. However, in two cases there was ob-
jective evidence of imbalances in baseline characteristics (Arthur
2002; Cowie 2012), in one study the baseline characteristics were
not reported (Miller 1984 Brief) and two additional studies were
judged as having unclear risk of bias because they have not yet
been published in full and we did not have access to baseline data
(Hadadzadeh 2013; Hadadzadeh 2015).
Groups received same co-interventions?
Most trials were judged to be low risk of bias in terms of whether
groups received the same co-interventions. Because the rehabilita-
tion interventionwas usually tailored to the individual participant,
it is difficult to quantify the precise level of intervention; how-
ever, the intensity of the rehabilitation programme often seemed
to differ substantively between home- and centre-based arms. For
example, the studies by Bell 1998, Carlson 2000 and Jolly 2007
included hospital cardiac rehabilitation programmes which were
fixed in terms of frequency and content over the period of the
study. In contrast, the home-based intervention in these studies
consisted of use of the Heart Manual 2016 where the participants
could self-regulate the frequency and nature of rehabilitation ses-
sions they undertook. Kraal 2014 was also judged as having high
risk of bias in this domain, as while telephone coaching was of-
fered to the home-based cohort in this study, no coaching was of-
fered to patients receiving centre-based cardiac rehabilitation. The
study by Kassaian 2000 was judged as having unclear risk of bias
because the home-based programme was not adequately reported,
and the two studies by Hadadzadeh et al were judged as unclear
risk of bias because the full text was not available (Hadadzadeh
2013; Hadadzadeh 2015).
Effects of interventions
See: Summary of findings for the main comparison Home-
based versus supervised centre-based cardiac rehabilitation for
heart disease
Primary outcomes
Total mortality
Eleven trials (13 comparisons) reported total mortality up to one
year following the intervention (Aamot 2014 Treadmill; Aamot
2014Group; Bell 1998;Dalal 2007;Daskapan 2005;Hadadzadeh
2013; Jolly 2007; Kraal 2014; Miller 1984 Brief; Miller 1984
Expanded; Moholdt 2012; Oerkild 2011; Piotrowicz 2010). A
pooled analysis found no evidence of a significant difference in
mortality at three to 12 months of follow-up between home- and
centre-based cardiac rehabilitation (RR1.19, 95%CI0.65 to 2.16;
participants = 1505; studies = 11 (13 comparisons); I² = 0%; fixed-
effect; very low quality evidence; Analysis 1.1). Jolly 2007 reported
there to be no between-group difference inmortality at 24months
follow-up (home group: 6/263; centre group: 3/262, P = 0.32).
Subgroup analyses
Predictors of treatment effect on total mortality were examined
across the longest follow-up period of each individual study, using
univariate meta-regression. We found no evidence that mortality
risk is associated with case mix, type of cardiac rehabilitation,
duration of follow-up, year of publication, study location, study
location (continent) or sample size (Table 1). Due to lack of data,
we were unable to assess the impact of exercise dose.
Small study bias
Therewas no evidence of funnel plot asymmetry for totalmortality
(Egger test P = 0.304; Figure 4).
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Figure 4. Funnel plot of comparison: 1 home-base vs centre-based, outcome: 1.1 Total mortality.
Cardiac events
Only five studies (Arthur 2002; Dalal 2007; Jolly 2007; Oerkild
2011; Piotrowicz 2010) reported cardiac events, including re-
infarction, revascularisation (coronary artery bypass grafting
(CABG) and percutaneous coronary intervention (PCI)) or car-
diac-associated hospitalisation. While one study identified in this
latest update (Aamot 2014 Treadmill; Aamot 2014 Group) re-
ported that there were “no severe adverse events, defined as car-
diac arrests or acute MI”, none of the other new studies reported
the occurrence of cardiac events. Given the differing nature of the
events reported it was not possible to pool the data.
Dalal 2007 and Jolly 2007 reported no difference in revascularisa-
tion or recurrentmyocardial infarction (MI) events betweenhome-
and centre-based cardiac rehabilitation. Piotrowicz 2010 reported
no heart failure-related admissions in either group. Oerkild 2011
stated that “the number and length of acute and non-acute admis-
sions and adverse events (admission for MI, progressive angina,
decompensated congestive heart failure, severe bleeding, new ma-
lignant disease and performance of (percutaneous coronary inter-
vention)) to be equally distributed (across groups at 12 months
follow-up)” but did not report numbers of events. The six-year
follow-up report of the Arthur 2002 study described that a total
of 46/79 (62%) centre-based cardiac rehabilitation patients expe-
rienced a hospitalisation compared to 35/70 (50%) in the home-
based group (P = 0.31). However, the total number of hospitalisa-
tions in centre-based patients was greater than that in home-based
participants (79 versus 42, P < 0.0001).
Subgroup analyses
Due to the small number of studies reporting cardiac events, it was
not possible to examine the effects of potential treatment effect
modifiers on these outcomes.
Small study bias
Due to the small number of studies reporting cardiac events, it
was not possible to examine small study bias.
Exercise capacity
With the exception of Hadadzadeh 2013, all included studies
reported on exercise or functional capacity in the short-term (8
weeks to 12 months follow-up); three (Arthur 2002; Jolly 2007;
Marchionni 2003) presented longer-term data (> 12 months fol-
low-up) and one reported outcomes at six-year follow-up (Arthur
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2002). All studies reported absolute exercise capacity at follow-
up, except two trials (3 comparisons; Gordon 2002 Supervised;
Gordon 2002 Community; Oerkild 2011) which reported change
in exercise capacity at follow-up compared to baseline. Studies re-
ported exercise capacity using a variety of metrics that included
direct measures of oxygen uptake, walking distance and workload
on a static cycle.
The pooled analysis showed no evidence of a difference in short-
term exercise capacity between home-based and centre-based car-
diac rehabilitation (SMD -0.13, 95% CI -0.28 to 0.02; partici-
pants = 2255; studies = 22 (26 comparisons); I² = 63%; random-
effects; low quality evidence; Analysis 1.2).
In a pooled analysis of three studies reporting longer-term data (>
12months; Arthur 2002; Jolly 2007;Marchionni 2003), there was
no evidence of a difference in exercise capacity following home-
based cardiac rehabilitation compared with centre-based cardiac
rehabilitation (SMD 0.11, 95% CI -0.01 to 0.23; participants =
1074; studies = 3; I² = 0%; fixed effect; moderate quality evidence;
Analysis 1.3). Arthur 2002 reported that mean peak oxygen con-
sumption (VO ) at six-year follow-up was higher in the 96 par-
ticipants who had undergone home-based cardiac rehabilitation
(1543 mL/min (SD 444)) compared to the 74 participants who
had received centre-based cardiac rehabilitation (1412 mL/min
(SD 356); P = 0.01).
Subgroup analyses
Predictors of treatment effect on exercise capacity were examined
across the longest follow-up of each individual study, using uni-
variate meta-regression. We found no evidence that exercise ca-
pacity is associated with case mix, dose of exercise, type of cardiac
rehabilitation, duration of follow-up, year of publication, study
location, study location (continent) or sample size (Table 2).
Small study bias
There was no evidence of funnel plot asymmetry for exercise ca-
pacity (Egger test P = 0.661; Figure 5).
Figure 5. Funnel plot of comparison: 1 home-base vs centre-based, outcome: 1.2 Exercise capacity ≤ 12
months.
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Health-related quality of life (HRQoL)
Fourteen of the trials reported validated measures of HRQoL
(Table 3). These included four generic HRQoL instruments: EQ-
5D (EuroQoL 1990), Nottingham Health Profile (Hunt 1980),
Short-Form 36 (SF-36; McHorney 1993), Sickness Impact Pro-
file (Bergner 1976) and two disease-specific instruments (Mac-
New; Höfer 2004) and the Minnesota Living With Heart Failure
Questionnaire (MLWHF; Rector 1993). This wide variation in
HRQoL outcomes meant that pooling across studies was inappro-
priate.
Taking individual findings of all studies into account, there was
no strong evidence of a difference in overall HRQoL outcomes
or domain scores at follow-up between home- and centre-based
cardiac rehabilitation.
Individual studies reported consistent improvements in HRQoL
at follow-up with both home- and centre-based cardiac rehabil-
itation compared to baseline. The notable exception was in two
of the three studies which used the EQ-5D and failed to iden-
tify significant improvements with home- or centre-based cardiac
rehabilitation (Dalal 2007; Jolly 2007). The third study which
used the EQ-5D reported a significant improvement at six weeks
follow-up for home-based cardiac rehabilitation, but not for cen-
tre-based cardiac rehabilitation, and reported no improvements in
HRQoL at six months follow-up (Varnfield 2014).
Withdrawal from the intervention programme
Withdrawal from the interventionwas inconsistently reported and
the reasons were often unclear. Using the number of completers
i.e. the number of participants with outcome data at follow-up,
we found some limited evidence of a small increase in the level
of completion with home-based compared with centre-based pro-
grammes (RR 1.04, 95% CI 1.00 to 1.08; participants = 2615;
studies = 22 (26 comparisons); I² = 53%; random-effects; low
quality evidence; Analysis 1.4).
Subgroup analyses
Predictors of withdrawal were examined across the longest follow-
up period of each individual study using univariate meta-regres-
sion. We found no evidence that withdrawal risk is associated with
case mix, dose of exercise, type of cardiac rehabilitation, duration
of follow-up, year of publication, study location, study location
(continent), or sample size (Table 4).
Small study bias
There was no evidence of funnel plot asymmetry for withdrawal
(Egger test P = 0.440; Figure 6).
Figure 6. Funnel plot of comparison: 1 home-base vs centre-based, outcome: 1.4 Completers.
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Secondary outcomes
Modifiable coronary risk factors
Blood lipids
Nine of the included trials (10 comparisons) reported data on
blood lipids (Bell 1998; Carlson 2000; Dalal 2007; Gordon
2002 Community; Gordon 2002 Supervised; Jolly 2007; Kassaian
2000; Moholdt 2012; Oerkild 2011; Varnfield 2014). All re-
ported total cholesterol values, seven studies (8 comparisons) re-
ported high density lipoprotein concentrations (Carlson 2000;
Gordon 2002 Community; Gordon 2002 Supervised; Jolly 2007;
Kassaian 2000; Moholdt 2012; Oerkild 2011; Varnfield 2014),
and five studies (6 comparisons) reported low density lipopro-
tein and triglyceride concentrations (Carlson 2000; Gordon 2002
Community; Gordon 2002 Supervised; Kassaian 2000; Oerkild
2011; Varnfield 2014). All reported absolute follow-up data ex-
cept two studies (3 comparisons) where data were reported as the
change at follow up from baseline (Gordon 2002 Community;
Gordon 2002 Supervised; Oerkild 2011). Study results were ex-
pressed asmillimols per litre (mmol/L; Bell1998;Dalal 2007; Jolly
2007) or milligrams per decilitre (mg/dL; Carlson 2000; Gordon
2002 Community; Gordon 2002 Supervised; Kassaian 2000); in
the latter case we converted values into mmol/L before pooling for
meta-analysis.
Total cholesterol
The pooled analysis of data at three to 12 months of follow-up
revealed no evidence of a difference in the total cholesterol between
home- and centre-based groups (MD 0.06, 95% CI -0.10 to 0.23;
participants = 1151; studies = 9, comparisons = 10; I² = 57%;
random-effects; Analysis 1.5).
Jolly 2007 reported no significant difference between home- and
centre-based cardiac rehabilitation groups in total cholesterol con-
centration at 24 months follow up (MD = -0.11 mmol/L, 95%
CI 0.06 to -0.28).
Subgroup analyses
Predictors of total cholesterol were examined across the longest
follow-up period of each individual study using univariate meta-
regression.We found no evidence that the cardiac rehabilitation ef-
fect on cholesterol is associated with type of cardiac rehabilitation,
duration of follow-up, year of publication, study location, study
location (continent) or sample size (Table 5). However, we found
evidence of a relationship between case mix and total cholesterol,
with a greater reduction in total cholesterol reported in studies
with a higher proportion of participants with MI (Table 5). Due
to lack of data, we were unable to assess the impact of exercise
dose.
Small study bias
There was no evidence of funnel plot asymmetry for total choles-
terol (Egger test P = 0.913; Figure 7).
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Figure 7. Funnel plot of comparison: 1 home-base vs centre-based, outcome: 1.5 Total cholesterol 3 to 12
months.
High density lipoprotein (HDL) cholesterol
The pooled analysis of data at 3 to 12months of follow up revealed
some evidence of a lower high density lipoprotein concentration
after centre- compared to home-based cardiac rehabilitation (MD
-0.07, 95% CI -0.11 to -0.03; participants = 925; studies = 7;
comparisons = 8; I² = 35%; fixed-effects; Analysis 1.6).
Jolly 2007 reported no significant difference between home- and
centre-based cardiac rehabilitation groups in high density lipopro-
tein level at 24 months follow-up (MD = 0.03 mmol/L, 95% CI
-0.10 to 0.04).
Low density lipoprotein (LDL) cholesterol
In the pooled analysis of data at 3 to 12 months of follow up there
was no evidence of a difference in low density lipoprotein con-
centration between home- and centre-based cardiac rehabilitation
(MD 0.04, 95% CI -0.14 to 0.22; participants = 430; studies = 5
comparisons = 6; I² = 54%; random-effects; Analysis 1.7).
Triglycerides
In the pooled analysis of data at 3 to 12 months of follow up
there was evidence of slightly lower triglyceride levels in centre-
based cardiac rehabilitation participants (MD 0.15, 95% CI 0.00
to 0.29; participants = 396; studies = 5, comparisons = 6 ; I² =
39%; fixed-effect; Analysis 1.8).
Subgroup analyses
Due to the small number of studies reporting blood lipid levels,
it was not possible to examine the effects of potential treatment
effect modifiers on these outcomes.
Small study bias
Due to the small number of studies reporting blood lipid levels, it
was not possible to examine small study bias in these outcomes.
Blood pressure
Ten and nine of the included trials (12 and 11 comparisons)
reported on systolic and diastolic blood pressure respectively
(Aamot 2014 Treadmill; Aamot 2014 Group; Carlson 2000;Dalal
2007; Daskapan 2005; Gordon 2002 Community; Gordon 2002
Supervised; Jolly 2007; Kassaian 2000; Oerkild 2011; Varnfield
2014) or systolic blood pressure alone (Bell 1998). Absolute values
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at follow-up were reported in all but two studies (3 comparisons;
Gordon 2002 Supervised; Gordon 2002 Community; Oerkild
2011) where the change from baseline was reported. We obtained
unpublished data for the study by Dalal et al (Dalal 2007).
No evidence of a difference was found at follow-up between groups
in either pooled systolic blood pressure (MD -0.27, 95% CI -
3.13 to 2.60; participants = 1292; studies = 10, comparisons =
12; I² = 55%; random-effects; Analysis 1.9) or diastolic blood
pressure (MD 0.74, 95% CI -1.04 to 2.53; participants = 1146;
studies = 9, comparisons = 11; I² = 60%; random-effects; Analysis
1.10) following home- or centre-based cardiac rehabilitation. At
24 months follow up, Jolly 2007 reported no significant difference
between home- and centre-based cardiac rehabilitation groups in
systolic blood pressure (MD = -0.85 mm Hg; 95% CI 2.48 to -
4.18) or diastolic blood pressure (MD = -0.76 mm Hg, 95% CI
1.12 to -2.64).
Subgroup analyses
Predictors of blood pressure were examined across the longest fol-
low-up period of each individual study using univariate meta-re-
gression. No statistically significant associations were seen in any
of the analyses for systolic blood pressure with the exception of
study location (Table 6). No statistically significant associations
were seen in any of the analyses for diastolic blood pressure (Table
7).
Small study bias
There was no evidence of funnel plot asymmetry for systolic blood
pressure (Egger test P = 0.066; Figure 8) or diastolic blood pressure
(Egger test P = 0.318; Figure 8).
Figure 8. Funnel plot of comparison: 1 home-base vs centre-based, outcome: 1.9 Systolic blood pressure 3
to 12 months.
Smoking behaviour
Five studies (6 comparisons) reported on participants’ self-re-
ported smoking behaviour at three to 12 months of follow up
(Bell 1998; Dalal 2007; Gordon 2002 Community; Gordon 2002
Supervised; Jolly 2007; Oerkild 2011). There was no evidence in-
dicating a difference in the proportion of smokers at follow up be-
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tween home- and centre-based cardiac rehabilitation (RR 0.1.02,
95% CI 0.83 to 1.27; participants = 986; studies = 5, comparisons
= 6; I² = 0%; fixed-effect; Analysis 1.11). Jolly 2007 reported no
difference in smoking between home- and centre-based arms at
24 months (RR = 1.16, 95% CI 0.58 to 33.3).
There was evidence of a consistent reduction in self-reported
smoking behaviour following both home- and centre-based car-
diac rehabilitation. This finding was confirmed in the one study
that used cotinine-validated assessments of smoking (Jolly 2007).
Subgroup analyses
Due to the small number of studies reporting smoking, it was
not possible to examine the effects of potential treatment effect
modifiers on these outcomes.
Small study bias
Due to the small number of studies reporting smoking behaviour,
it was not possible to examine small study bias.
Adherence
All but six studies (Bell 1998; Daskapan 2005; Hadadzadeh 2013;
Hadadzadeh 2015; Kassaian 2000; Wu 2006) reported adherence
to cardiac rehabilitation over the duration of the study (Table 8).
There was substantial variation in the way in which adherence was
defined and measured, and some studies reported more than one
measure of adherence. Pooling across studies was therefore deemed
to be inappropriate. Eight studies (11 comparisons: Carlson 2000;
Cowie 2012; Dalal 2007; Gordon 2002 Community; Gordon
2002 Supervised; Grace 2016 Mixed; Grace 2016 Women; Jolly
2007; Karapolat 2009; Miller 1984 Brief; Miller 1984 Expanded)
found no evidence of a significant difference in the level of ad-
herence between groups, although there was evidence of supe-
rior adherence in home-based cardiac rehabilitation in five studies
(Arthur 2002; Kraal 2014; Marchionni 2003; Piotrowicz 2010;
Varnfield 2014) and evidence of superior adherence in centre-
based cardiac rehabilitation in one study (Aamot 2014 Treadmill).
Three other studies reported adherence (Daskapan 2005;Moholdt
2012; Sparks 1993) but it was not possible to assess if there was a
statistically significant difference between home- and centre-based
cardiac rehabilitation.
Costs and health service use
Six studies reported costs (Carlson 2000; Cowie 2012;Dalal 2007;
Jolly 2007; Marchionni 2003; Varnfield 2014; Table 9). Differ-
ences in currencies and timing of studies meant that it was not
possible compare the costs directly across studies. In four of the
five studies, healthcare costs associated with cardiac rehabilitation
were lower for the home-based than centre-based programmes
(Carlson 2000; Dalal 2007; Marchionni 2003; Varnfield 2014),
although cost was significantly lower in only one study (Dalal
2007). Jolly 2007 found that home-based cardiac rehabilitation
was more expensive than centre-based cardiac rehabilitation, al-
though the costs of the two would have been the same if partici-
pant costs were included. One study (Cowie 2012) included the
costs of a no cardiac rehabilitation control and showed that cardiac
rehabilitation costs were offset by a reduction in hospital admis-
sions over five years resulting in a substantive cost saving when
compared with control, i.e. GBP -3304 per participant for home-
based cardiac rehabilitation and GBP -3784 per participant for
hospital-based cardiac rehabilitation. Eight studies reported dif-
ferent aspects of consumption of healthcare resources, including
re-admissions to hospital, primary care consultations and use of
secondary care medication (Table 10; Table 11). No significant
between-group differences were seen.
D I S C U S S I O N
Summary of main results
The mainstay approach to cardiac rehabilitation delivery in many
countries is an inpatient and outpatient hospital-based provision,
which often takes place in a supervised university, hospital or com-
munity setting. The availability of home-based programmes may
provide an opportunity to widen access and increase participa-
tion in cardiac rehabilitation and, may therefore, improve uptake
and adherence. Figures from the UK suggest that the dominant
mode of delivery in the UK is group-based, with just 10% cardiac
rehabilitation programmes currently offering home-based cardiac
rehabilitation provision (NACR 2016).
This updated review included 23 trials which randomised 2890
participants following an acute myocardial infarction (MI) or
revascularisation, or with heart failure, to either home- or centre-
based cardiac rehabilitation. The model of home-based provision
in the largest three included trials was the Heart Manual 2016
(Bell 1998; Dalal 2007; Jolly 2007), a cardiac rehabilitation pro-
gramme that consists of a self-help manual supported by a nurse
facilitator (Lewin 1992). We found no evidence supporting im-
portant differences in outcomes for patients receiving home-based
or centre-based cardiac rehabilitation either in the short-term (3 to
12 months) or longer-term (up to 24 months) for mortality, car-
diac events, exercise capacity, modifiable risk factors (total choles-
terol; low density lipoprotein cholesterol; systolic blood pressure;
diastolic blood pressure; proportion of smokers at follow up) or
health-related quality of life. Small outcome differences in favour
of centre-based participants were seen in high density lipoprotein
cholesterol and triglycerides. In contrast, in home-based partici-
pants, there was evidence ofmarginally higher levels of programme
completion and adherence to the programme. Healthcare costs
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seem to depend on the healthcare economy in which cardiac reha-
bilitation provision is made. However, this review found no con-
sistent evidence to support an important difference in the cost of
providing home- versus centre-based programmes. Home-based
programmes often require support from healthcare staff which can
be the major cost driver.
Overall completeness and applicability of
evidence
The inclusion criteria for this review are broad, in order to reflect
current practice where an increasingly diverse patient population
is accessing cardiac rehabilitation services (NACR 2016). While
the original version of this review was primarily limited to trials
in participants with stable coronary heart disease (CHD) either
following an acute myocardial infarction (MI) or revascularisation
(Taylor 2009), the 2015 update included an additional five trials,
which included 345 participants with heart failure (Taylor 2015).
However, while this latest update added a further six trials inmixed
populations of participants withCHD, none included people with
heart failure. Similarly, only 19%of all participants included in this
review were women and most participants were from studies that
took place in high-income nations (Europe and North America).
It is therefore not clear whether or not our findings generalise to
women, or to the wider population in general. However, while
ethnicity was poorly reported bymost studies, this review included
several studies with a substantive proportion of ethnic groups, and
in studies that reported ethnicity, fewer than 50% of participants
were described as Caucasian. The applicability of our findings to
low- and middle-income countries is uncertain.
Interventions varied substantially in content, mode of delivery,
level of support or supervision and dose. It could be argued that
a benefit of this heterogeneity is that the results are more likely to
be applicable to the wider population of people with CHD and
clinical practice. However, we must also acknowledge this hetero-
geneity when interpreting the effect of these interventions on out-
comes. This review also included studies which followed partici-
pants for as little as eight weeks post-randomisation, which limits
the clinical relevance of the findings. Similarly, fidelity (whether
the intervention was delivered as intended) and dose (the quantity
of intervention implemented) are important aspects of the deliv-
ery of a complex intervention, such as cardiac rehabilitation, and
were generally poorly reported by studies included in this review.
Quality of the evidence
The general lack of reporting of methods in the included ran-
domised controlled trial (RCT) reports made it difficult to as-
sess their methodological quality and thereby judge their risk of
bias, although there was some evidence of an improvement in the
quality of reporting in more recent trials. It was also not possi-
ble to consistently judge whether the rehabilitation programmes
included in the studies fulfilled recommended quality criteria for
delivery of cardiac rehabilitation programmes, such as the BACPR
guidelines (BACPR 2012).
Due to this poor reporting, the quality of the evidence for out-
comes was assessed as moderate at best. Other reasons for down-
grading the quality of evidence included inconsistency (exercise
capacity ≤ 12 months and withdrawal) and imprecision (mortal-
ity).
Potential biases in the review process
Our review has limitations. Given the inconsistent reporting of
outcomes, we were unable to judge the degree of publication bias
for all outcomes, although there was no evidence of funnel plot
asymmetry or statistically significant Egger tests for any outcome
where thiswas tested (totalmortality, exercise capacity, withdrawal,
total cholesterol or blood pressure).
Although most participants represented in this review who re-
ceived home-based cardiac rehabilitation were exposed to the
HeartManual model, there was evidence of considerable statistical
heterogeneity across a number of outcomes among trials. This het-
erogeneitymaywell reflect the variety of centre-based cardiac reha-
bilitation interventions. Most studies were of relatively short dura-
tion, with only three trials reporting outcomes beyond 12 months
of follow-up (Arthur 2002; Jolly 2007; Marchionni 2003). The
number of deaths and cardiac events reported by most trials was
therefore correspondingly small. Details of interventions were of-
ten poorly reported and it was therefore difficult to assess whether
the cardiac rehabilitation programmes used would meet current
recommendations of good practice (BACPR 2012; Piepoli 2010).
It has been hypothesised that patient preference may have an im-
pact on uptake and adherence to home-based cardiac rehabilita-
tion and there is evidence that white patients who work full- or
part-time and who perceive time constraints as a barrier to adher-
ence are more likely to have a preference for home-based provision
(Grace 2005). However, such a hypothesis is difficult to test in a
traditional RCT and therefore our finding of similar adherence
between home- and centre-based cardiac rehabilitation needs to be
interpreted with caution. Dalal 2007 employed a comprehensive
cohort design in addition to the randomised element of home-
and centre-based allocation in which there was also a patient pref-
erence element (participants could choose between home- and
hospital-based cardiac rehabilitation). The study authors reported
that outcome differences between the home and hospital arms in
the preference (non-randomised) sample were very similar to those
in the randomised comparison. Adherence to home-based cardiac
rehabilitationwas also comparable between the randomised (75%)
and preference arms (73%). This finding does not support the
hypothesis that patients who can choose a programme to suit their
lifestyle and preferences will have a higher adherence rate and im-
proved outcomes. However, as with the randomised comparison,
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the number of participants in the preference arms was small (N =
126).
Agreements and disagreements with other
studies or reviews
The findings of this update are consistent with the previous ver-
sions of this Cochrane Review (Taylor 2009; Taylor 2015) and
another systematic review which reported that home-based car-
diac rehabilitation programmes are as effective as centre-based pro-
grammes in terms of mortality, morbidity, short-term exercise ca-
pacity, blood pressure, smoking cessation and health-related qual-
ity of life (HRQoL) (Crawford-Faucher 2010).
Our findings are also consistent with a recent systematic review
which compared the effectiveness of “telehealth intervention-de-
livered cardiac rehabilitation” with centre-based supervised car-
diac rehabilitation (Huang 2015) in nine trials, eight of which are
included in this current review. The authors of the review con-
cluded that telehealth intervention-delivered cardiac rehabilitation
does not have significantly inferior outcomes compared to cen-
tre-based supervised programmes in low-to-moderate risk patients
with CHD (Huang 2015). Similarly, another review which narra-
tively synthesised 11 studies comparing “telerehabilitation” with
other delivery models of cardiac rehabilitation in patients with
cardiopulmonary diseases (Hwang 2015) found no differences be-
tween telerehabilitation and other delivery models, in terms of ex-
ercise capacity, quality of life or adverse events, while higher ad-
herence rates were found for patients participating in the telere-
habilitation programmes compared with centre-based exercise.
Finally, our results also concur with a recent systematic review
which assessed the effectiveness of home-based cardiac rehabilita-
tion for heart failure compared to either usual medical care (i.e.
no cardiac rehabilitation) or centre-based cardiac rehabilitation on
mortality, morbidity, exercise capacity, HRQoL, adherence and
costs (Zwisler 2016). This review found that outcomes and costs
were similar between home- and centre-based cardiac rehabilita-
tion with the exception of higher levels of trial completion in the
home-based group.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Home-based and hospital- or centre-based cardiac rehabilitation
seem to be of similar effectiveness in improving clinical and health-
related quality of life (HRQoL) outcomes in patients after acute
myocardial infarction (MI), revascularisation or with heart failure.
This finding, together with a lack of evidence of differences in
healthcare costs between the approaches, supports that the choice
of participating in a more traditional supervised centre- or home-
based programme should reflect local availability and consider the
preference of the individual patient.
Implications for research
Data are needed to determine whether the effects of home- and
centre-based cardiac rehabilitation reported in short-term trials
can be confirmed in the longer term. Further comparative trials
are needed to assess the relative impact of supervised centre- ver-
sus home-based cardiac rehabilitation in patients with heart fail-
ure and angina pectoris and need to consider adequately powered
non-inferiority or equivalence study designs. Such studies need to
consider economic factors, better methods of assessing and report-
ing adherence and patient-related outcomes including costs to the
healthcare system and HRQoL.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Aamot 2014 Group
Methods Study design: Multicentre RCT with 3 parallel groups
Number of centres: 2
Country: Norway
Dates patients recruited: October 2009 to April 2011
When randomised: After the baseline tests
Maximum follow up: 12 weeks
Participants Inclusion criteria: Aged over 18 years, diagnosed MI, CABG surgery, or acute coronary
syndrome (ACS), and able to perform a maximal treadmill test
Exclusion criteria:Heart failure, severe arrhythmias, drug abuse, or a medical condition
contraindicative to high-intensity training
N randomised: total: 90; home-based cardiac rehabilitation: 28; centre-based cardiac
rehabilitation (treadmill exercise): 34; centre-based cardiac rehabilitation (group exercise)
: 28
Method of assessment: NR
Diagnosis (% of pts):
Previous AMI: home-based cardiac rehabilitation: 71.4%; treadmill exercise: 67.6%
group exercise: 64.3%
Previous CABG: home-based cardiac rehabilitation: 21.4%; treadmill exercise: 26.5%;
group exercise: 25.0%
ACS: home-based cardiac rehabilitation: 7.2%; treadmill exercise: 5.9% group exercise:
10.7%
Age (mean ± SD): total: NR; home-based cardiac rehabilitation: 58 ± 8 years; treadmill
exercise: 56 ± 9 years; group exercise: 58 ± 8 years
Percentage male: total: 88.9%; home-based cardiac rehabilitation: 96.4%; treadmill
exercise: 82.4%; group exercise: 89.3%
Ethnicity: NR
Interventions All participants in all groups performed HIT twice a week for 12 weeks
Every session started with a 10 minute warm up at low-to-moderate intensity (50% to
70% of peak heart rate, HR) and continued with four intervals lasting 4 minutes each,
at an exercise intensity of 85% to 95% of peak HR. Each interval was separated by 4
minutes of active breaks at an intensity of 70% of peak HR. After the last interval, a cool
down period of 3 to 5 minutes was performed at 50% of peak HR. All participants were
individually instructed in use of theHRmonitor, and how to reach targetHR. As aerobic
capacity increased, the participants increased work load to maintain relative exercise
intensity. Completion of 70% of the exercise sessions was considered to be training per
protocol
Description of intervention (home-based cardiac rehabilitation): The home-based
exercise started with two initial sessions with personal instruction of a physiotherapist
where they learned how to performHIT and to use theHRmonitors. These sessionswere
performed as up-hill walking or jogging. After the introduction, HIT was performed in
preferred exercisemode in their home environment; up-hill walking, cross country skiing,
bicycling, running, or using indoor equipment such as treadmills or cross trainers. All
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Aamot 2014 Group (Continued)
participants varied their exercise mode, but they kept to the exercise design and relative
exercise intensity. A Holter electrocardiogram was recorded during the first exercise
session to ensure that no arrhythmia occurred during or immediately after exercise
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: HIT was performed in preferred exercise mode e.g. up-hill walking, cross
country skiing, bicycling, running, or using indoor equipment such as treadmills or cross
trainers
Dose:
Length of session: 45 mins
Frequency/no of sessions: twice a week
Intensity: 50% to 95% of peak HR
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: None described
Description of comparator (centre-based cardiac rehabilitation):
Treadmill exercise: The treadmills were used at the hospitals, in smaller groups consisting
of 3-7 patients. Work load was adjusted individually, either by fast walking with inclina-
tion or running with less inclination. A physiotherapist was present to provide monitors
and to assist if necessary
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: Treadmills
Dose:
Length of session: 45 mins
Frequency/no of sessions: twice a week
Intensity: 50% to 95% of peak HR
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: None described
Group exercise:
The group exercise sessions were held at the hospitals in groups of 10 to 15 people,
instructed by a physiotherapist. After a warm up consisting of aerobics, the HIT was
organised as circuit training and the intervals performed with a variety of exercises, from
running to cycling, squats, and steps. Active breaks could consist of strength exercises
(push ups, sit ups) or walking
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: Circuit training
Dose:
Length of session: 45 mins
Frequency/no of sessions: twice a week
Intensity: 50% to 95% of peak HR
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Aamot 2014 Group (Continued)
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: None described
Outcomes Peak VO , HRQoL
Follow up 12 weeks
Source of funding This work was supported by the Liaison Committee between the Central Norway Re-
gional Health Authority and the Norwegian University of Science and Technology
(NTNU)
Conflicts of interest The authors declare that there is no conflict of interest
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was performed after the
baseline tests, by a web-based randomiza-
tion system.”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “The test personnel were not blinded for
allocation.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Home-based cardiac rehabilitation: 2/28
(7.1 %) lost to follow-up
Treadmill: 2/34 (5.9 %) lost to follow-up
Group exercise: 3/28 (10.7 %) lost to fol-
low-up
Selective reporting (reporting bias) Low risk All outcomes described in the methods are
reported in results section
Groups balanced at baseline? Low risk “Group differences were not significant”
Groups received same co-intervention(s)? Low risk No co-interventions were received by any
group
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Aamot 2014 Treadmill
Methods Study design: Multicentre RCT with 3 parallel groups
No of centres: 2
Country: Norway
Dates patients recruited: October 2009 to April 2011
When randomised: After the baseline tests
Maximum follow up: 12 weeks
Participants Inclusion criteria: Aged over 18 years, diagnosed MI, CABG surgery, or acute coronary
syndrome (ACS), and able to perform a maximal treadmill test
Exclusion criteria:Heart failure, severe arrhythmias, drug abuse, or a medical condition
contraindicative to high-intensity training
N randomised: total: 90; home-based cardiac rehabilitation: 28; centre-based cardiac
rehabilitation (treadmill exercise): 34; centre-based cardiac rehabilitation (group exercise)
: 28
Method of assessment: NR
Diagnosis (% of pts):
Previous AMI: home-based cardiac rehabilitation: 71.4%; treadmill exercise: 67.6%
group exercise: 64.3%
Previous CABG: home-based cardiac rehabilitation: 21.4%; treadmill exercise: 26.5%;
group exercise: 25.0%
ACS: home-based cardiac rehabilitation: 7.2%; treadmill exercise: 5.9% group exercise:
10.7%
Age (mean ± SD): total: NR; home-based cardiac rehabilitation: 58 ± 8 years; treadmill
exercise: 56 ± 9 years; group exercise: 58 ± 8 years
Percentage male: total: 88.9%; home-based cardiac rehabilitation: 96.4%; treadmill
exercise: 82.4%; group exercise: 89.3%
Ethnicity: NR
Interventions All participants in all groups performed HIT twice a week for 12 weeks
Every session started with a 10-minute warm up at low-to-moderate intensity (50% to
70% of peak heart rate, HR) and continued with four intervals lasting 4 minutes each,
at an exercise intensity of 85% to 95% of peak HR. Each interval was separated by 4
minutes of active breaks at an intensity of 70% of peak HR. After the last interval, a cool
down period of 3-5 minutes was performed at 50% of peak HR. All participants were
individually instructed in use of theHRmonitor, and how to reach targetHR. As aerobic
capacity increased, the participants increased work load to maintain relative exercise
intensity. Completion of 70% of the exercise sessions was considered to be training per
protocol
Description of intervention (home-based cardiac rehabilitation): The home-based
exercise started with two initial sessions with personal instruction of a physiotherapist
where they learned how to performHIT and to use theHRmonitors. These sessionswere
performed as up-hill walking or jogging. After the introduction, HIT was performed in
preferred exercisemode in their home environment; up-hill walking, cross country skiing,
bicycling, running, or using indoor equipment such as treadmills or cross trainers. All
participants varied their exercise mode, but they kept to the exercise design and relative
exercise intensity. A Holter electrocardiogram was recorded during the first exercise
session to ensure that no arrhythmia occurred during or immediately after exercise
Time of start after event: NR
Components: Exercise only
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Aamot 2014 Treadmill (Continued)
Aerobic exercise:
Modality: HIT was performed in preferred exercise mode e.g. up-hill walking, cross
country skiing, bicycling, running, or using indoor equipment such as treadmills or cross
trainers
Dose:
Length of session: 45 mins
Frequency/no of sessions: twice a week
Intensity: 50% to 95% of peak HR
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: None described
Description of comparator (centre-based cardiac rehabilitation):
Treadmill exercise:The treadmillswere used at the hospitals, in smaller groups consisting
of 3 to 7 patients. Work load was adjusted individually, either by fast walking with
inclination or running with less inclination. A physiotherapist was present to provide
monitors and to assist if necessary
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: Treadmills
Dose:
Length of session: 45 mins
Frequency/no of sessions: twice a week
Intensity: 50% to 95% of peak HR
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: None described
Group exercise: The group exercise sessions were held at the hospitals in groups of 10
to 15 people, instructed by a physiotherapist. After a warm up consisting of aerobics,
the HIT was organised as circuit training and the intervals performed with a variety
of exercises, from running to cycling, squats, and steps. Active breaks could consist of
strength exercises (push ups, sit ups) or walking
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: Circuit training
Dose:
Length of session: 45 mins
Frequency/no of sessions: twice a week
Intensity: 50% to 95% of peak HR
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: None described
Outcomes Peak VO , HRQoL
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Aamot 2014 Treadmill (Continued)
Follow up 12 weeks
Source of funding This work was supported by the Liaison Committee between the Central Norway Re-
gional Health Authority and the Norwegian University of Science and Technology
(NTNU)
Conflicts of interest The authors declare that there is no conflict of interest
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was performed after the
baseline tests, by a web-based randomiza-
tion system.”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “The test personnel were not blinded for
allocation.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Home-based cardiac rehabilitation: 2/28
(7.1 %) lost to follow-up
Treadmill: 2/34 (5.9 %) lost to follow-up
Group exercise: 3/28 (10.7 %) lost to fol-
low-up
Selective reporting (reporting bias) Low risk All outcomes described in the methods are
reported in results section
Groups balanced at baseline? Low risk “Group differences were not significant”
Groups received same co-intervention(s)? Low risk No co-interventions were received by any
group
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Arthur 2002
Methods Study design: Single centre RCT
No of centres: 1
Country: Canada
Dates patients recruited: July 1997 to October 1998
When randomised: 35 to 49 day post-CABG surgery, after baseline assessment
Maximum follow up: 6 years
Participants Inclusion criteria: 35 to 49 days post-CABG, able to achieve 40 to 80% of age/sex-
predicted METs on cycle ergometry, read/write English
Exclusion criteria: Recurrent angina, positive graded exercise test, unable to attend
rehabilitation 3 times weekly, physical limitations, previously participant of out-patient
cardiac rehabilitation
N randomised: total: 242; home-based cardiac rehabilitation: 120; centre-based cardiac
rehabilitation: 122
Method of assessment: NR
Diagnosis (% of pts):
Previous CABG: 100%
Age (mean ± SD): total: 63.3 ± 13 years
Percentage male: total: 81%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:Patients also attended 1 hour exercise
consultation with exercise specialist at baseline and after 3 months training, completed
exercises log reviewed every 2 months, and telephone support call every 2 weeks
Time of start after event: 35 to 49 day post-CABG surgery
Components: Exercise, education. psychosocial
Aerobic exercise:
Modality: walking
Dose:
Length of session: 40 min/session
Frequency/no of sessions: 5 sessions weekly
Intensity: 60% to 70% VO max
Total duration: 6 months
Intermittent nurse or exercise specialist telephone support?Home patients were tele-
phoned every 2 weeks by the exercise specialist to monitor progress, assess and docu-
ment adherence, revise the exercise prescription if necessary, and provide support and
education. Exercise logs were reviewed monthly
Co-interventions: Dietary advice and psychological support
Description of centre-based cardiac rehabilitation:
Supervised by exercise specialist and completed exercises log reviewed every month
Time of start after event: 35 to 49 day post-CABG surgery
Components:Exercise. education. psychosocial
Aerobic exercise:
Modality: cycle ergometer, treadmill, track walking, and stair climbing
Dose:
Length of session: 40 min/session
Frequency/no of sessions: 3 sessions weekly
Intensity: 60% to 70% VO max
Total duration: 6 months
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Arthur 2002 (Continued)
Co-interventions: Dietary advice and psychological support
Outcomes Primary: exercise capacity (METs)
Secondary: HRQoL (SF-36); cardiac morbidity, mortality
Follow up 6 and 18 months and 6 years post randomisation
Source of funding Heart and Stroke Foundation of Ontario (grant no. T 4004)
Conflicts of interest NR
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Low risk “...the data analyst, who had no role in this
project, prepared the randomization sched-
ule using a blocked format”; “...the result-
ing group assignments were than sealed in
opaque envelopes that were opened in se-
quence after consent”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “...the physicians who evaluated the pri-
mary variables were blind to the patients
assignment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk CONSORTflowdiagram shows loss to fol-
low up 20/242 (8%) at 6months follow up
and 24/242 (10%) at 18months follow up.
No imputation of missing data undertaken
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? High risk “There were statistically significant differ-
ences at baseline between the two groups in
weight, resting heart rate, and social sup-
port.”
Groups received same co-intervention(s)? Low risk “Similar numbers of patients in the [hospi-
tal and home] groups chose to consult with
either clinic dietician or psychologist.”
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Bell 1998
Methods Study design: Multicentre RCT
No of centres: 5 district hospitals
Country: UK
Dates patients recruited: NR
When randomised: NR
Maximum follow up: 52 weeks
Participants Inclusion criteria: Acute MI (2 of: elevated serum creatinine kinase or oxaloacetic
transaminase, prolonged chest pain consistent with AMI, new Q waves or evolutionary
ST changes in ECG)
Exclusion criteria: Physical infirmity, unable to speak or read English, dementia or
psychosis, aged > 75 years, living > 20 miles from CCU, serious persisting medical
complications, any other excluding conditions (consultants opinion), for some hospitals
- participation in the previous rehabilitation programme
N randomised: total: 252; home-based cardiac rehabilitation: 152; centre-based cardiac
rehabilitation: 100
Method of assessment: NR
Diagnosis (% of pts):
AMI: 100%
Age (mean ± SD): total: 59 ± 8.9 years
Percentage male: total: 77%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: Heart Manual
Time of start after event: NR
Components: Exercise, education and psychological
Aerobic exercise:
Modality: Walking
Dose:
Length of session: NR
Frequency/no of sessions: NR
Intensity: NR
Total duration: 6 weeks
Intermittent nurse or exercise specialist telephone support? 4 phone calls by facilita-
tor, health education, stress management
Co-interventions: NR
Description of centre-based cardiac rehabilitation:
Time of start after event: NR
Components: Exercise, education and psychological
Aerobic exercise:
Modality: Walking
Dose:
Length of session: ≥ 20 min
Frequency/no of sessions: 1 session/week or 4 weeks of 2 sessions/week
Intensity: 3 to 4 on Borg RPE scale
Total duration: 12 weeks
Co-interventions: Education sessions - CHD causes, medication, risk factor modifica-
tion, stress management, and exercise
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Bell 1998 (Continued)
Outcomes Primary: exercise capacity (METs)
Secondary: total cholesterol; systolic blood pressure; HRQoL (Nottingham Health Pro-
file); smoking; mortality; readmission rate; use of primary care services
Follow up 16 and 48 weeks post randomisation (20 and 52 weeks post MI)
Source of funding NR
Conflicts of interest NR
Notes Published as PhD thesis only
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Low risk “Series of sealed envelopes containing
cards evenly distributed between condi-
tions …envelopes were taken sequentially
…opened envelopes were retained and re-
turned to trial coordinator”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All measurements were performed ’blind’
by members of the medical staff and tech-
nicians”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Follow up data on all randomised patients
is not reported, no CONSORT flow dia-
gram is reported and it is difficult to deter-
mine from the report those who were lost
to follow up or who dropped out
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk There were no statistically significant dif-
ferences in population demographics be-
tween the two groups
Groups received same co-intervention(s)? High risk Although the intervention for both groups
consisted of exercise, education, and stress
management, the nature and amount of in-
tervention was quite different
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Carlson 2000
Methods Study design: Single centre RCT
No of centres: 1
Country: USA, single hospital centre
Dates patients recruited: NR
When randomised: within 2 weeks of entering cardiac rehabilitation
Maximum follow up: 6 months
Participants Inclusion criteria: Men and women aged 35 to 75 years referred for the first time to
outpatient cardiac rehabilitation, living ≤ 30 miles from the rehabilitation facility, of
low-to-moderate cardiac risk
Exclusion criteria: NR
N Randomised: total: 80; home-based cardiac rehabilitation: 38; centre-based cardiac
rehabilitation: 42
Method of assessment: NR
Diagnosis (% of pts):
MI: home-based cardiac rehabilitation: 47%; centre-based cardiac rehabilitation: 26%
Angioplasty: home-based cardiac rehabilitation: 55%; centre-based cardiac rehabilita-
tion: 40%
CABG: home-based cardiac rehabilitation: 32%; centre-based cardiac rehabilitation:
40%
Age (mean ± SD): total: NR; home-based cardiac rehabilitation: 59 ± 10 years; centre-
based: 59 ± 9 years
Percentage male: total: NR; home-based cardiac rehabilitation: 82%; centre-based car-
diac rehabilitation: 83%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: First 4 weeks - 3 hospital based
exercise sessions/weekwith ECGmonitoring, progressively reducing frequency of centre-
based sessions
Time of start after event: NR
Components: Exercise, education, psychosocial
Aerobic exercise:
Modality: NR
Dose:
Length of session: 30 to 40 min/session
Frequency/no of sessions: 2 to 5 sessions/week
Intensity: 60 to 85% aerobic capacity
Total duration: 25 weeks
Co-interventions: Weekly educational and counselling meetings that included sessions
on exercise, diet, risk factors, drugs, and overcoming barriers to behaviour change. Based
on Bandura’s self-efficacy theory
Description of centre-based cardiac rehabilitation:
Centre-based cardiac rehabilitation(control):
Exercise: modality: aerobic exercise
Time of start after event: NR
Components: e.g. exercise only, exercise and education, exercise and psychosocial
Aerobic exercise:
Modality: NR
Dose:
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Length of session: 30 to 45 min/session
Frequency/no of sessions: 2 to 3 sessions/week
Intensity: 60 to 85% aerobic capacity
Resistance training included?
Total duration: 25 weeks
Co-interventions: Three sessions of education and counselling that included sessions
on exercise, diet, risk factors, and drugs
Outcomes Primary: peak functional capacity (METs), LDL cholesterol
Secondary: total cholesterol, HDL cholesterol, triglycerides, blood pressure, cardiovas-
cular medications, costs, adherence (exercise sessions attended)
Follow up 6 months post randomisation
Source of funding NR
Conflicts of interest NR
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk ”...it was not possible to blind the clinicians
to the protocol patients were assigned“.
Outcome blinding not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk ”...significantly more [centre-based CR]
participants dropped out“, ”Because more
[centre-based CR] participants dropped
out and failed to return for their 6-month
[exercise test] evaluation, this evaluation is a
representation of more compliant patients”
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk “…only significant difference between
groups was a higher resting systolic blood
pressure in [centre-based CR] …selected
demographic and psychological measures
including socioeconomic status and social
support were comparable between the 2
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groups at baseline”
Groups received same co-intervention(s)? High risk “The primary differences in the [home-
based CR] compared with the [centre-
based CR] included: …(2) an ongoing
weekly education/support group, and (3)
education and counselling that emphasized
overcoming barriers associated with devel-
oping independent exercise and nutrition
behaviours”
Although both groups received exercise
training, education, and counselling, the
amount and nature of this intervention was
different between groups
Cowie 2012
Methods Study design: Single centre RCT
No of centres: 1
Country: UK
Dates patients recruited: May 2007 and August 2008
When randomised: After baseline tests
Maximum follow up: 8 weeks
Participants Inclusion criteria: (1) left ventricular systolic dysfunction on echocardiography, (2)
clinically stable for at least one month, and (3) on optimised medication dosages
Exclusion criteria: (1) significant ischaemic symptoms at low workloads, (2) uncon-
trollable diabetes, (3) acute systematic illness or fever, (4) recent embolism, (5) acute
pericarditis, (6) moderate to severe aortic stenosis, (7) regurgitant valvular heart disease
requiring surgery, (8) myocardial infarction within the past three weeks, (9) new onset of
atrial fibrillation, (10) signs and symptoms of decompensation, (11) other comorbidities
(life-threatening, uncontrolled, infectious, or exacerbated by exercise)
N randomised: total: 60; home-based cardiac rehabilitation: 20; centre-based cardiac
rehabilitation: 20; control: 20 (usual care - no cardiac rehabilitation - not considered in
this review)
Method of assessment: Echocardiography
Diagnosis (% of pts):
NYHA class II/III post-H: F100%
Age (range): total: 66 (35-85) years; home-based cardiac rehabilitation: 65.5 (35 to 82)
years; centre-based cardiac rehabilitation: 71.2 (59 to 85) years; control: 61.4 (39 to 79)
years
Percentage male: total: 85%; home-based cardiac rehabilitation: 90%; centre-based
cardiac rehabilitation: 80%; control: 85%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: Exercise: 1-hour aerobic-based ex-
ercise session (DVD and booklet), started with a 15-minute warm-up, and ended with a
15-minute cool-down. Aerobic overload: 2 x 15 minute circuits (10 simple, functional
aerobic exercises e.g. knee lifts, side steps); interspersed with low-paced ‘active recovery’
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Cowie 2012 (Continued)
(toe tapping or slow walking; 90 seconds for each exercise). Gradually increasing the
proportion of time spent on aerobic overload in relation to active recovery provided
interval training, which was individually tailored and progressed
Time of start after event: NR
Components: Exercise and education
Aerobic exercise:
Modality: Functional aerobic exercises e.g. knee lifts, side steps interspersed with low-
paced ‘active recovery’ (toe tapping or slow walking)
Dose:
Length of session: 1 hour
Frequency/no of sessions: twice a week
Intensity: NR
Total duration: eight weeks
Intermittent nurse or exercise specialist telephone support? Physiotherapist tele-
phoned every two weeks to modify exercise prescriptions where appropriate
Co-interventions: Educated on symptoms of unstable heart failure. Use of heart rate
monitors to guide training intensity. Encouraged to work at 12 to 13 on the Borg RPE.
Advised to adhere to usual heart failure nursing care and daily routines
Description of centre-based cardiac rehabilitation: As above i.e. 1-hour aerobic-based
exercise session (physiotherapist-led) started with a 15-minute warm-up, and ended with
15-minute cool-down. Aerobic overload: 2 x 15 minute circuits (10 simple, functional
aerobic exercises e.g. knee lifts, side steps); interspersed with low-paced ‘active recovery’
(toe tapping or slow walking; 90 seconds for each exercise). Gradually increasing the
proportion of time spent on aerobic overload in relation to active recovery provided
interval training, which was individually tailored and progressed
Components: Exercise and education
Aerobic exercise:
Modality: Functional aerobic exercises e.g. knee lifts, side steps interspersed with low-
paced ‘active recovery’ (toe tapping or slow walking)
Dose:
Length of session: 1 hour
Frequency/no of sessions: twice a week
Intensity: NR
Total duration: eight weeks
Co-interventions: Educated on symptoms of unstable heart failure. Use of heart rate
monitors to guide training intensity. Encouraged to work at 12 to 13 on the Borg RPE.
Advised to adhere to usual heart failure nursing care and daily routines
Outcomes Exercise capacity (shuttle walk test), health-related quality of life (SF-36 and Minnesota
Living With Heart Failure)
Follow up 8 weeks
Source of funding This work was supported by NHS Ayrshire and Arran’s coronary heart disease Managed
Clinical Network
Conflicts of interest Professor Malcolm Granat is a co-inventor of the activPALTM and a director of PAL
Technologies Ltd.,Glasgow,UK. ProfessorGranat hadno involvement in data collection,
or analysis of results. No other conflicts of interest declared
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Cowie 2012 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Low risk “...participants were randomised (using
concealed envelopes) to one of three
groups”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “...measurements obtained by researcher
blind to participants”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 5/20 (25%) centre-based and 5/20 (25%)
dropped out
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? High risk “...the mean age of the hospital group was
10 years older than the control group (P =
0.001)”
Groups received same co-intervention(s)? Low risk “[both groups were] ...advised to adhere to
usual heart failure nursing care and daily
routines”
Dalal 2007
Methods Study design: Single centre RCT
No of centres: 1
Country: UK
Dates patients recruited: December 2000 to September 2003
When randomised: Following consent
Maximum follow up: 9 months
Participants Inclusion criteria: Confirmed acute myocardial infarction (WHO criteria), ability to
read English, registered with family doctor in one of two primary care trusts
Exclusion criteria: Severe heart failure, unstable angina, uncontrolled arrhythmia, his-
tory of major psychiatric illness, other significant comorbidity precluding the ability to
exercise on the treadmill, patients re-admitted with acute myocardial infarction who had
already received an intervention earlier in the study
N randomised: total: 104; home-based cardiac rehabilitation: 60; centre-based cardiac
rehabilitation: 44
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Dalal 2007 (Continued)
Method of assessment: Confirmed acute myocardial infarction (WHO criteria)
Diagnosis (% of pts):
Post MI: 100%
Age (mean ± SD): total: 62 ± 15 years; home-based cardiac rehabilitation: 60.6 ± 10.1
years; centre-based cardiac rehabilitation: 64.3 ± 11.2 years
Percentage male: total: 81%; home-based cardiac rehabilitation: 82%; centre-based
cardiac rehabilitation: 80%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: Heart Manual
Time of start after event:
Components: Exercise, education and psychosocial
Aerobic exercise:
Modality: walking
Dose:
Length of session: NR
Frequency/no of sessions: NR
Intensity: NR
Total duration: 6 weeks
Intermittent nurse or exercise specialist telephone support?Home visit in first week
after discharge by cardiac rehabilitation nurse followed up by up to 4 telephone calls at
2, 3, 4, and 6 weeks
Co-interventions: NR
Description of centre-based cardiac rehabilitation:
Components: Exercise, education and psychosocial
Aerobic exercise:
Modality: NR
Dose:
Length of session: NR
Frequency/no of sessions: 1 to 5 sessions/week
Intensity: NR
Total duration: 8 to 10 weeks
Co-interventions: Input from dietician, psychologist, occupational therapist, and phar-
macist
Outcomes Primary: quality of life (MacNew questionnaire), total cholesterol
Secondary: exercise capacity (METs), self-reported smoking, cardiovascular morbidity,
mortality, secondary prevention medication use
Follow up 9 months post randomisation
Source of funding NHS Executive South West (Research and Development) Project Grant D/02/10.99
Conflicts of interest NR
Notes
Risk of bias
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Dalal 2007 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...computerised random number trial al-
location sequence was determined before
the study”
Allocation concealment (selection bias) Low risk “...allocation was transferred to sequen-
tially numbered, opaque, sealed envelopes
and concealed from the research nurse, who
carried out baseline assessment”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “...the person assessing the primary out-
come questionnaires was blinded to alloca-
tion“
Incomplete outcome data (attrition bias)
All outcomes
Low risk “...the last known observation carried for-
ward to replace missing values at 9 months
for the primary outcome measures.”
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk ”The randomized groups were well bal-
anced, apart from a higher proportion of
patients in employment in the home based
group (51% versus 26%, p=0.013)”
Groups received same co-intervention(s)? Low risk Both groups received similar advice regard-
ing exercise, stress management, and edu-
cation
Daskapan 2005
Methods Study design: Single centre RCT
No of centres: 1
Country: Turkey
Dates patients recruited: 2000 to 2001
When randomised: NR
Maximum follow up: 12 weeks
Participants Inclusion criteria: Heart failure > 3 month duration
Exclusion criteria: Valvular heart disease, exercise-induced cardiac arrhythmias, symp-
tomatic myocardial ischaemia within 3 months, taking beta-blockers
N randomised: total: 29; home-based cardiac rehabilitation: 15; centre-based cardiac
rehabilitation: 14
Method of assessment: Patients fulfilled criteria of the New York Heart Association;
class II or III CHF
Diagnosis (% of pts):
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Daskapan 2005 (Continued)
Class II or III NYHA with ischaemic or idiopathic dilated cardiomyopathy: 100%
Age (mean ± SD): total: NR; home-based cardiac rehabilitation: 49 ± 11 years; centre-
based cardiac rehabilitation: 52 ± 8 years
Percentage male: total: 73%; home-based cardiac rehabilitation: 73%; centre-based
cardiac rehabilitation: 73%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: The home-based exercise training
group (HETG) performed 12 weeks of physical training by themselves. Follow up logs
completed daily/returned bi-weekly
Components: Exercise only
Aerobic exercise:
Modality: Walking
Dose:
Length of session: 45 min/session (including warm-up, cool-down, recovery)
Frequency/no of sessions: 3 sessions/week
Intensity: up to 60% peak heart rate (RPE 12 to 16)
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?Weekly phone calls from
staff monitoring adherence and progress, monthly phone calls from patients for control
purposes
Co-interventions: NR
Description of centre-based cardiac rehabilitation:
The supervised exercise training group (SETG) performed 12 weeks of physical training
on treadmill at the laboratory
Components: Exercise only
Aerobic exercise:
Modality: Walking on a treadmill
Dose:
Length of session: 45 min/session (including warm-up, cool-down, recovery)
Frequency/no of sessions: 3 sessions/week
Intensity: up to 60% peak heart rate (RPE 12 to 16)
Total duration: 12 weeks
Co-interventions: NR
Outcomes (Primary and secondary outcomes not distinguished) exercise capacity (mL/kg/min),
resting BP, systolic and diastolic BP, adherence, dropouts, mortality
Follow up 12 weeks post randomisation
Source of funding NR
Conflicts of interest NR
Notes Data on mortality obtained by personal contact
Risk of bias
Bias Authors’ judgement Support for judgement
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Daskapan 2005 (Continued)
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors not described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 3/11 (27%) centre-based patients and 4/11
(36%) home-based patients dropped out
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk “Among patients who completed the study,
no differences in demographic characteris-
tics were seen between the 2 study groups
after randomization (p>0.05).”
Groups received same co-intervention(s)? Low risk “We chose lower intensity …training pre-
scriptions in the HETG to avoid any ad-
verse occurrences and also in the SETG to
provide comparable training intensity lev-
els between 2 groups.”
Gordon 2002 Community
Methods Study design: Single centre RCT
No of centres: 1
Country: USA
Dates patients recruited: NR
When randomised: Following baseline testing
Maximum follow up: 12 weeks
Participants Inclusion criteria: Diagnosed CAD; low-to-moderate risk of cardiac events (1. no car-
diac arrest within 1 year, 2. no complex ventricular dysrhythmia, 3. ejection fraction <
40%. 4. no complicated MI or cardiac surgery, 5. no increasing systolic BP response
to exercise testing, 6. no angina pectoris < 5.0 METs); ≥ 4 weeks post-hospitalisation;
aged 21 to 75 years; no life-threatening illness and/or psychological abnormality; speak/
write English; ability to complete exercise treadmill test; ability to attend 36 cardiac
rehabilitation sessions
Exclusion criteria: NR
N randomised: total: 155; physician-supervised home-based cardiac rehabilitation: 54;
community home-based cardiac rehabilitation: 49; centre-based cardiac rehabilitation:
52
Method of assessment: NR
Diagnosis (% of pts):
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History of prior MI: physician-supervised home-based cardiac rehabilitation: 29%;
community home-based cardiac rehabilitation: 16%; centre-based cardiac rehabilitation:
6%
History of prior CABG: physician-supervised home-based cardiac rehabilitation: 37%;
community home-based cardiac rehabilitation: 40%; centre-based cardiac rehabilitation:
38%
History of prior PTCA: physician-supervised home-based cardiac rehabilitation: 42%;
community home-based cardiac rehabilitation: 47%; centre-based cardiac rehabilitation:
53%
Age (mean ± SD): total: NR; physician-supervised home-based cardiac rehabilitation:
61 ± 10 years; community home-based cardiac rehabilitation: 60 ± 9 years; centre-based
cardiac rehabilitation: 60 ± 9 years
Percentage male: total: NR; physician-supervised home-based cardiac rehabilitation:
73%; community home-based cardiac rehabilitation: 78%; centre-based cardiac rehabil-
itation: 76%
Ethnicity: NR
Interventions Description of physician-supervised home-based cardiac rehabilitation:
Components: Exercise and education
Aerobic exercise:
Modality: NR
Dose:
Length of session: individually prescribed (30 to 60 min of aerobic exercise)
Frequency/no of sessions: individually prescribed
Intensity: 60% to 85% peak HR
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support? appointments: 2 office
visits, 4 phone calls
Co-interventions: Written materials, audiotapes, nutrition, weight and stress manage-
ment, smoking cessation programme, individual CAD risk factors management
Description of community home-based cardiac rehabilitation:
Components: Exercise and education
Aerobic exercise:
Modality: NR
Dose:
Length of session: individually prescribed (30 to 60 min of aerobic exercise)
Frequency/no of sessions: individually prescribed
Intensity: 60 to 85% peak HR
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support? 12 on site visits or tele-
phone calls (patient choice)
Co-interventions: Written materials, audiotapes, nutrition, weight and stress manage-
ment, smoking cessation programme, individual CAD risk factors management
Description of centre-based cardiac rehabilitation:
Components: e.g. exercise only, exercise and education, exercise and psychosocial
Aerobic exercise:
Modality: e.g. running, cycling, skipping.
Dose:
Length of session: Individually prescribed (30 to 60 min of aerobic exercise)
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Frequency/no of sessions: 3 sessions/week (total of 36 sessions = appointments)
Intensity: 60 to 85% peak HR
Total duration: 12 weeks
Co-interventions: Written materials, audiotapes, education on CAD risk factors and
lifestyle modification
Outcomes (Primary and secondary risk factors not distinguished) maximal oxygen uptake, blood
pressure, fasting serum lipids, self-reported smoking status, rehospitalisation, adherence
(completion of appointments)
Follow up 12 weeks post randomisation
Source of funding NR
Conflicts of interest NR
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data for 142 pts who completed exercise
testing at baseline and at follow up (not all
155 pts randomised) reported only; num-
bers of dropouts reported and reasons de-
scribed
Selective reporting (reporting bias) Low risk All outcomes mentioned inmethods are re-
ported in results
Groups balanced at baseline? Low risk “Randomization did not result in statisti-
cal significant differences among patients
assigned to the 3 interventions”
Groups received same co-intervention(s)? Low risk All groups received similar written materi-
als and advice
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Gordon 2002 Supervised
Methods Study design: Single centre RCT
No of centres: 1
Country: USA
Dates patients recruited: NR
When randomised: Following baseline testing
Maximum follow up: 12 weeks
Participants Inclusion criteria: Diagnosed CAD; low-to-moderate risk of cardiac events (1. no car-
diac arrest within 1 year, 2. no complex ventricular dysrhythmia, 3. ejection fraction <
40%. 4. no complicated MI or cardiac surgery, 5. no increasing systolic BP response
to exercise testing, 6. no angina pectoris < 5.0 METs); ≥ 4 weeks post-hospitalisation;
aged 21 to 75 years; no life-threatening illness and/or psychological abnormality; speak/
write English; ability to complete exercise treadmill test; ability to attend 36 cardiac
rehabilitation sessions
Exclusion criteria: NR
N randomised: total: 155; physician-supervised home-based cardiac rehabilitation: 54;
community home-based cardiac rehabilitation: 49; centre-based cardiac rehabilitation:
52
Method of assessment: NR
Diagnosis (% of pts):
History of prior MI: physician-supervised home-based cardiac rehabilitation: 29%;
community home-based cardiac rehabilitation: 16%; centre-based cardiac rehabilitation:
6%
History of prior CABG: physician-supervised home-based cardiac rehabilitation: 37%;
community home-based cardiac rehabilitation: 40%; centre-based cardiac rehabilitation:
38%
History of prior PTCA: physician-supervised home-based cardiac rehabilitation: 42%;
community home-based cardiac rehabilitation: 47%; centre-based cardiac rehabilitation:
53%
Age (mean ± SD): total: NR; physician-supervised home-based cardiac rehabilitation:
61 ± 10 years; community home-based cardiac rehabilitation: 60 ± 9 years; centre-based
cardiac rehabilitation: 60 ± 9 years
Percentage male: total: NR; physician-supervised home-based cardiac rehabilitation:
73%; community home-based cardiac rehabilitation: 78%; centre-based cardiac rehabil-
itation: 76%
Ethnicity: NR
Interventions Description of physician-supervised home-based cardiac rehabilitation:
Components: Exercise and education
Aerobic exercise:
Modality: NR
Dose:
Length of session: individually prescribed (30 to 60 min of aerobic exercise)
Frequency/no of sessions: individually prescribed
Intensity: 60% to 85% peak HR
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support? appointments: 2 office
visits, 4 phone calls
Co-interventions: Written materials, audiotapes, nutrition, weight and stress manage-
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ment, smoking cessation programme, individual CAD risk factors management
Description of community home-based cardiac rehabilitation:
Components: Exercise and education
Aerobic exercise:
Modality: NR
Dose:
Length of session: individually prescribed (30 to 60 min of aerobic exercise)
Frequency/no of sessions: individually prescribed
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support? 12 on site visits or tele-
phone calls (patient choice)
Co-interventions: Written materials, audiotapes, nutrition, weight and stress manage-
ment, smoking cessation programme, individual CAD risk factors management
Description of centre-based cardiac rehabilitation:
Components: e.g. exercise only, exercise and education, exercise and psychosocial
Aerobic exercise:
Modality: e.g. running, cycling, skipping.
Dose:
Length of session: Individually prescribed (30 to 60 min of aerobic exercise)
Frequency/no of sessions: 3 sessions/week (total of 36 sessions = appointments)
Intensity: 60 to 85% peak HR
Total duration: 12 weeks
Co-interventions: Written materials, audiotapes, education on CAD risk factors and
lifestyle modification
Outcomes (Primary and secondary risk factors not distinguished) maximal oxygen uptake, blood
pressure, fasting serum lipids, self-reported smoking status, rehospitalisation, adherence
(completion of appointments)
Follow up 12 weeks post randomisation
Source of funding NR
Conflicts of interest NR
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors not described
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Data for 142 pts (8%) who completed ex-
ercise testing at baseline and at follow up
(not all 155 pts randomised) reported only;
numbers of dropouts reported and reasons
described
Selective reporting (reporting bias) Low risk All outcomes mentioned inmethods are re-
ported in results
Groups balanced at baseline? Low risk “Randomization did not result in statisti-
cal significant differences among patients
assigned to the 3 interventions”
Groups received same co-intervention(s)? Low risk All groups received similar written materi-
als and advice
Grace 2016 Mixed
Methods Study design: Single-blind, 3 parallel-arm multicentre RCT
No of centres: 6
Country: Canada
Dates patients recruited: 1 November 2009 to 31 July 2013
When randomised: After intake assessment
Maximum follow up: Six months
Participants Inclusion criteria: Residency in the city where the cardiac rehabilitation programs were
offered, proficiency in English, approval to participate in cardiac rehabilitation program
by cardiac specialist or general practitioner, and eligibility for home-based cardiac reha-
bilitation (i.e. low to moderate risk of an adverse event during exercise as demonstrated
by lack of complex ventricular dysrhythmia, New York Heart Association class 1-2 clas-
sification, and left ventricular ejection fraction of > 40%, or Canadian Cardiovascular
Society class 1-2 classification)
Exclusion criteria:Musculoskeletal, neuromuscular, visual, cognitive, or serious mental
illness, or any serious illness that would preclude cardiac rehabilitation eligibility; deemed
not suitable for cardiac rehabilitation by physician; plans to leave area; discharged to a
long-term care facility; and participation in another RCTwith behavioural interventions.
N randomised: total: 169; home-based cardiac rehabilitation: 55; comparator 1 (mixed
sex): 59 comparator 2 (women only): 55
Method of assessment: Clinical charts were reviewed for inclusion/exclusion criteria
Diagnosis (% of pts):
PCI: total: 49.1%; home-based cardiac rehabilitation: 50.0%;mixed sex: 50.0%;women
only: 47.3%
Angina/ACS/CAD: total: 36.2%; home-based cardiac rehabilitation: 35.8%; mixed sex:
36.4%; women only: 36.4%
MI: total: 35.8%; home-based cardiac rehabilitation: 34.0%; mixed sex: 38.6%; women
only: 34.5%
CABG: total: 25.5%; home-based cardiac rehabilitation: 25.9%; mixed sex: 21.4%;
women only: 29.1%
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Valve: total: 19.4%; home-based cardiac rehabilitation: 20.4%; mixed sex: 19.3%;
women only: 18.5%
Age (mean ± SD): total: 63.64 ± 10.42 years; home-based cardiac rehabilitation: 63.13
± 10.94 years; mixed sex: 61.56 ± 9.73 years; women only: 66.22 ± 10.21 years
Percentage male: total: NR
Ethnicity (%white): total: 62.5%; home-based cardiac rehabilitation: 65.3%; mixed
sex: 62.7%; women only: 59.1%
Interventions Female patients were randomised to 1 of 3 models: (1)supervised mixed-sex, (2) super-
vised women only, or (3) home-based cardiac rehabilitation
There were 3 cardiac rehabilitation sites involved in the trial, each offering all 3 models of
cardiac rehabilitation. The programs lasted 4 to 6 months. At each site, a graded exercise
stress test was performed pre-program and post-program. Results were used to develop
individualised exercise prescriptions and participants were encouraged to accumulate at
least 150 minutes of exercise per week at their target heart rate, preferably exercising
most days of the week via stationary bicycle/treadmill/walking
Description of intervention (home-based cardiac rehabilitation):
Home-based cardiac rehabilitation participants had at least 3 onsite visits and then
exercised at home
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: stationary bicycle/treadmill/walking
Dose: Participants were encouraged to accumulate at least 150 minutes of exercise per
week
Length of session: NR
Frequency/no of sessions: NR
Intensity: Participants exercised according to an individualised exercise prescription
which included a target heart rate
Resistance training included? No
Total duration: 4 to 6 months
Intermittent nurse or exercise specialist telephone support? Patients were phoned
weekly or biweekly, depending on program protocols and based on patient need
Co-interventions: Patients were provided the same education materials as patients at-
tending the supervised models at their initial visit, which was reviewed on the phone
with program staff
Description of comparator (centre-based cardiac rehabilitation):
Comparator 1: supervised mixed-sex
Comparator 2: supervised women only
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: stationary bicycle/treadmill/walking
Dose:
Length of session: up to 1 hour
Frequency/no of sessions: 1 to 2 times/week
Intensity: Individualised target heart rate
Resistance training included? Yes
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Total duration: 4 to 6 months
Co-interventions: Education materials provided
Outcomes Adherence to cardiac rehabilitation, exercise capacity
Follow up 6 months
Source of funding Heart and Stroke Foundation of Ontario (Grant in Aid no. NA 6682)
Conflicts of interest None declared
Notes SD values for adherence data were provided by the author on request
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomization sequence was com-
puter generated, in blocks of 6, and strat-
ified by condition…through randomize.
net.”
Allocation concealment (selection bias) Low risk “Recruiters went online to ascertain ran-
dom allocation and informed patients and
CR sites.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The CR program staff members were not
aware of study objectives or which partic-
ipants were involved in the trial. As a ma-
nipulation check, a masked research assis-
tant checkedCR charts to confirm the pro-
gram model attended at the expected CR
discharge date. Post-test CR data extrac-
tion, including stress test results, and pro-
gram adherence were also undertaken by
the masked research assistant.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Home-based cardiac rehabilitation: 35/55
(64 %) lost to follow-up
Mixed sex centre-based cardiac rehabilita-
tion: 38/59 (64 %) lost to follow-up
Women only centre-based cardiac rehabil-
itation: 34/55 (62 %) lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes described in the methods
were reported in the results section
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Groups balanced at baseline? Low risk There were no significant differences be-
tween patients randomized to each of the 3
models (all P>.05)
Groups received same co-intervention(s)? Low risk “Patients were provided the same education
materials as patients attending the super-
vised models at their initial visit, which was
reviewed on the phone with program staff.
”
Grace 2016 Women
Methods Study design: Single-blind, 3 parallel-arm multicentre RCT
No of centres: 6
Country: Canada
Dates patients recruited: 1 November 2009 to 31 July 2013
When randomised: After intake assessment
Maximum follow up: Six months
Participants Inclusion criteria: Residency in the city where the cardiac rehabilitation programs were
offered, proficiency in English, approval to participate in cardiac rehabilitation program
by cardiac specialist or general practitioner, and eligibility for home-based cardiac reha-
bilitation (i.e. low to moderate risk of an adverse event during exercise as demonstrated
by lack of complex ventricular dysrhythmia, New York Heart Association class 1 to 2
classification, and left ventricular ejection fraction of > 40%, or Canadian Cardiovascular
Society class 1 to 2 classification)
Exclusion criteria:Musculoskeletal, neuromuscular, visual, cognitive, or serious mental
illness, or any serious illness that would preclude cardiac rehabilitation eligibility; deemed
not suitable for cardiac rehabilitation by physician; plans to leave area; discharged to a
long-term care facility; and participation in another RCTwith behavioural interventions
N randomised: total: 169; home-based cardiac rehabilitation: 55; comparator 1 (mixed
sex): 59 comparator 2 (women only): 55
Method of assessment: Clinical charts were reviewed for inclusion/exclusion criteria
Diagnosis (% of pts):
PCI: total: 49.1%; home-based cardiac rehabilitation: 50.0%;mixed sex: 50.0%;women
only: 47.3%
Angina/ACS/CAD: total: 36.2%; home-based cardiac rehabilitation: 35.8%; mixed sex:
36.4%; women only: 36.4%
MI: total: 35.8%; home-based cardiac rehabilitation: 34.0%; mixed sex: 38.6%; women
only: 34.5%
CABG: total: 25.5%; home-based cardiac rehabilitation: 25.9%; mixed sex: 21.4%;
women only: 29.1%
Valve: total: 19.4%; home-based cardiac rehabilitation: 20.4%; mixed sex: 19.3%;
women only: 18.5%
Age (mean ± SD): total: 63.64 ± 10.42 years; home-based cardiac rehabilitation: 63.13
± 10.94 years; mixed sex: 61.56 ± 9.73 years; women only: 66.22 ± 10.21 years
Percentage male: total: NR
Ethnicity (%white): total: 62.5%; home-based cardiac rehabilitation: 65.3%; mixed
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sex: 62.7%; women only: 59.1%
Interventions Female patients were randomised to 1 of 3 models: (1)supervised mixed sex, (2) super-
vised women only, or (3) home-based cardiac rehabilitation
There were 3 cardiac rehabilitation sites involved in the trial, each offering all 3 models of
cardiac rehabilitation. The programs lasted 4 to 6 months. At each site, a graded exercise
stress test was performed pre-program and post-program. Results were used to develop
individualised exercise prescriptions and participants were encouraged to accumulate at
least 150 minutes of exercise per week at their target heart rate, preferably exercising
most days of the week via stationary bicycle/treadmill/walking
Description of intervention (home-based cardiac rehabilitation):Home-based cardiac
rehabilitation participants had at least 3 onsite visits and then exercised at home
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: stationary bicycle/treadmill/walking
Dose: Participants were encouraged to accumulate at least 150 minutes of exercise per
week
Length of session: NR
Frequency/no of sessions: NR
Intensity: Participants exercised according to an individualised exercise prescription
which included a target heart rate
Resistance training included? No
Total duration: 4 to 6 months
Intermittent nurse or exercise specialist telephone support? Patients were phoned
weekly or biweekly, depending on program protocols and based on patient need
Co-interventions: Patients were provided the same education materials as patients at-
tending the supervised models at their initial visit, which was reviewed on the phone
with program staff
Description of comparator (centre-based cardiac rehabilitation):
Comparator 1: supervised mixed sex
Comparator 2: supervised women only
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: stationary bicycle/treadmill/walking
Dose:
Length of session: up to 1 hour
Frequency/no of sessions: 1 to 2 times/week
Intensity: Individualised target heart rate
Resistance training included? Yes
Total duration: 4 to 6 months
Co-interventions: Education materials provided
Outcomes Adherence to cardiac rehabilitation, exercise capacity
Follow up 6 months
Source of funding Heart and Stroke Foundation of Ontario (Grant in Aid no. NA 6682)
62Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Grace 2016 Women (Continued)
Conflicts of interest None declared
Notes SD values for adherence data were provided by the author on request
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomization sequence was com-
puter generated, in blocks of 6, and strat-
ified by condition…through randomize.
net.”
Allocation concealment (selection bias) Low risk “Recruiters went online to ascertain ran-
dom allocation and informed patients and
CR sites.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The CR program staff members were not
aware of study objectives or which partic-
ipants were involved in the trial. As a ma-
nipulation check, a masked research assis-
tant checkedCR charts to confirm the pro-
gram model attended at the expected CR
discharge date. Post-test CR data extrac-
tion, including stress test results, and pro-
gram adherence were also undertaken by
the masked research assistant.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Home-based cardiac rehabilitation: 35/55
(64 %) lost to follow-up
Mixed sex centre-based cardiac rehabilita-
tion: 38/59 (64 %) lost to follow-up
Women only centre-based cardiac rehabil-
itation: 34/55 (62 %) lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes described in the methods
were reported in the results section
Groups balanced at baseline? Low risk There were no significant differences be-
tween patients randomized to each of the 3
models (all P > 0.05)
Groups received same co-intervention(s)? Low risk “Patients were provided the same education
materials as patients attending the super-
vised models at their initial visit, which was
reviewed on the phone with program staff.
”
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Hadadzadeh 2013
Methods Study design: Single centre RCT
No of centres: 1
Country: India
Dates patients recruited: 2007 to 2008
When randomised: As recruitment proceeded
Maximum follow up: 1 year
Participants Inclusion criteria: Low and moderate risk post-PTCA patients, aged 35 to 75 years
Exclusion criteria:High risk post-PTCA patients; any musculoskeletal; neuromuscular,
or any other medical conditions with exercise contraindications; not willing to give
consent
N randomised: total: 105; home-based cardiac rehabilitation (HmCR): 35; centre-based
cardiac rehabilitation (HsCR): 35; control (no cardiac rehabilitation - usual standard
care in the centre at the time of study): 35
Diagnosis (% of pts): Post-PTCA patients; 100%
Age (mean ± SD): total: 56.1 ± 9.1; home-based cardiac rehabilitation (HmCR): NR;
centre-based cardiac rehabilitation: NR
Percentagemale: total: 71.4%; home-based cardiac rehabilitation (HmCR):NR; centre-
based cardiac rehabilitation: NR
Ethnicity: Asian Indian 100%
Interventions Description of intervention (home-based cardiac rehabilitation):
Time of start after event: within 2 weeks post-PTCA
Components: Exercise and education
Aerobic exercise:
Modality: Brisk walking
DOSE: Moderate
Length of session: 20 to 60 min, progressively increased in 3 month duration of treat-
ment including 5 to 10 min warm up and cool down
Frequency/no of sessions: 3 times/week
Intensity: 40% to 70% of HRR, progressively increased in 12 weeks. HRmax was
obtained from symptom-limited Bruce protocol exercise test at baseline
Resistance training included? No
Total duration: 3 months (12 weeks)
Intermittent nurse or exercise specialist telephone support?Every 2 weeks to increase
intensity based on HR, other times as per needed on the telephone
Co-interventions: NR
Description of comparator (centre-based cardiac rehabilitation):
Time of start after event: within 2 weeks post-PTCA
Components: Exercise (supervised by trained physical therapist at centre)
Aerobic exercise: Yes
Modality: Brisk walking on treadmill
DOSE: Moderate
Length of session: 20 to 60 min, progressively increased in 3 month duration of treat-
ment including 5 to 10 min warm up and cool down
Frequency/no of sessions: 3 days/week
Intensity: 40% to 70% HRR, progressively increased in 12 weeks
Resistance training included? No
Total duration: 3 months (12 weeks)
Co-interventions: NR
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Outcomes Mortality
Follow up 3 months, 1 year
Source of funding Manipal University, India
Conflicts of interest “None”
Notes This study has not yet been published and we do not have access to the full manuscript.
All study information and outcome data were provided by the study author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block randomisation through concealed
envelope method
Allocation concealment (selection bias) Low risk Block Randomisation through concealed
envelope method
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blinded to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Home-based cardiac rehabilitation: 0/35
(0%) lost to follow-up
Centre-based cardiac rehabilitation: 4/35
(11.4 %) lost to follow-up
Selective reporting (reporting bias) Unclear risk This study has not yet been published and
we did not have access to a published pro-
tocol or description of the methods
Groups balanced at baseline? Unclear risk This study has not yet been published and
we did not have access to the baseline data
Groups received same co-intervention(s)? High risk The home-based group received education;
the centre-based group did not
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Hadadzadeh 2015
Methods Study design: Multicentre RCT
No of centres: 3
Country: India, and Iran
Dates patients recruited: 2007 to 2009
When randomised: As recruitment proceeded
Maximum follow up: 1 year
Participants Inclusion criteria: Low and moderate risk post-event CAD patients (post-MI on con-
servative Rx, CABG, PTCA), aged 35 to 75 years
Exclusion criteria: High risk post-event CAD patients, Any musculoskeletal, neuro-
muscular, or any other medical conditions with exercise contra-indications, not willing
to give consent
N randomised: total: 180; hospital-based cardiac rehabilitation: 60; centre-based cardiac
rehabilitation; 60; control (no exercise): 60
Diagnosis (% of pts): Post-event CAD patients treated conservatively, CABG or PTCA
Age (mean ± SD): total: 57 ± 9.3 years; intervention: NR; comparator: NR
Percentage male: total: 81.1%; intervention: NR; comparator: NR
Ethnicity: Asian Indian 70%, Middle Eastern (white) 30%
Interventions Description of intervention (home-based cardiac rehabilitation):
Time of start after event: within 2 weeks post-event
Components: Exercise and education
Aerobic exercise: Yes
Modality: Brisk walking
DOSE: Moderate
Length of session: 20 to 60 min, progressively increased in 3 month duration of treat-
ment including 5 to 10 min warm up and cool down
Frequency/no of sessions: 3 times/week
Intensity: 40% to 70% HRR, progressively increased over 12 weeks
Resistance training included? No
Total duration: 3 months (12 weeks)
Intermittent nurse or exercise specialist telephone support?Every 2 weeks to increase
intensity based on HR, other times as per needed on the phone
Co-interventions: None
Description of comparator (centre-based cardiac rehabilitation):
Time of start after event: within 2 weeks post-event
Components: e.g. exercise only
Aerobic exercise:
Modality: Brisk walking on treadmill
DOSE: Moderate
Length of session: 20 to 60 min, progressively increased in 3 month duration of treat-
ment including 5 to 10 min warm up and cool down
Frequency/no of sessions: 3 days/week
Intensity: 40% to 70% HRR, progressively increased over 12 weeks
Resistance training included? No
Total duration: 3 months (12 weeks)
Co-interventions: None
Outcomes Quality of life measured by SF-36v2, Functional Capacity measured by achieved MET
level on a symptom limited Bruce protocol treadmill test
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Follow up 3 months
Source of funding Manipal University, India; MOE Iran
Conflicts of interest None
Notes This study has not been published yet and we do not have access to the full manuscript.
All study information and outcome data has been provided by the author of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block randomisation
Allocation concealment (selection bias) Low risk Concealed envelope method
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blinded to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Home-based cardiac rehabilitation: 5/60
(8.0%) lost to follow-up
Centre-based cardiac rehabilitation: 2/60
(3.3 %) lost to follow-up
Selective reporting (reporting bias) Unclear risk This study has not yet been published and
we did not have access to a published pro-
tocol or description of the methods
Groups balanced at baseline? Unclear risk This study has not yet been published and
we did not have access to baseline data
Groups received same co-intervention(s)? High risk The home-based group received education;
the centre-based group did not
Jolly 2007
Methods Study design: Multicentre RCT
No of centres: 4
Country: UK
Dates patients recruited: February 2002 to January 2004
When randomised: Following baseline assessment
Maximum follow up: 24 months
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Participants Inclusion criteria: Acute MI, coronary angioplasty (± stenting) or CABG
Exclusion criteria: Inability to speak either English or Punjabi, dementia, severe hearing
impairment, sight defects of sufficient severity to prevent reading the HeartManual, and
serious persisting complications
N randomised: total: 525; home-based cardiac rehabilitation: 263; centre-based cardiac
rehabilitation: 262
Method of assessment: Killip Class
Diagnosis (% of pts):
MI: home-based cardiac rehabilitation: 49.0%; centre-based cardiac rehabilitation: 49.
2%
PTCA: home-based cardiac rehabilitation: 38.4; centre-based cardiac rehabilitation: 42.
0%
CABG: home-based CR: 12.5; centre-based cardiac rehabilitation: 8.8%
Age (mean ± SD): home-based cardiac rehabilitation: 60.3 ± 10.5 years; centre-based
cardiac rehabilitation: 61.8 ± 11.0 years
Percentage male: home-based cardiac rehabilitation: 77.2%; centre-based cardiac reha-
bilitation: 76.0%
Ethnicity: home-based cardiac rehabilitation: 80.2%; centre-based cardiac rehabilita-
tion: 79.3%
Interventions Description of home-based cardiac rehabilitation: The home-based programme con-
sisted of a manual, three home visits (at 10 days, 6 weeks and 12 weeks) and telephone
contact at 3 weeks. Patients who had had an MI were discharged home with the Heart
Manual. Additional visits were made as deemed necessary by the rehabilitation nurse.
The manual encourages patients to build up their exercise gradually to achieve a mini-
mum of 15 minutes of moderately intense activity daily
Components: Exercise, education and psychosocial
Aerobic exercise:
Modality: walking
Dose:
Length of session: minimum of 15 mins
Frequency/no of sessions: up to daily
Intensity: NR
Total duration: 6 weeks Heart Manual programme and 12 weeks nurse support
Intermittent nurse or exercise specialist telephone support? Three home visits (at 10
days, 6 weeks and 12 weeks) and telephone contact at 3 weeks
Co-interventions: Education on risk factors, lifestyle changes, medications and stress
management (relaxation tapes)
Description of centre-based cardiac rehabilitation: The four centre-based programmes
varied in length, including nine sessions at weekly intervals, 12 sessions over 8 weeks and
24 individualised sessions over 12 weeks. Programmes commenced between 4 weeks and
8 weeks following the cardiac event. Patients exercised to 65% to 75% of their predicted
maximal heart rate and the exercise element of the sessions lasted from 25 minutes to 40
minutes plus warm-up and cool-down elements
Components: Exercise, education and psychosocial
Aerobic exercise:
Modality: circuit training, cycle ergometer
Dose:
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Length of session: 25 to 30 min/session
Frequency/no of sessions: 1 or 2 sessions/week
Intensity: 65% to 75% HRmax
Resistance training included?
Total duration: 6 to 12 weeks
Co-interventions: Education and stress management (relaxation)
Outcomes Primary: serum cholesterol, total cholesterol, HDL cholesterol, blood pressure, exercise
capacity (ISWT), smoking (cotinine-validated)
Secondary: quality of life (EQ-5D), health service utilisation (hospital readmissions,
primary care visits, medication), mortality, cardiovascular events, costs
Follow up 6, 12, 24 months
Source of funding Funded by the UK Department of Health through its Health Technology Assessment
Programme. National Heart Research funded the development of the Heart Manual for
patients following a revascularisation procedure
Conflicts of interest “None”
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients who consented to randomisation
were randomised on an individual basis
with minimisation by (1) original diagno-
sis (MI/revascularisation), (2) age (<50/50-
74/75+ years), (3) sex, (4) ethnicity (Cau-
casian/Asian/other) and (5) hospital of re-
cruitment.”
Allocation concealment (selection bias) Low risk “Allocation was undertaken by the Birm-
ingham Cancer Clinical Trials Unit, a
group that was independent from the trial
team …When a patient agreed to be ran-
domised…the research nurse telephoned
the Clinical Trials Unit…and was given an
allocation group.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Assessments were blinded, with follow-up
undertaken by a research nurse who had
neither recruited the patient nor provided
home cardiac rehabilitation support.”
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Incomplete outcome data (attrition bias)
All outcomes
Low risk “A sensitivity analysis was undertaken on
the 12-month data to assess the potential
impact of the missing values for the ISWT,
[systolic] BP, [diastolic] BP, [total choles-
terol] and the Hospital Anxiety and De-
pression Scale scores.”
Selective reporting (reporting bias) Low risk all outcomes described in the methods sec-
tion are reported in the results
Groups balanced at baseline? Low risk “Demographic characteristics, diagnosis,
past medical history and cardiac risk factors
were well matched between the two arms
at baseline.”
Groups received same co-intervention(s)? High risk Although both groups received exercise, ed-
ucation and stress management, the na-
ture and amount of intervention between
groups was different
Karapolat 2009
Methods RCT parallel groups
Study design: Single centre RCT
No of centres: 1
Country: Turkey
Dates patients recruited: 2007 to 2008
When randomised: NR
Maximum follow up: 8 weeks
Participants Inclusion criteria: HF as a result of ischaemic and dilated cardiomyopathy, clinical
stability for at least 3months, left ventricular ejection fraction≤ 40%, NYHA functional
class II-III, optimal and standard pharmacological treatment, the ability to speak and
understand Turkish, absence of psychiatric disease, the ability to remain stable during
exercise tests, and willingness to volunteer to participate in this study
Exclusion criteria: Neurological orthopaedic, peripheral vascularisation, or severe pul-
monary disease; NYHA class IV patients; unstable angina pectoris; poorly controlled or
exercise-induced cardiac arrhythmias; recent acute coronary syndrome or revascularisa-
tion (≤ 3 months); significant valvular disease; atrial fibrillation; uncontrolled arterial
hypertension; and performing exercise training at regular intervals during the previous
6 weeks
Method of assessment: Standard echocardiography and Tissue Doppler Imaging
echocardiography (TDI)
N randomised: total: 74; home-based cardiac rehabilitation: 37; centre-based cardiac
rehabilitation: 37
Diagnosis (% of pts):
Heart failure: 100%
Age (mean ± SD): home-based cardiac rehabilitation: 44.05 ± 11.49 years; centre-based
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cardiac rehabilitation: 45.16 ± 13.58 years
Percentage male: home-based cardiac rehabilitation: 62%; centre-based cardiac rehabil-
itation: 66%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: All sessions were performed at home,
supervised by a physician. A specific program was designed for each patient based on
individual muscle strength, joint flexibility, and aerobic endurance. Exercise sessions
included flexibility exercises, aerobic exercises, and breathing exercises. The flexibility
exercises focused on range of motion and included exercises designed to stretch the
cervical and lumbar spine and the upper and lower extremities. Training HR measured
by monitor
Components: Exercise only
Aerobic exercise:
Modality: walking
Dose:
Length of session: NR
Frequency/no of sessions: NR
Intensity: NR
Total duration: 8 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: NR
Description of centre-based cardiac rehabilitation:
Centre-based cardiac rehabilitation(control):
Exercise: All rehabilitation sessions were supervised by a physician. A specific program
was designed for each patient based on individual muscle strength, joint flexibility, and
aerobic endurance. Exercise sessions included flexibility exercises, aerobic exercises, and
breathing exercises. The flexibility exercises focused on range of motion and included
exercises designed to stretch the cervical and lumbar spine and the upper and lower
extremities. Training HR measured by monitor
Components: e.g. exercise only, exercise and education, exercise and psychosocial
Aerobic exercise:
Modality: Treadmill
Dose:
Length of session: 45 to 60 min (including 5 min warm-up, 30 min aerobic exercise
and 5 min cool-down)
Frequency/no of sessions: 3 sessions/week
Intensity: 60% to 70% heart rate reserve, level 13 to 15 on the Borg scale
Total duration: 8 weeks
Co-interventions: NR
Outcomes Exercise capacity, quality of life (SF-36)
Follow up 8 weeks
Source of funding “We have no support for this study”
Conflicts of interest NR
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Low risk “...randomized (using concealed
envelopes)”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow diagram shows loss to follow up 5/
37 (14%)hospital-based, 1/37 (3%)home-
based group; no imputation ofmissing data
undertaken
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk Good balance in patient demographics
Groups received same co-intervention(s)? Low risk Only difference between groups is whether
exercise training performed in hospital or
home
Kassaian 2000
Methods Study design: Single centre RCT
No of centres: 1
Country: Iran
Dates patients recruited: NR
When randomised: Immediately after baseline tests (one to two months after acute Q
wave MI or CABG)
Maximum follow up: 12 weeks
Participants Inclusion criteria: AMI or CABG in last 1 to 2 months, NYHA class < IV, ejection
fraction ≥ 30%, able to exercise on a treadmill and participate in exercise programme
Exclusion criteria: High-risk stress test, decompensated CHF (NYHA IV), unstable
angina, uncontrolled atrial fibrillation, high-grade atrioventricular block (grade 2 or 3),
active pericarditis ormyocarditis, recent pulmonary thromboembolism, exercise-induced
asthma, claudication, fixed-rate permanent pacemaker, severe medical problem
N randomised: total: 125; home-based cardiac rehabilitation: 60; centre-based cardiac
rehabilitation: 65
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Diagnosis (% of pts):
MI: total: 23.2%; home-based cardiac rehabilitation: 13.3%; centre-based cardiac reha-
bilitation: 32.3%
CABG: total:76.8%; home-based cardiac rehabilitation: 86.7%; centre-based cardiac
rehabilitation: 67.7%
Age (mean ± SD): 55 ± 9.5 years
Percentage male: total: 100%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: Patients were taught to count their
pulse rate
TIme of start after even: One to two months after acute Q wave MI or CABG
Components: Exercise only
Aerobic exercise:
Modality: NR
Dose:
Length of session: NR
Frequency/no of sessions: NR
Intensity: “based on exercise test results”
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: NR
Description of centre-based cardiac rehabilitation:
Components: Exercise only
Aerobic exercise:
Modality: treadmill
Dose:
Length of session: 20 to 30 min + 10 min warm-up + 10 min cool-down/session
Frequency/no of sessions: 3 sessions week
Intensity: 60% to 85% (not reported if relative to HRmax)
Total duration: 12 weeks
Co-interventions: NR
Outcomes (Primary and secondary outcomes not distinguished) systolic BP, diastolic BP, heart rate
(all resting and sub-maximal), functional capacity (METs), BMI, cholesterol: total, LDL,
HDL, triglyceride
Follow up 12 weeks post randomisation
Source of funding NR
Conflicts of interest NR
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information on loss to follow up or
missing data management
Selective reporting (reporting bias) Unclear risk Not all outcomes reported mentioned in
methods section
Groups balanced at baseline? Low risk “Among patients who completed the study
no differences in demographic characteris-
ticswere seenbetween the two study groups
after randomisation.”
Groups received same co-intervention(s)? Unclear risk Details of home-based intervention not re-
ported
Kraal 2014
Methods Study design: Single centre RCT
No of centres: 1
Country: Netherlands
Dates patients recruited: March 2013 to March 2014
When randomised: After written consent, one week after cardiac rehabilitation intake
Maximum follow up: 12 weeks
Participants Inclusion criteria: Patients entering cardiac rehabilitation after hospitalisation for MI,
unstable angina, or a revascularisation procedure (PCI or CABG). Only patients with
a low-to-moderate risk of future cardiac events according to the Dutch cardiac rehabil-
itation guidelines were included. Patients were required to have Internet access and a
computer at home
Exclusion criteria: None described
N randomised: total: 55;intervention: 26; comparator: 26
Method of assessment: NR
Diagnosis (% of pts):
ACS with PCI: home-based cardiac rehabilitation: 56%; centre-based cardiac rehabili-
tation: 40%
ACS without PCI: home-based cardiac rehabilitation: 16%; centre-based cardiac reha-
bilitation: 20%
Angina pectoris with PCI: home-based cardiac rehabilitation: 8%; centre-based cardiac
rehabilitation: 16%
Angina pectoris without PCI: home-based cardiac rehabilitation: 8%; centre-based
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cardiac rehabilitation: 0%
CABG: home-based cardiac rehabilitation: 12%; centre-based cardiac rehabilitation:
24%
Age (mean ± SD) (N = 25): total: NR; home-based cardiac rehabilitation: 60.6 ± 7.5
years; centre-based cardiac rehabilitation: 56.1 ± 8.7 years
Percentage male (N = 25): total: NR; home-based cardiac rehabilitation: 88%; centre-
based cardiac rehabilitation: 84%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: Patients in the HT group received
three initial supervised training sessions. During these sessions, patients received instruc-
tions on how to use a wearable heart rate monitor (Garmin Forerunner 70) and how to
upload the recorded exercise data to a web application (Garmin Connect) through the
Internet. The web application was used to review the training data by the patient, the
physical therapist and the exercise specialist. During the first sessions, the patients were
also familiarised with the training programme (duration, intensity) and their preferred
training modality in the home environment was discussed. After three supervised train-
ing sessions, patients in the HT group started training in their home environment
Time of start after event: NR
Components: Exercise plus behavioural change
Aerobic exercise:
Modality: Patient’s preferred training modality
Dose:
Length of session: 45 to 60 min
Frequency/no of sessions: at least two training sessions per week
Intensity: 70% to 85% of maximal heart rate
Resistance training included? No
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?Patients received feedback
on training frequency, duration and intensity from the physical therapist once a week
via telephone. After 12 weeks, the telephonic feedback was terminated and the patients
were advised to continue their training with the heart rate monitor
Co-interventions: Patients in the home-based training group received coaching from
their therapist through weekly telephone calls. During this phone call the therapist gave
feedback on training parameters that were measured during the preceding week, and
discussed progress with respect to the personal training goals. In addition, based on the
principles of motivational interviewing, they discussed barriers and facilitative factors in
adhering to the exercise training protocol
Descriptionofcentre−based cardiac rehabilitation:
Time of start after event: NR
Components: Exercise only
Aerobic exercise:
Modality: Group-based training sessions on a treadmill or cycle ergometer, supervised
by physical therapists and exercise specialists
Dose:
Length of session: 45 to 60 min
Frequency/no of sessions: at least two training sessions per week
Intensity: 70% to 85% of their maximal heart rate
Resistance training included? No
75Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kraal 2014 (Continued)
Total duration: 12 weeks
Co-interventions: None described
Outcomes Exercise capacity; HRQoL; adherence to cardiac rehabilitation
Follow up 12 weeks
Source of funding ZonMw, theDutchOrganisation forHealthResearch andDevelopment (project number
837001003)
Conflicts of interest The FIT@Home study is executed in collaboration with Philips Research; the heart rate
monitors used during home-based training were provided by Philips Research
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...patients were randomly allocated to
homebased training (HT) or centre-based
training (CT)”. Method of randomisation
not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Home-based cardiac rehabilitation: 4/29
(13.8%) lost to follow-up
Centre-based cardiac rehabilitation: 1/26
(3.8%) lost to follow-up
Loss to follow-up was disproportionately
higher in the intervention group
“Data were analysed per protocol”
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results section
Groups balanced at baseline? Low risk NoPvalueswere given, but baseline charac-
teristics appear to be similar in both groups
Groups received same co-intervention(s)? High risk “…patients in the HT group started train-
ing at home and received coaching from
their therapist through weekly telephone
calls...” No coaching was given to the cen-
tre-based cardiac rehabilitation group
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Marchionni 2003
Methods Study design: Single centre RCT
No of centres: 1
Country: Italy
Dates patients recruited: NR
When randomised: NR
Maximum follow up: 14 months
Participants Inclusion criteria: Aged > 45 years, MI
Exclusion criteria: Severe cognitive impairment; physical disability; left ventricular ejec-
tion fraction < 35%; contraindications to vigorous exercise; eligibility for myocardial
revascularisation, living too far from cardiac rehabilitation unit
N randomised: total: 180; home-based cardiac rehabilitation: 90; centre-based cardiac
rehabilitation: 90
Method of assessment: NR
Diagnosis (% of pts):
MI: 100%
Age (mean ± SD): total: 69 ± 1.6 years; home-based cardiac rehabilitation: NR; centre-
based cardiac rehabilitation: NR
Percentage male: total: 71%; home-based cardiac rehabilitation: NR%; centre-based
cardiac rehabilitation: NR
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:
Components: Exercise only
Aerobic exercise:
Modality: cycle ergometer
Dose:
Length of session: NR
Frequency/no of sessions: 3 days/week
Intensity: 70% to 85% peak HR
Total duration: 8 weeks
Intermittent nurse or exercise specialist telephone support? Physical therapist home
visits every other week
Co-interventions: Monthly family-oriented support groups
Description of centre-based cardiac rehabilitation:
Components: Exercise only
Aerobic exercise: cycle ergometer
Modality: e.g. running, cycling, skipping.
Dose:
Length of session: NR
Frequency/no of sessions: 3 days/week
Intensity: 70% to 85% peak HR
Total duration: 12 weeks
Co-interventions: Risk factor management counselling; support group meetings
Outcomes Primary: total work capacity
Secondary: HRQoL (Sickness Impact Profile), mortality, morbidity (cardiovascular
events), healthcare utilisation (medical visits, rehospitalisations), costs, and adherence
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(number of completed training sessions)
Follow up 2, 8, 14 months post randomisation
Source of funding National Research Council (CNR), the University of Florence, and the Regional Gov-
ernment of Tuscany, Italy
Conflicts of interest NR
Notes Subgroup analysis in age groups (middle-aged: 45 to 65 years, old: 65 to 75 years, very
old: >75 years)
Data presented separately for 3 age groups. Follow up data on charts only; authors
contacted for numerical data at follow up and these have been supplied for total work
capacity and Sickness Impact Profile separately for 3 groups; we pooled data across age
groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Testing personnel were blinded to patient
assignment.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “...we performed a sensitivity analysis com-
paring results obtained with and without
replacement of missing data with data ob-
tained with the expectation-maximization
imputation method. Because the 2 analy-
ses provided similar results, whichwere also
similar with missing data substituted with
data estimated in a worst-case scenario,
only the data from patients who completed
the study are presented”
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk “...baseline sociodemographic and clinical
characteristics were similar across the 3
arms of the trial”
Baseline characteristics by home and hospi-
tal group allocation not reported in tabular
format
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Groups received same co-intervention(s)? Low risk “Patients received an exercise prescription
similar to that of the Hosp-CR group.... A
physical therapist made home visits every
other week to adjust if necessary the ex-
ercise prescription, to enhance adherence
with intervention”
Miller 1984 Brief
Methods Study design: Single centre RCT
No of centres: 1
Country: USA
Dates patients recruited: NR
When randomised: NR
Maximum follow up: 23 weeks
Participants Inclusion criteria:Uncomplicated AMI (elevated serum creatinine kinase or oxaloacetic
transaminase, prolonged chest pain consistent with AMI, new Q waves or evolutionary
ST changes in ECG)
Exclusion criteria: Unable to undertake exercise test, congestive heart failure, unstable
angina pectoris, valvular heart disease, atrial fibrillation, bundle branch block, history of
bypass, stroke, orthopaedic abnormalities, peripheral vascular disease, chronic pulmonary
obstructive disease, obesity
N randomised: total: 127; home-based cardiac rehabilitation: 66 (33 in brief exercise
programme subgroup and 33 in extended subgroup); centre-based cardiac rehabilitation:
61 (31 in brief subgroup and 30 in extended subgroup)
Method of assessment: MI was documented by the combination of characteristic ele-
vation of serum creatine kinase or oxaloacetic transaminase, a history of prolonged chest
pain consistent withMI, and the appearance of newQwaves or evolutionary ST segment
changes
Diagnosis (% of pts):
Uncomplicated acute MI: 100%
Age (mean ± SD): total: 52 ± 9 years; home-based cardiac rehabilitation: NR; centre-
based cardiac rehabilitation: NR
Percentage male: total: 100%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:
Aerobic exercise:
Modality: stationary cycling. Portable heart rate monitors and teletransmissions of ECG
Dose:
Length of session: 30 min/session
Frequency/no of sessions: 5 sessions/week
Intensity: 70% to 85% HRmax
Resistance training included? NR
Total duration: 8 weeks (brief ) or 23 weeks (extended)
Intermittent nurse or exercise specialist telephone support? 2 phone calls/week by
staff to verify training intensity, clinical status and medication
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Co-interventions: NR
Description of centre-based cardiac rehabilitation:
Time of start after event: 3 weeks after infarction
Components: Exercise only
Aerobic exercise:
Modality: walking/jogging; Group based and supervised
Dose:
Length of session: 60 mins/session
Frequency/no of sessions: 5 sessions/week
Intensity: 70% to 85% HRmax
Resistance training included? NR
Total duration: 8 weeks (brief ) or 23 weeks (extended)
Co-interventions: NR
Outcomes Exercise capacity; mortality and cardiovascular morbidity
Follow up 23 weeks post randomisation
Source of funding Grant HL18907 from the NHLBI, Bethesda, and by a grant from the PepsiCo Founda-
tion, Purchase, NY
Conflicts of interest NR
Notes Results reported according to the two subgroups, i.e. brief versus extended exercise
training and included into analysis separately
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop out reported; no imputation of miss-
ing data discussed
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Unclear risk Baseline characteristics not reported
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Groups received same co-intervention(s)? Low risk Both home and centre groups were very
closely balanced in terms of the exercise
training received
Miller 1984 Expanded
Methods Study design: Single centre RCT
No of centres: 1
Country: USA
Dates patients recruited: NR
When randomised: NR
Maximum follow up: 23 weeks
Participants Inclusion criteria:Uncomplicated AMI (elevated serum creatinine kinase or oxaloacetic
transaminase, prolonged chest pain consistent with AMI, new Q waves or evolutionary
ST changes in ECG)
Exclusion criteria: Unable to undertake exercise test, congestive heart failure, unstable
angina pectoris, valvular heart disease, atrial fibrillation, bundle branch block, history of
bypass, stroke, orthopaedic abnormalities, peripheral vascular disease, chronic pulmonary
obstructive disease, obesity
N randomised: total: 127; home-based cardiac rehabilitation: 66 (33 in brief exercise
programme subgroup and 33 in extended subgroup); centre-based cardiac rehabilitation:
61 (31 in brief subgroup and 30 in extended subgroup)
Method of assessment: MI was documented by the combination of characteristic ele-
vation of serum creatine kinase or oxaloacetic transaminase, a history of prolonged chest
pain consistent withMI, and the appearance of newQwaves or evolutionary ST segment
changes
Diagnosis (% of pts):
Uncomplicated acute MI: 100%
Age (mean ± SD): total: 52 ± 9 years; home-based cardiac rehabilitation: NR; centre-
based cardiac rehabilitation: NR
Percentage male: total: 100%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:
Aerobic exercise:
Modality: stationary cycling. Portable heart rate monitors and teletransmissions of ECG
Dose:
Length of session: 30 min/session
Frequency/no of sessions: 5 sessions/week
Intensity: 70% to 85% HRmax
Resistance training included? NR
Total duration: 8 weeks (brief ) or 23 weeks (extended)
Intermittent nurse or exercise specialist telephone support? 2 phone calls/week by
staff to verify training intensity, clinical status and medication
Co-interventions: NR
Description of centre-based cardiac rehabilitation:
Time of start after event: 3 weeks after infarction
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Components: Exercise only
Aerobic exercise:
Modality: walking/jogging; Group based and supervised
Dose:
Length of session: 60 mins/session
Frequency/no of sessions: 5 sessions/week
Intensity: 70% to 85% HRmax
Resistance training included? NR
Total duration: 8 weeks (brief ) or 23 weeks (extended)
Co-interventions: NR
Outcomes Exercise capacity; mortality and cardiovascular morbidity
Follow up 23 weeks post randomisation
Source of funding Grant HL18907 from the NHLBI, Bethesda, and by a grant from the PepsiCo Founda-
tion, Purchase, NY
Conflicts of interest NR
Notes Results reported according to the two subgroups, i.e. brief versus extended exercise
training and included into analysis separately
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop out reported; no imputation of miss-
ing data discussed
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Unclear risk Baseline characteristics not reported
Groups received same co-intervention(s)? Low risk Both home and centre groups were very
closely balanced in terms of the exercise
training received
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Methods Study design: Single centre RCT
No of centres: 1
Country: Norway
Dates patients recruited: NR
When randomised: 4 to 8 weeks after CABG surgery
Maximum follow up: 6 months
Participants Inclusion criteria: Had coronary artery bypass surgery 4 to 8 weeks before enrolment
and clinically stable (defined as the absence of unstable angina pectoris, symptoms of
heart failure, pleural liquid limiting respiration, lungdisease limiting respiration, ongoing
infections, and atrial fibrillation limiting circulation)
Exclusion criteria: Left ventricular ejection fraction < 30%, contraindications to vigor-
ous physical activity (unstable angina, uncontrolled abnormal heart rhythms, severe aor-
tic stenosis, suspected or known dissecting aneurysm, infection in the heart or any other
systemic infection), pulmonary disease clearly limiting exercise capacity, pregnancy, or
drug abuse
N randomised: total: 30; home-based cardiac rehabilitation: 14; centre-based cardiac
rehabilitation: 16
Diagnosis (% of pts):
CABG: 100%
Age (mean ± SD): total: 63 ± 77 years; home-based cardiac rehabilitation: 61.7 ± 8.0
years; centre-based cardiac rehabilitation: 63.6 ± 7.3 years
Percentage male: total: 80%; home-based cardiac rehabilitation: 78.6%; centre-based
cardiac rehabilitation: 81.3%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:
Time of start after event: 4 to 8 weeks after CABG surgery
Components: Exercise and education
Aerobic exercise:
Modality: walking, jogging, swimming or cycling (patient choice)
Dose:
Length of session: 38 min (10 min warm up, 4 x 4 min intervals of high intensity
exercise, 4 x 3 min intervals of moderate intensity
Frequency/no of sessions: 3 sessions/week
Intensity: 70% HRmax (moderate intensity) to 85% to 95% HRmax (high intensity)
Resistance training included?
Total duration: 6 months
Intermittent nurse or exercise specialist telephone support?
Co-interventions:Diet counselling, a smoking cessation program, lectures about healthy
lifestyle in general. After discharge from the rehabilitation centre, the patients were
advised to keep on exercising at home, and were invited back for follow up testing after
6 months
Description of centre-based cardiac rehabilitation(residential rehabilitation):
Time of start after event: 4 to 8 weeks after CABG surgery
Components: Exercise and education
Aerobic exercise:
Modality: Outdoor walking, cross-country skiing in winter time, indoor cycling, hall
games
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Dose:
Length of session: NR
Frequency/no of sessions: 30 exercise sessions with low intensity, 16 with moderate
intensity, and 10 with high intensity
Intensity: Up to 11 on the Borg scale (light intensity); 12 to 14 on the Borg scale
(moderate intensity); and 15 to 17 on the Borg scale (high intensity)
Resistance training included? strength training
Total duration: 4 weeks
Co-interventions:Diet counselling, a smoking cessation program, lectures about healthy
lifestyle in general. After discharge from the rehabilitation centre, the patients were
advised to keep on exercising at home, and were invited back for follow up testing after
6 months. They did not receive a training diary or concrete advice about how to exercise
on discharge
Outcomes Primary: peak oxygen consumption
Secondary: HRQoL total, HDL cholesterol and triglycerides
Follow up 6 months post randomisation
Source of funding EXTRA funds from the Norwegian Foundation for Health and Rehabilitation. The
funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript
Conflicts of interest The authors declared that no competing interests exist
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Allocation was done by a computer using
block randomisation. The first, the smallest
and the largest block, were defined by the
technicians at the unit of Applied Clinical
Research at the university”
Allocation concealment (selection bias) Low risk “The person including the patients got the
allocation results on screen and by e-mail
by logging on to a website.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk CONSORTflowdiagram shows loss to fol-
low 4/30 (13%) at 6 months
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Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk Although no statement of similarity of
baseline characteristics, the provided char-
acteristic of both groups appeared similar
Groups received same co-intervention(s)? Low risk Co-interventions received by both groups
Oerkild 2011
Methods Study design: Single centre RCT
No of centres: 1
Country: Denmark
Dates patients recruited: January 2007 to July 2008
When randomised: NR
Maximum follow up: 12 months
Participants N = 36 pts home-based intervention; N = 39 pts centre-based intervention, 100%
coronary heart disease, mean age home 74.4 (5.8), mean age centre 74.7 (5.9), 19 males:
17 females home, 26 males: 13 females centre
Inclusion criteria: ≥ 65 years old with a ‘new’ event of coronary heart disease defined
as AMI, percutaneous transluminal coronary intervention or CABG
Exclusion criteria: mental disorders (dementia), social disorders (severe alcoholism and
drug abuse), living at nursing home, language barriers and the use of wheelchair
N randomised: total: 75; home-based cardiac rehabilitation: 36; centre-based cardiac
rehabilitation: 39
Method of assessment: NR
Medical history (% of pts):
Previous MI: home-based cardiac rehabilitation: 27.8%; centre-based cardiac rehabili-
tation: 30.8%
Previous PCI: home-based cardiac rehabilitation: 19.4%; centre-based cardiac rehabil-
itation: 18.0%
Previous CABG: home-based cardiac rehabilitation: 16.7%; centre-based cardiac reha-
bilitation: 5.4%
Heart failure LVEF ≤45%: home-based cardiac rehabilitation: 38.9%; centre-based
cardiac rehabilitation: 30.8%
Age (mean ± SD): total: NR; home-based cardiac rehabilitation: 74.4 ± 5.8 years; centre-
based cardiac rehabilitation: 74.7 ± 5.9 years
Percentage male: total: 60.0%; home-based cardiac rehabilitation: 52.8%; centre-based
cardiac rehabilitation: 66.7%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: The exercise programmes were indi-
vidualised but followed international recommendations. A physiotherapist individually
tailored the exercise programmes. At 3 months when the intervention ceased, partici-
pants were encouraged to continue to exercise 30 min 6 days/week at an 11 to 13 on the
Borg scale
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Time of start after event: NR (“new event”)
Components: Exercise and education
Aerobic exercise:
Modality: Self-passed brisk walking and stationary cycling
Dose:
Length of session: 30 min
Frequency/no of sessions: 6 days/week
Intensity: 11 to 13 on a Borg scale
Resistance training included? NR
Total duration: 6 weeks
Intermittent nurse or exercise specialist telephone support?A cardiologist counselled
the patients at baseline and after 3, 6 and 12 months. At 4 and 5 months, a telephone
call was made to answer any questions, regarding risk factor intervention and medical
adjustment
Co-interventions: Patients were offered six education lectures, two dietary counselling
sessions, three practical cooking and (if needed) smoking cessation counselling sessions
Description of centre-based cardiac rehabilitation:
This consisted of a six week intensive programme where patients were offered group-
based supervised exercise training 60min twice a week and were encouraged to exercise at
home to comply with the international recommendations. As for the home programme,
a physiotherapist individually tailored the exercise programmes. At 3 months when the
intervention ceased, participants were encouraged to continue to exercise 30 min 6 days/
week at 11 to 13 on the Borg scale
Other:
Time of start after event: NR
Components: Individually tailored
Aerobic exercise:
Modality: e.g. running, cycling, skipping.
Dose:
Length of session: 60 min
Frequency/no of sessions: 2 sessions/week
Intensity: NR
Resistance training included? NR
Total duration: 6 weeks
Co-interventions: Patients were offered dietary counselling and (if needed) smoking
cessation. A cardiologist counselled the patients at baseline and after 3, 6 and 12 months.
At 4 and 5 months, a telephone call was made to answer any questions
Outcomes Primary: exercise capacity (VO and 6MWT)
Secondary: systolic anddiastolic bloodpressure; cholesterol (total,HDL, LDL), smoking,
HRQoL (SF-12)
Follow up 3 and 12 months
Source of funding The Velux Foundation
Conflicts of interest There were no conflicts of interest to declare
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomised in alternate
block sizes of four to six using computer-
generated randomly permuted blocks”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “Because of the nature of CR, the result
of the randomisation could not be blinded
and was therefore open to the investigator,
involved health personnel and patients”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 4/75 (5%) drop out
Selective reporting (reporting bias) Low risk All outcomes outlined in the methods are
reported in results
Groups balanced at baseline? Low risk ”Baseline characteristics according to inter-
vention...show no significant difference be-
tween the two groups. In addition, no sig-
nificant differences were found in the use
of medication and in socio-demographic
data”
Groups received same co-intervention(s)? Low risk “The pharmacological treatment followed
international guidelines and were thus
identical in the two groups” “Regarding
risk factor intervention andmedical adjust-
ment, a cardiologist counselled the patients
both at home and in the centre intervention
at baseline and after 3, 6 and 12 months.”
Piotrowicz 2010
Methods Study design: Single centre RCT
No of centres: 1
Country: Poland
Dates patients recruited: NR
When randomised: Following baseline measurements
Maximum follow up: 8 weeks
Participants Inclusion criteria: (i) patients of either sex with any aetiology of left ventricular systolic
HF (as defined in the European Society of Cardiology (ESC) guidelines) diagnosed for
> 3 months; (ii) with a left ventricular ejection fraction ≤ 40% on echocardiography;
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(iii) in NYHA class II or III; (iv) who were clinically stable and receiving an optimal and
stable medication regimen for at least 4 weeks before enrolment; and (v) who were able
to exercise using the new model of home-based exercise
Exclusion criteria: (i) NYHA class I or IV; (ii) unstable angina; (iii) a history of an
acute coronary syndrome within the last month, coronary artery bypass grafting within
the last 2 months, or initiation of cardiac resynchronisation therapy (CRT) within the
last year; (iv) symptomatic and/or exercise-induced cardiac arrhythmia or conduction
disturbances; (v) valvular or congenital heart disease requiring surgical treatment; (vi)
hypertrophic cardiomyopathy; (vii) severe pulmonary hypertension or other severe pul-
monary disease; (viii) uncontrolled hypertension; (ix) anaemia (haemoglobin,10.0 g/
dL); (x) acute and/or decompensated non-cardiac disease; (xi) physical disability related
to severe or neurological problems; (xii) acute or chronic inflammatory disease; (xiii)
cancer; (xiv) severe psychiatric disorder; and (xv) patient refusal to participate
N randomised: total: 152; home-based cardiac rehabilitation (tele-monitored cardiac
rehabilitation): 77; centre-based cardiac rehabilitation (outpatient-based standard cardiac
rehabilitation): 75
Method of assessment: Two-dimensional echocardiography
Diagnosis (% of pts):
Heart failure: 100%
Ischaemic: home-based cardiac rehabilitation: 73.3%; centre-based cardiac rehabilita-
tion: 85.7%
Non-ischaemic: home-based cardiac rehabilitation: 26.7%; centre-based cardiac reha-
bilitation: 14.3%
MI: home-based cardiac rehabilitation: 64.0%; centre-based cardiac rehabilitation: 78.
6%
Age (mean ± SD): total: 58.1 ± 10.2 years; home-based cardiac rehabilitation: 56.4 ±
10.9 years; centre-based cardiac rehabilitation: 60.5 ± 8.8 years
Percentage male: total: NR; home-based cardiac rehabilitation: 85%; centre-based car-
diac rehabilitation: 95%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:Tomake the ET safe forHF patients,
the following recommendations were taken into account: (i) special attention was paid
to appropriate patient risk stratification before cardiac rehabilitation; (ii) contraindica-
tions to ET were never overlooked; (iii) in patients with an implantable cardioverter
defibrillator (ICD), maximal training HR was set at 20 bpm lower than the defibrillator
discharge threshold; and (iv) in patients with a pacemaker, the rate-response function
was switched on, enabling HR adjustment to the physical effort which facilitates reach-
ing the desired training HR. Exercise training was planned individually for each patient
during hospitalisation. The chosen workload reflected individual effort tolerance with
regard to: (i) perceived exertion according to the Borg scale and (ii) the training HR range
established individually for each patient. In line with the standards, the assumption was
that patients should not exceed perceived moderate exertion during the ET (i.e. a score
of 11 on the Borg scale)
Components: Exercise, education and psychological
Aerobic exercise:
Modality: Continuous walking training on level ground
Length of session: 20 to 45min (i) warm-up: 5 to 10mins (breathing and light exercises,
callisthenics), (ii) basic aerobic endurance training for 10 to 30 mins (walking), and (iii)
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a 5 min cooling down (a period when patients could calm down and relax)
Frequency/no of sessions: 3 sessions/week
Intensity: Individually tailored
Resistance training included? NR
Total duration: 8 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: All patients and partners participated in an education programme:
how to measure HR, BP, and body weight; evaluate signs and symptoms; level perceived
exertion and how to perform exercise training. Each patient received psychological sup-
port
Description of centre-based cardiac rehabilitation:
Components: Exercise, education and psychological
Aerobic exercise:
Modality: Cycle ergometer
Dose:
Length of session: 20 to 45 min (i) warm-up: 5 to 10 min (breathing and light exercises,
callisthenics), (ii) basic aerobic endurance training for 10 to 30 min (walking), and (iii)
a 5 min cooling down (a period when patients could calm down and relax)
Frequency/no of sessions: 3 sessions/week
Intensity: Individually tailored
Resistance training included? NR
Total duration: 8 weeks
Co-interventions: All patients and partners participated in an education programme:
how to measure HR, BP, and body weight; evaluate signs and symptoms; level perceived
exertion and how to perform exercise training. Each patient received psychological sup-
port
Outcomes Exercise capacity (6-MWT), quality of life (SF-36), mortality, hospitalisation
Follow up 8 weeks
Source of funding National Institute of Cardiology, Warsaw, Poland (study number 2.9/I/06)
Conflicts of interest “none declared”
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
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Piotrowicz 2010 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk CONSORT flow diagram shows 19/75
(25%) of centre-based group and 2/77
(3%) of home-based group failed to pro-
vide 8 week data; no imputation of missing
data undertaken
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion are reported in the results
Groups balanced at baseline? Low risk “At baseline there were no significant in-
tergroup differences in terms of demo-
graphic and clinical parameters, NYHA
functional class, echocardiographic param-
eters, 6-MWT distance, functional capac-
ity in [cardiopulmonary exercise testing],
medical therapy, or the SF-36 question-
naire score”
Groups received same co-intervention(s)? Low risk Both groups received some education and
psychological support co-intervention
Sparks 1993
Methods Study design: Single centre RCT
No of centres: 1
Country: USA
Dates patients recruited: NR
When randomised: NR
Maximum follow up: 12 weeks
Participants Inclusion criteria: Male cardiac patient
Exclusion criteria:Not capable of exercising on a bicycle ergometer, serious arrhythmias,
symptoms of frequent chest pain, shortness of breath, hypertension
N randomised: total: NR; home-based cardiac rehabilitation 10; centre-based cardiac
rehabilitation: 10
Method of assessment: NR
Diagnosis (% of pts): MI, CABG, PTCA
Age (mean ± SD): total: 51.6 ± 12 years
Percentage male: total: 100%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:
Components: Exercise and education
Aerobic exercise:
Modality: cycle ergometer with trans-telephonic ECG monitoring
Dose:
Length of session: 1 hour
Frequency/no of sessions: 3 days/week
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Sparks 1993 (Continued)
Intensity: 60% to 75% peak HR
Resistance training included? NR
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support? trans-telephonic ECG
monitoring
Co-interventions: Education materials on diet, medications, risks and benefits of the
exercise
Description of centre-based cardiac rehabilitation:
Modality: cycle ergometer
Dose:
Length of session: 1 hour
Frequency/no of sessions: 3 days/week
Intensity: 60% to 75% peak HR
Resistance training included? NR
Total duration: 12 weeks
Co-interventions: Education materials on diet, medications, risks and benefits of the
exercise
Outcomes Exercise capacity (peak VO max); adherence (compliance with exercise); safety (drop
out)
Follow up 12 weeks post randomisation
Source of funding NR
Conflicts of interest NR
Notes Data read from graphs
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of assessors was not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1/20 (5%) drop out reported
Selective reporting (reporting bias) Low risk All outcomes described in themethods sec-
tion were reported in the results
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Sparks 1993 (Continued)
Groups balanced at baseline? Low risk Although no statement of similarity of
baseline characteristics, the characteristics
presented appeared similar between groups
Groups received same co-intervention(s)? Low risk Education materials on diet, medications,
risks and benefits of the exercise given to
both groups
Varnfield 2014
Methods Study design: Multicentre RCT
No of centres: 4
Country: Australia
Dates patients recruited: 2009 to 2011
When randomised: Prior to baseline assessment
Maximum follow up: 6 months
Participants Inclusion criteria: Post-MI patients referred to cardiac rehabilitation
Exclusion criteria: Unable to participate in self-management programmes due to medi-
cal care needs, operate smart phone for purposes of trial (e.g. vision, hearing, cognitive or
dexterity impairment) or attend TCR, or involved in another trial or had no experience
with mobile/smart phones
N randomised: total: 120; intervention: 60; comparator: 60
Method of assessment: NR
Diagnosis (% of pts):
STEMI: home-based cardiac rehabilitation: 49%; centre-based cardiac rehabilitation:
56%
NSTEMI: home-based cardiac rehabilitation: 49%; centre-based cardiac rehabilitation:
44%
Angina: home-based cardiac rehabilitation: 6%; centre-based cardiac rehabilitation: 5%
Heart failure: home-based cardiac rehabilitation: 4%; centre-based cardiac rehabilita-
tion: 2%
Bypass surgery: home-based cardiac rehabilitation: 11%; centre-based cardiac rehabil-
itation: 5%
Angioplasty/stent: home-based cardiac rehabilitation: 66%; centre-based cardiac reha-
bilitation: 80%
Age (mean ± SD): total: NR; home-based cardiac rehabilitation: 54.9 ± 9.6 years; centre-
based cardiac rehabilitation: 56.2 ± 10.1 years
Percentage male: total: NR; home-based cardiac rehabilitation: 91%; centre-based car-
diac rehabilitation: 83%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation: The Care Assessment Platform of
Cardiac Rehabilitation (CAP-CR) platform used a smart phone for health and exercise
monitoring, and delivery of motivational and educational materials to participants via
text messages and pre-installed audio and video files (including understanding cardiovas-
cular disease symptoms andmanagement). The platform included a web portal with par-
ticipant data for mentors to provide weekly consultations. Each participant was equipped
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Varnfield 2014 (Continued)
with a smart phone pre-installed with health diary and activity monitoring applications;
blood pressure monitor; and weight scale. Activity monitoring (step number, duration
and intensity) was automatic through the phone’s in-built accelerometer. Participants
were advised to make daily health diary entries: weight, BP, sleep duration and quality,
exercise other than automatically monitored steps, stress, meals and, if relevant, alcohol
consumption and smoking. Mentors reviewed updated data prior to weekly consulta-
tions
Time of start after event: Average = 54 days
Components: Exercise and education
Aerobic exercise:
Modality: walking
Dose:
Length of session: Target = at least 30 min
Frequency/no of sessions: Target = most days of the week
Intensity: Borg’s scale 11 to 13
Resistance training included? No
Total duration: 6 weeks
Intermittent nurse or exercise specialist telephone support?Weekly consultations via
the web portal to provide informed, personalised feedback according to goals set
Co-interventions: Educational materials
Description of centre-based cardiac rehabilitation: The traditional, centre-based pro-
gramme (TCR) programme comprised of two supervised exercise and 1 h educational
sessions on a weekly basis for 6 weeks at one of four Health Service District community
centres. Participants started education sessions once enrolled to cardiac rehabilitation and
twice-weekly exercise sessions commenced once centre appointments became available
Time of start after event: Average = 68 days
Components: Exercise and education
Aerobic exercise:
Modality: Circuit-based exercise e.g. treadmill, rower, squats and modified push-ups
Dose:
Length of session: NR
Frequency/no of sessions: twice a week
Intensity: Borg’s scale 6 to 10 (light) to 11 to 13 (moderate)
Resistance training included? Resistance bands, weights
Total duration: 6 weeks
Co-interventions: 1 h educational sessions on a weekly basis for 6 weeks
Outcomes Adherence, risk factors (BP, heart rate, weight, BMI, waist circumference (WC), lipid
profile), functional capacity and HRQoL
Costs are reported separately by Whittaker and Wade 2014
Follow up 6 week and 6 month
Source of funding A joint venture between Australian eHealth Research Centre and Queensland Health
Conflicts of interest “None”
Notes 6 month outcome data provided by the author on request
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Varnfield 2014 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Permuted-block randomisation, by com-
puter-generated random numbers…”
Allocation concealment (selection bias) Low risk “…using sequentially numbered opaque,
sealed envelopes, was conducted”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “We conducted an unblinded RCT in four
CR centres”. Blinding of assessors not de-
scribed
Incomplete outcome data (attrition bias)
All outcomes
High risk Home-based cardiac rehabilitation: 14/60
(23.3 %) lost to follow-up
Centre-based cardiac rehabilitation: 34/60
(56.7 %) lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes described in the methods
were reported in the results section
Groups balanced at baseline? Low risk “There were no significant differences in
baseline demographic and clinical charac-
teristics of participants who commenced
CR”
Groups received same co-intervention(s)? Low risk Both groups received educational materials
or sessions
Wu 2006
Methods Study design: Single centre RCT
No of centres: 1
Country: Taiwan (China)
Dates patients recruited: NR
When randomised: NR
Maximum follow up: 12 weeks
Participants Inclusion criteria: No previous CABG, no neurologic impairment like stroke/brain
injury, no severe musculoskeletal disease, no complications during hospitalisations like
infection, shock, arrhythmia, prolonged ventilation
Exclusion criteria:uncontrolled dysrhythmia or continuous ventricular tachycardia dur-
ing exercise testing, no possibility of completing test at discharge or 12 weeks later
N randomised: total: 36; intervention: 18; comparator: 18
Diagnosis (% of pts):
Post CABG: 100%
Age (mean ± SD): total: 61.9 ± 7.3 years
94Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wu 2006 (Continued)
Percentage male: total: 100%
Ethnicity: NR
Interventions Description of home-based cardiac rehabilitation:Exercise documented in record book.
Prescription of exercise individually given and updated every 2 weeks by rehabilitation
nurse
Components: Exercise only
Aerobic exercise:
Modality: fast walking or jogging
Dose:
Length of session: 30 to 60 min + 10 min warm-up + 10 min cool-down/session
Frequency/no of sessions: ≥ 3 sessions/week
Intensity: 60% to 85% HRmax
Resistance training included? NR
Total duration: 12 weeks
Intermittent nurse or exercise specialist telephone support?NR
Co-interventions: NR
Description of centre-based cardiac rehabilitation: Exercise supervised by cardiopul-
monary physical therapist
Components: Exercise only
Aerobic exercise:
Modality: cycle ergometer, treadmill
Dose:
Length of session: 30 to 60 min + 10 min warm-up + 10 min cool-down/session
Frequency/no of sessions: 3 sessions/week (total 36 sessions)
Intensity: 60% to 85% HRmax
Resistance training included? NR
Total duration: 12 weeks
Co-interventions: NR
Outcomes (Primary and secondary outcomes not distinguished) exercise capacity (METs)
Follow up 12 weeks post randomisation
Source of funding NR
Conflicts of interest NR
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects were randomly assigned by draw-
ing lots”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
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Wu 2006 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The evaluators of the exercise stress test
were alsomasked to the group assignments.
”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in methods section
were reported in results
Groups balanced at baseline? Low risk “Randomization did not result in statisti-
cal significances among subjects assigned to
the three groups.”
Groups received same co-intervention(s)? Low risk Neither group received any co-interven-
tions
6MWT = six minute walk test
AMI = acute myocardial infarction
BP = blood pressure
BMI - body mass index
CABG = coronary artery bypass graft
CAD = coronary artery disease
CCU = coronary care unit
CHD = coronary heart disease
CHF = congestive heart failure
ECG = electrocardiogram
HF = heart failure
HDL = high-density lipoprotein
HR = heart rate
HRmax = maximum heart rate
HRQoL = health related quality of life
ISWT = incremental shuttle walking test
ITT = intention to treat
LDL = low-density lipoprotein
METs = metabolic equivalents
MI = myocardial infarction
min = minutes
NR = not reported
NYHA = New York Heart Association
PTCA = percutaneous transluminal coronary angioplasty
pts = participants
RCT = randomised controlled trial
RPE = rating of perceived exertion
SF-36 = Short Form (36) Health Survey
SD = standard deviation
VO max = maximal oxygen consumption
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ades 2000 Not RCT
Austin 2005 Not home- versus centre-based cardiac rehabilitation comparison
Babu 2016 Comparator group did not receive exercise-based cardiac rehabilitation
Belardinelli 1999 Not home- versus centre-based cardiac rehabilitation comparison
Bubnova 2014 Comparator group did not receive exercise-based cardiac rehabilitation
Byrnes 2015 Comparator group did not receive exercise-based cardiac rehabilitation
Chan 2012 Comparator group did not receive exercise-based cardiac rehabilitation
Chen 2016 Comparator group did not receive exercise-based cardiac rehabilitation
Chien 2011 Comparator group did not receive exercise-based cardiac rehabilitation
Chow 2015 Intervention not exercise-based cardiac rehabilitation
Cinar 2015 All patients had a Left ventricular Assist Device
Corvera-Tindel 2004 Not home- versus centre-based cardiac rehabilitation comparison
Dracup 2007 Not home- versus centre-based cardiac rehabilitation comparison
Haddadzadeh 2011 Comparator group did not receive exercise-based cardiac rehabilitation
HF ACTION 2009 Not home- versus centre-based cardiac rehabilitation comparison
Higgins 2001 Comparator group did not receive exercise-based cardiac rehabilitation
Hovland-Tanneryd 2016 Intervention not exercise-based cardiac rehabilitation
Jolly 2009 Not home- versus centre-based cardiac rehabilitation comparison
Khalife-Zadeh 2015 Intervention includes home- and centre-based cardiac rehabilitation
Kim 2011 Not a RCT
Lear 2014 Comparator group did not receive exercise-based cardiac rehabilitation
Lee 2013 Comparator group did not receive exercise-based cardiac rehabilitation
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(Continued)
Maddison 2015 Comparator group did not receive formal exercise-based cardiac rehabilitation
Maru 2015 Intervention not exercise-based cardiac rehabilitation
McKelvie 2002 Not home- versus centre-based cardiac rehabilitation comparison
Moosavi-Sohroforouzani 2015 Not a RCT
Mutwalli 2012 Not home- versus centre-based cardiac rehabilitation comparison
Oka 2000 Relevant outcomes not reported
Olson 2015 Comparator group did not receive exercise-based cardiac rehabilitation
Pfaeffli 2015 Intervention not exercise-based cardiac rehabilitation
Piotrowicz 2015 Comparator group did not receive exercise-based cardiac rehabilitation
Salavati 2016 Comparator group did not receive exercise-based cardiac rehabilitation
Senuzun 2006 Trial experimental arm received home-based cardiac rehabilitation; the programme issued in control
arm was not described
Siabani 2016 Intervention not exercise-based cardiac rehabilitation
Sinclair 2005 Trial experimental arm received home-based cardiac rehabilitation, while the control group did not
receive centre based cardiac rehabilitation (only 6% (N = 12) of the participants in the control
group were referred to cardiac rehabilitation and only 3% (N = 8) were known to have attended)
Takase 2015 Comparator group did not receive exercise-based cardiac rehabilitation
Tygesen 2001 Both trial arms received home-based cardiac rehabilitation
Vahedian-Azimi 2016 Intervention not exercise-based cardiac rehabilitation
Vibulchai 2016 Intervention not exercise-based cardiac rehabilitation
Wolkanin-Bartnik 2011 Intervention not exercise-based cardiac rehabilitation
Xueyu 2015 Comparator group did not receive exercise-based cardiac rehabilitation
RCT = randomised controlled trial
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Characteristics of studies awaiting assessment [ordered by study ID]
Doletsky 2013
Methods RCT
Participants 70 patients during 3 to 14 days after planned PCI were randomized into three groups
Interventions 1. Ambulatory training in the hospital 3 times per week with ECG control for 8 weeks
2. One hospital based ECG-controlled training session followed within the first week with 2 home-based training
sessions on stationary bike under simultaneous tele-ECG and video-control with use of Skype via Internet. This was
followed by home-based sessions with patient’s weekly phone reports and training diaries
3. Uncontrolled home-based training.
Outcomes Peak VO
Notes We were unable to trace authors or find full publication of this conference abstract
Gelati 2013
Methods RCT
Participants 46 patients, aged 60 years (range 38 -75), with Left Ventricle Dysfunction, stable with optimal treatment, with EF<
45%. The patients were in sinusal rhythm
Interventions Subjects were randomized and stratified to 3 groups: Group 1: 16 patients at high intensity aerobic exercise training,
warmed up for 10 minutes at 60-70% of PHR of exercise test, before walking 4 minute intervals at 90-95% of PHR
of exercise test. Each interval was separated by 3 minutes active pauses, walking at 70% of PHR. Total exercise time
was 38 minutes. Group 2: 14 patients at moderate continuous training, walked at 70-75% of PHR; Group 3: 16
patients at home standard training (control group). The rehabilitation protocol was, 3 times per week for 24 sessions
(groups 1 e 2). All patients at the end of the cardiac rehabilitation or after two months (group 3), repeated the baseline
tests
Outcomes Adverse effects (arrhythmias, myocardial ischaemic events and/or symptoms); Nt-pro BNP; 6MWT
Notes We were unable to trace authors or find full publication of this conference abstract
Pomeshkina 2012
Methods RCT
Participants 112 patients (mean age 56.8 ± 5.5 years) with coronary artery disease (CAD), 1 month post-CABG
Interventions Group 1 with supervised cycling training (SCT) (N = 35),
Group 2 - home-based walking training (HBWT) (N = 36)
Group 3 - comparison group (N = 41).
Subjects did 3 trainings per week for 3 months
Outcomes Adherence to medication
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Pomeshkina 2012 (Continued)
Notes We were unable to find full publication of this conference abstract. Authors were emailed, but no reply was received
Characteristics of ongoing studies [ordered by study ID]
ACTRN12616000426482
Trial name or title SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: A Random-
ized Controlled Trial Protocol [SMART-REHAB Trial]
Methods Randomised, parallel assignment, single blinded
Participants Inclusion criteria:
• Acute coronary syndromes with documented coronary artery disease
• Smartphone ownership
• Adults aged over 18 years
Exclusion criteria:
• Untreated ventricular tachycardia
• Severe heart failure
• Significant residual coronary artery disease requiring revascularisation treatment with coronary artery
bypass surgery
• Life-threatening coexisting disease with life-expectancy less than 1 year
• Significant exercise limitations for reasons other than CHD
Interventions The smart phone-based secondary prevention program will be delivered over 8 weeks starting at time of
discharge from hospital through a smart phone application (app). This is a multi-faceted intervention with
particular emphasis on early mobilisation. The app provides a platform to deliver a comprehensive secondary
prevention program. The different components of the program include an Exercise Prescription Control
group is assigned to usual post-discharge acute coronary syndrome care which includes traditional cardiac
rehabilitation
Outcomes Exercise capacity; risk factors HRQoL
Starting date 04/04/2016
Contact information Dr Matia Yudi matias.yudi@austin.org.au
Notes
Maddison 2014
Trial name or title The remote exercise monitoring trial for exercise-based cardiac rehabilitation (REMOTE-CR): a randomised
controlled trial protocol
Methods A two-arm, parallel, non-inferiority, randomised controlled trial will be conducted at two sites inNewZealand
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Maddison 2014 (Continued)
Participants 162 adults aged 18 years or more,with a diagnosis of CHD (angina, myocardial infarction, percutaneous
coronary intervention or coronary revascularisation)
within the previous six months. Participants are current outpatients who have been clinically stable for at least
six weeks, are able to perform exercise, and can understand and write English
Interventions 12-week program of technology-assisted, home-based, remote monitored exercise-based cardiac rehabilita-
tion (intervention) versus 8 to 12 week program of standard supervised exercise-based cardiac rehabilitation
(control)
Outcomes V O max; cardiovascular risk factors; HRQoL; costs
Starting date Registered 7 August 2014
Contact information r.maddison@auckland.ac.nz
Notes Study ID number: ACTRN12614000843651
NCT01567189
Trial name or title Cost-effectiveness of Outpatient Versus Hospital Cardiac Rehabilitation (CERC1)
Methods Randomised, parallel assignment, open label
Participants Inclusion criteria:
• patients referred to cardiac rehabilitation program in the first 12 weeks after an acute coronary
syndrome (myocardial infarction or unstable angina) or after percutaneous or surgical revascularization who
have no contraindication to participate in the program
Exclusion criteria:
• contra-indication to participate in the program
• high-risk criteria for home cardiac rehabilitation
Interventions Hospital-based cardiac rehabilitation versus home-based cardiac rehabilitation
Outcomes Morbidity, re-admissions, percutaneous or surgical revascularisation, costs
Starting date April 2012
Contact information Fernando Aros Borau, LUISFDO.AROSBORAU@osakidetza.net
Notes
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NCT02047942
Trial name or title Telerehabilitation in Coronary Heart Disease (TRiCH)
Methods Randomised, parallel assignment, single blind
Participants 105 participants
Inclusion criteria:
• Patients with CAD (post-PCI, post-MI, post-CABG)
• Patients on optimal medical treatment and stable with regard to symptoms and pharmacotherapy for at
least 6 weeks
• Patients have successfully completed the 3 month ambulatory cardiac rehabilitation in hospital program
• 39 years < age < 76 years
• Access to Internet facilities or PC at home
Exclusion criteria:
• Significant undercurrent illness last 6 weeks
• Known severe ventricular arrhythmia with functional or prognostic significance; significant myocardial
ischaemia, haemodynamic deterioration or exercise-induced arrhythmia at screening or heart disease that
limits exercise
• Comorbidity that may significantly influence one-year prognosis
• Functional of mental disability that may limit exercise
Interventions Centre-based cardiac rehabilitation versus Home-based training with telemonitoring guidance
Outcomes Exercise tolerance; comparison of evolution of exercise tolerance from baseline to 12 weeks and one year
Starting date February 2014
Contact information Luc Vanhees, PhD, luc.vanhees@faber.kuleuven.be
Notes
NCT02711631
Trial name or title Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation
Methods Randomised, parallel assignment, single blind
Participants Inclusion criteria:
• diagnosis of stable ischaemic heart disease
• received a recent uncomplicated coronary angioplasty or coronary artery bypass graft
• participants will be required to have a referral for cardiac rehabilitation.
Exclusion criteria:
• a history of heart failure
• a history of cardiac arrhythmia requiring cardioversion
• an implantable cardiac defibrillator
• unable to cycle on a bike
Interventions MedBIKE - exercise cardiac rehabilitation system that allows participants to perform clinical cardiac rehabil-
itation at home versus standard cardiac rehabilitation
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NCT02711631 (Continued)
Outcomes Fitness; compliance
Starting date May 2016
Contact information Contact: Peter W Wood, MSc; pwwood@ualberta.ca
Notes
NCT02791685
Trial name or title Smartphone Delivered In-home Cardiopulmonary Rehabilitation
Methods Randomised, parallel assignment, open label
Participants Inclusion criteria:
Meet eligibility for cardiac rehabilitation program as defined by Centres for Medicare and Medicaid Services
(CMS)
1. Following acute myocardial infarction (within the preceding 12 months)
2. Coronary artery bypass grafting (CABG)
3. Current stable angina pectoris
4. Heart valve repair or replacement
5. Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting
6. Heart or heart-lung transplant
7. Other diagnosis by specific physician referral
Interventions MULTIFIT CR program delivered by the Movn smart phone application versus centre-based CR
Outcomes Six minute walk test; HRQoL
Starting date 2 June 2016
Contact information Abarmard Zafari, MD, azafari@emory.edu
Notes
NCT02796404
Trial name or title Homebased Monitoring Cardiac Rehabilitation Program (NUUBO)
Methods Randomised, parallel assignment, open label
Participants Inclusion criteria:
All of the following:
• Age ≤ 80 years.
• Stable Ischemic heart disease, revascularized by angioplasty or underwent surgery by coronary bypass ≤
one year from the acute episode.
• Good cognitive level.
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NCT02796404 (Continued)
• Ability to perform aerobic exercise tape or cycle ergometer.
• Understand the use of a mobile Smartphone or Tablet.
• Signature of informed consent;
and at least one of the following:
• Ventricular dysfunction by ejection fraction (FE) 40 - 50%.
• Functional capacity 5-7 metabolic equivalents (METS).
• Raising the blood pressure with the effort.
Interventions Home-based cardiac rehabilitation program versus traditional cardiac rehabilitation program
Outcomes Cardiovascular risk factors; functional capacity; adherence; safety
Starting date Aug 2015
Contact information Raquel Bravo, MD, rbravoescobar@yahoo.es
Notes
NTR5156
Trial name or title Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalized patient-
centred ICT platform: the SmartCare-CAD study
Methods Randomised, parallel assignment
Participants Inclusion criteria:
• Age 18 or over
• Referral for cardiac rehabilitation due to stable angina pectoris, acute coronary syndrome (with or
without ST-segment elevation) or after coronary revascularization, i.e. (primary or elective) percutaneous
coronary intervention (PCI) or coronary artery bypass grafting (CABG)
• Indication for exercise training as a part of outpatient cardiac rehabilitation, based on the individual
needs assessment from the guidelines on outpatient cardiac rehabilitation of the Dutch Society of Cardiology
• Internet access at home.
Exclusion criteria:
• Ventricular arrhythmia or myocardial ischaemia during low to moderate exercise intensity as assessed
by symptom limited exercise testing at baseline
• Heart failure NYHA class IV
• Severe comorbidity precluding exercise training (e.g. orthopaedic or neurological conditions
Interventions The core component of the study intervention is a secured and personalized patient-centred web-based ICT
platform. This platform enables patients to register, evaluate and adjust rehabilitation goals, training goals
and medication and to upload and inspect exercise training and daily physical activity data (as measured by a
heart rate monitor and accelerometer). After three supervised in-hospital training sessions, patients are given
the opportunity to continue exercise training at home, based on prescriptions from their physical therapist
Comparator: Centre based cardiac rehabilitation, consisting of one or more of the following treatments:
exercise training, an information program, a relaxation program, psycho-educative prevention program and/
or individual treatment by a psychologist or dietician. Exercise training sessions are performed under direct
supervision of a physical therapist specialised in cardiac rehabilitation
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NTR5156 (Continued)
Outcomes HRQoL, cost effectiveness
Starting date 01/06/2015
Contact information Hareld MC Kemps, Máxima Medical Centre, Department of Sport Medicine, P.O. Box 7777 5500 MB
Veldhoven The Netherlands; H.Kemps@wxs.nl
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. home-base vs centre-based
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Total mortality 13 1505 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [0.65, 2.16]
2 Exercise capacity ≤ 12 months 26 2255 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.28, 0.02]
3 Exercise capacity 12 to 24
months
3 1074 Std. Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.01, 0.23]
4 Completers 26 2615 Risk Ratio (M-H, Random, 95% CI) 1.04 [1.00, 1.08]
5 Total cholesterol 3 to 12 months 10 1151 Mean Difference (IV, Random, 95% CI) 0.06 [-0.10, 0.23]
6 HDL cholesterol 3 to 12 months 8 925 Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.11, -0.03]
7 LDL cholesterol 3 to 12 months 6 430 Mean Difference (IV, Random, 95% CI) 0.04 [-0.14, 0.22]
8 Triglycerides 3 to 12 months 6 396 Mean Difference (IV, Fixed, 95% CI) 0.15 [0.00, 0.29]
9 Systolic blood pressure 3 to 12
months
12 1292 Mean Difference (IV, Random, 95% CI) -0.27 [-3.13, 2.60]
10 Diastolic blood pressure 3 to
12 months
11 1146 Mean Difference (IV, Random, 95% CI) 0.74 [-1.04, 2.53]
11 Smoking 3 to 12 months 6 986 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.83, 1.27]
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Analysis 1.1. Comparison 1 home-base vs centre-based, Outcome 1 Total mortality.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 1 Total mortality
Study or subgroup home-based CR centre-based CR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aamot 2014 Group 0/14 0/28 Not estimable
Aamot 2014 Treadmill 0/14 0/34 Not estimable
Bell 1998 12/152 7/99 44.7 % 1.12 [ 0.46, 2.74 ]
Dalal 2007 4/60 1/44 6.1 % 2.93 [ 0.34, 25.35 ]
Daskapan 2005 1/15 0/14 2.7 % 2.81 [ 0.12, 63.83 ]
Hadadzadeh 2013 0/35 0/35 Not estimable
Jolly 2007 3/263 3/262 15.9 % 1.00 [ 0.20, 4.89 ]
Kraal 2014 0/29 0/26 Not estimable
Miller 1984 Brief 0/31 0/30 Not estimable
Miller 1984 Expanded 0/30 0/33 Not estimable
Moholdt 2012 0/14 1/16 7.4 % 0.38 [ 0.02, 8.59 ]
Oerkild 2011 4/36 3/39 15.2 % 1.44 [ 0.35, 6.02 ]
Piotrowicz 2010 0/77 1/75 8.0 % 0.32 [ 0.01, 7.85 ]
Total (95% CI) 770 735 100.0 % 1.19 [ 0.65, 2.16 ]
Total events: 24 (home-based CR), 16 (centre-based CR)
Heterogeneity: Chi2 = 2.26, df = 6 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.56 (P = 0.58)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours home-based CR Favours centre-based CR
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Analysis 1.2. Comparison 1 home-base vs centre-based, Outcome 2 Exercise capacity ≤ 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 2 Exercise capacity≤ 12 months
Study or subgroup home-based CR centre-based CR
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Aamot 2014 Group 13 37.2 (5.2) 25 36 (6.2) 2.9 % 0.20 [ -0.47, 0.87 ]
Aamot 2014 Treadmill 13 37.2 (5.2) 32 39 (8) 3.0 % -0.24 [ -0.89, 0.41 ]
Arthur 2002 113 5.22 (2.1) 109 5.21 (2) 5.7 % 0.00 [ -0.26, 0.27 ]
Bell 1998 91 7.29 (2.81) 91 7.1 (3.12) 5.5 % 0.06 [ -0.23, 0.35 ]
Carlson 2000 34 7.4 (1.5) 29 6.8 (1.7) 3.9 % 0.37 [ -0.13, 0.87 ]
Cowie 2012 15 318 (153) 15 312 (155) 2.7 % 0.04 [ -0.68, 0.75 ]
Dalal 2007 60 9.66 (3.1) 44 7.68 (2.8) 4.6 % 0.66 [ 0.26, 1.06 ]
Daskapan 2005 11 23.6 (7.4) 11 23.3 (6.8) 2.2 % 0.04 [ -0.80, 0.88 ]
Gordon 2002 Community 40 1.6 (2.2) 22 1.6 (2.1) 3.8 % 0.0 [ -0.52, 0.52 ]
Gordon 2002 Supervised 49 0.9 (1.9) 22 1.6 (2.1) 3.9 % -0.35 [ -0.86, 0.15 ]
Grace 2016 Mixed 9 18.63 (6.11) 19 19.4 (4.97) 2.4 % -0.14 [ -0.93, 0.65 ]
Grace 2016 Women 9 18.63 (6.11) 21 19.54 (4.7) 2.4 % -0.17 [ -0.95, 0.61 ]
Hadadzadeh 2015 60 11 (1.2) 60 11.5 (1.2) 4.9 % -0.41 [ -0.78, -0.05 ]
Jolly 2007 191 391.3 (162.11) 179 407.4 (157.6) 6.2 % -0.10 [ -0.30, 0.10 ]
Karapolat 2009 36 18.12 (6) 32 19.43 (4.59) 4.1 % -0.24 [ -0.72, 0.24 ]
Kassaian 2000 60 8.9 (2.9) 65 12.4 (2.7) 4.8 % -1.24 [ -1.63, -0.86 ]
Kraal 2014 25 26 (5.9) 25 26.1 (7.6) 3.6 % -0.01 [ -0.57, 0.54 ]
Marchionni 2003 74 3650.67 (3957.23) 79 3509.33 (3343.82) 5.3 % 0.04 [ -0.28, 0.36 ]
Miller 1984 Brief 33 8 (1.5) 31 7.9 (1.3) 4.0 % 0.07 [ -0.42, 0.56 ]
Miller 1984 Expanded 33 7.9 (1.5) 30 8.9 (1.4) 3.9 % -0.68 [ -1.19, -0.17 ]
Moholdt 2012 12 27.7 (6.5) 14 30.2 (4.3) 2.4 % -0.45 [ -1.23, 0.34 ]
Oerkild 2011 30 -2.5 (3.63) 34 -2 (3.3) 4.0 % -0.14 [ -0.63, 0.35 ]
Piotrowicz 2010 75 462 (91) 56 462 (92) 5.1 % 0.0 [ -0.35, 0.35 ]
Sparks 1993 10 1900 (400) 10 1950 (150) 2.0 % -0.16 [ -1.04, 0.72 ]
Varnfield 2014 43 571 (88) 25 601 (95) 3.9 % -0.33 [ -0.82, 0.17 ]
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(. . . Continued)
Study or subgroup home-based CR centre-based CR
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Wu 2006 18 22.9 (3.6) 18 24.2 (4.4) 3.0 % -0.32 [ -0.97, 0.34 ]
Total (95% CI) 1157 1098 100.0 % -0.13 [ -0.28, 0.02 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 67.22, df = 25 (P<0.00001); I2 =63%
Test for overall effect: Z = 1.72 (P = 0.086)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 home-base vs centre-based, Outcome 3 Exercise capacity 12 to 24 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 3 Exercise capacity 12 to 24 months
Study or subgroup home-based CR centre-based CR
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arthur 2002 96 5.79 (1.6) 102 5.44 (1.5) 18.4 % 0.23 [ -0.05, 0.50 ]
Jolly 2007 179 5.35 (1.44) 163 5.28 (1.44) 31.9 % 0.05 [ -0.16, 0.26 ]
Marchionni 2003 267 4050.33 (4421.88) 267 3580.67 (3650.13) 49.8 % 0.12 [ -0.05, 0.29 ]
Total (95% CI) 542 532 100.0 % 0.11 [ -0.01, 0.23 ]
Heterogeneity: Chi2 = 0.97, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.061)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 home-base vs centre-based, Outcome 4 Completers.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 4 Completers
Study or subgroup home-based CR centre-based CR Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Aamot 2014 Group 13/14 25/28 3.1 % 1.04 [ 0.86, 1.26 ]
Aamot 2014 Treadmill 13/14 32/34 3.7 % 0.99 [ 0.83, 1.17 ]
Arthur 2002 113/120 109/122 7.6 % 1.05 [ 0.98, 1.14 ]
Carlson 2000 35/38 32/42 3.1 % 1.21 [ 1.00, 1.47 ]
Cowie 2012 15/20 15/20 1.1 % 1.00 [ 0.70, 1.43 ]
Dalal 2007 50/60 34/44 3.0 % 1.08 [ 0.89, 1.31 ]
Daskapan 2005 11/15 11/14 0.9 % 0.93 [ 0.62, 1.41 ]
Gordon 2002 Community 45/49 23/26 3.9 % 1.04 [ 0.88, 1.22 ]
Gordon 2002 Supervised 52/54 22/26 3.6 % 1.14 [ 0.96, 1.35 ]
Grace 2016 Mixed 9/28 19/59 0.4 % 1.00 [ 0.52, 1.92 ]
Grace 2016 Women 9/27 21/55 0.4 % 0.87 [ 0.46, 1.64 ]
Hadadzadeh 2013 35/35 31/35 5.0 % 1.13 [ 0.99, 1.28 ]
Hadadzadeh 2015 55/60 58/60 6.9 % 0.95 [ 0.87, 1.04 ]
Jolly 2007 239/263 236/262 8.7 % 1.01 [ 0.95, 1.07 ]
Karapolat 2009 36/37 32/37 4.7 % 1.13 [ 0.98, 1.29 ]
Kassaian 2000 60/60 65/65 9.8 % 1.00 [ 0.97, 1.03 ]
Kraal 2014 25/29 25/26 3.8 % 0.90 [ 0.76, 1.06 ]
Marchionni 2003 74/90 79/90 5.3 % 0.94 [ 0.83, 1.06 ]
Miller 1984 Brief 28/30 27/31 3.8 % 1.07 [ 0.91, 1.26 ]
Miller 1984 Expanded 26/33 26/30 2.4 % 0.91 [ 0.73, 1.14 ]
Moholdt 2012 12/14 14/16 1.7 % 0.98 [ 0.74, 1.30 ]
Oerkild 2011 30/36 34/39 3.2 % 0.96 [ 0.79, 1.16 ]
Piotrowicz 2010 75/77 56/75 4.7 % 1.30 [ 1.14, 1.50 ]
Sparks 1993 9/10 10/10 1.9 % 0.90 [ 0.69, 1.18 ]
Varnfield 2014 46/60 26/60 1.4 % 1.77 [ 1.28, 2.44 ]
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(. . . Continued)
Study or subgroup home-based CR centre-based CR Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Wu 2006 18/18 18/18 6.1 % 1.00 [ 0.90, 1.11 ]
Total (95% CI) 1291 1324 100.0 % 1.04 [ 1.00, 1.08 ]
Total events: 1133 (home-based CR), 1080 (centre-based CR)
Heterogeneity: Tau2 = 0.00; Chi2 = 53.58, df = 25 (P = 0.00075); I2 =53%
Test for overall effect: Z = 1.74 (P = 0.082)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 home-base vs centre-based, Outcome 5 Total cholesterol 3 to 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 5 Total cholesterol 3 to 12 months
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bell 1998 60 5.9 (1.1) 61 5.2 (0.8) 10.6 % 0.70 [ 0.36, 1.04 ]
Carlson 2000 34 4.68 (0.78) 28 4.71 (0.83) 9.0 % -0.03 [ -0.43, 0.37 ]
Dalal 2007 60 4.6 (1.12) 44 4.45 (1.01) 8.9 % 0.15 [ -0.26, 0.56 ]
Gordon 2002 Community 45 -0.32 (0.89) 22 -0.31 (0.61) 10.0 % -0.01 [ -0.37, 0.35 ]
Gordon 2002 Supervised 52 -0.29 (0.78) 23 -0.31 (0.61) 11.1 % 0.02 [ -0.31, 0.35 ]
Jolly 2007 232 3.99 (0.9) 233 3.88 (0.83) 16.5 % 0.11 [ -0.05, 0.27 ]
Kassaian 2000 60 5.58 (1.09) 65 5.63 (0.83) 10.7 % -0.05 [ -0.39, 0.29 ]
Moholdt 2012 12 4.3 (0.7) 14 4.3 (1) 4.8 % 0.0 [ -0.66, 0.66 ]
Oerkild 2011 30 -0.2 (0.56) 34 0.1 (0.59) 12.4 % -0.30 [ -0.58, -0.02 ]
Varnfield 2014 29 3.3 (1) 13 3.27 (0.8) 6.0 % 0.03 [ -0.54, 0.60 ]
Total (95% CI) 614 537 100.0 % 0.06 [ -0.10, 0.23 ]
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(. . . Continued)
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.04; Chi2 = 21.00, df = 9 (P = 0.01); I2 =57%
Test for overall effect: Z = 0.75 (P = 0.46)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 home-base vs centre-based, Outcome 6 HDL cholesterol 3 to 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 6 HDL cholesterol 3 to 12 months
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carlson 2000 32 0.98 (0.21) 28 0.98 (0.26) 11.2 % 0.0 [ -0.12, 0.12 ]
Gordon 2002 Community 45 -0.01 (0.25) 22 0.02 (0.25) 10.1 % -0.03 [ -0.16, 0.10 ]
Gordon 2002 Supervised 52 0.03 (0.25) 23 0.02 (0.25) 10.9 % 0.01 [ -0.11, 0.13 ]
Jolly 2007 233 1.29 (0.39) 233 1.33 (0.62) 18.5 % -0.04 [ -0.13, 0.05 ]
Kassaian 2000 60 0.85 (0.21) 65 0.98 (0.18) 34.6 % -0.13 [ -0.20, -0.06 ]
Moholdt 2012 12 1.2 (0.2) 14 1.4 (0.2) 6.9 % -0.20 [ -0.35, -0.05 ]
Oerkild 2011 30 -0.03 (0.47) 34 0.03 (0.5) 2.9 % -0.06 [ -0.30, 0.18 ]
Varnfield 2014 29 1.02 (0.4) 13 0.98 (0.2) 5.0 % 0.04 [ -0.14, 0.22 ]
Total (95% CI) 493 432 100.0 % -0.07 [ -0.11, -0.03 ]
Heterogeneity: Chi2 = 10.75, df = 7 (P = 0.15); I2 =35%
Test for overall effect: Z = 3.28 (P = 0.0010)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 home-base vs centre-based, Outcome 7 LDL cholesterol 3 to 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 7 LDL cholesterol 3 to 12 months
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carlson 2000 30 2.98 (0.67) 27 2.87 (0.6) 15.5 % 0.11 [ -0.22, 0.44 ]
Gordon 2002 Community 45 -0.22 (0.72) 22 -0.28 (0.59) 15.8 % 0.06 [ -0.26, 0.38 ]
Gordon 2002 Supervised 52 -0.3 (0.73) 23 -0.28 (0.59) 16.4 % -0.02 [ -0.33, 0.29 ]
Kassaian 2000 60 3.72 (0.96) 65 3.31 (0.7) 17.2 % 0.41 [ 0.11, 0.71 ]
Oerkild 2011 30 -0.2 (0.28) 34 -0.02 (0.54) 22.4 % -0.18 [ -0.39, 0.03 ]
Varnfield 2014 29 1.6 (0.6) 13 1.69 (0.6) 12.8 % -0.09 [ -0.48, 0.30 ]
Total (95% CI) 246 184 100.0 % 0.04 [ -0.14, 0.22 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 10.93, df = 5 (P = 0.05); I2 =54%
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 home-base vs centre-based, Outcome 8 Triglycerides 3 to 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 8 Triglycerides 3 to 12 months
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carlson 2000 34 1.58 (0.86) 27 1.63 (0.76) 12.8 % -0.05 [ -0.46, 0.36 ]
Gordon 2002 Community 45 -0.21 (0.72) 22 -0.14 (0.6) 19.7 % -0.07 [ -0.40, 0.26 ]
Gordon 2002 Supervised 52 0.03 (0.72) 23 -0.14 (0.6) 21.5 % 0.17 [ -0.14, 0.48 ]
Kassaian 2000 60 2.16 (0.94) 65 1.69 (0.61) 26.9 % 0.47 [ 0.19, 0.75 ]
Moholdt 2012 12 1.4 (0.7) 14 1.4 (0.2) 12.6 % 0.0 [ -0.41, 0.41 ]
Varnfield 2014 29 1.32 (0.8) 13 1.22 (0.9) 6.5 % 0.10 [ -0.47, 0.67 ]
Total (95% CI) 232 164 100.0 % 0.15 [ 0.00, 0.29 ]
Heterogeneity: Chi2 = 8.23, df = 5 (P = 0.14); I2 =39%
Test for overall effect: Z = 2.01 (P = 0.044)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 home-base vs centre-based, Outcome 9 Systolic blood pressure 3 to 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 9 Systolic blood pressure 3 to 12 months
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Aamot 2014 Group 13 135 (14) 25 138 (16) 5.7 % -3.00 [ -12.86, 6.86 ]
Aamot 2014 Treadmill 13 135 (14) 32 134 (14) 6.4 % 1.00 [ -8.02, 10.02 ]
Bell 1998 63 136.3 (20.9) 63 137.2 (20.9) 8.1 % -0.90 [ -8.20, 6.40 ]
Carlson 2000 35 125 (18) 32 137 (16) 7.2 % -12.00 [ -20.14, -3.86 ]
Dalal 2007 60 133.8 (16.1) 44 135.4 (22) 7.7 % -1.60 [ -9.27, 6.07 ]
Daskapan 2005 11 113.6 (16.9) 11 113.6 (21.4) 2.7 % 0.0 [ -16.11, 16.11 ]
Gordon 2002 Community 45 -6.3 (13.9) 22 -4.3 (11.1) 9.6 % -2.00 [ -8.17, 4.17 ]
Gordon 2002 Supervised 52 -5.2 (8.7) 23 -4.3 (11.1) 11.1 % -0.90 [ -6.02, 4.22 ]
Jolly 2007 235 133.55 (18.37) 232 132.18 (21.54) 13.5 % 1.37 [ -2.26, 5.00 ]
Kassaian 2000 60 120 (11) 65 113 (9) 13.7 % 7.00 [ 3.46, 10.54 ]
Oerkild 2011 30 4.6 (20.7) 34 1.4 (21.7) 5.3 % 3.20 [ -7.20, 13.60 ]
Varnfield 2014 46 123.1 (17.12) 46 124.4 (15) 9.0 % -1.30 [ -7.88, 5.28 ]
Total (95% CI) 663 629 100.0 % -0.27 [ -3.13, 2.60 ]
Heterogeneity: Tau2 = 12.31; Chi2 = 24.30, df = 11 (P = 0.01); I2 =55%
Test for overall effect: Z = 0.18 (P = 0.86)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours home-based CR Favours centre-based CR
115Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.10. Comparison 1 home-base vs centre-based, Outcome 10 Diastolic blood pressure 3 to 12
months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 10 Diastolic blood pressure 3 to 12 months
Study or subgroup home-based CR centre-based CR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Aamot 2014 Group 13 83 (8) 25 87 (8) 6.8 % -4.00 [ -9.36, 1.36 ]
Aamot 2014 Treadmill 13 83 (8) 32 81 (8) 7.1 % 2.00 [ -3.16, 7.16 ]
Carlson 2000 35 81 (10) 32 82 (8) 8.6 % -1.00 [ -5.32, 3.32 ]
Dalal 2007 60 81.3 (10.8) 44 78.7 (10.6) 8.9 % 2.60 [ -1.56, 6.76 ]
Daskapan 2005 11 76.8 (8.4) 11 80 (10.9) 3.8 % -3.20 [ -11.33, 4.93 ]
Gordon 2002 Community 45 -2.3 (7.4) 22 -3.3 (7.3) 9.8 % 1.00 [ -2.74, 4.74 ]
Gordon 2002 Supervised 52 -2 (6.1) 23 -3.3 (7.3) 10.6 % 1.30 [ -2.11, 4.71 ]
Jolly 2007 235 74.94 (9.82) 232 74.21 (10.66) 14.6 % 0.73 [ -1.13, 2.59 ]
Kassaian 2000 60 80 (3) 65 76 (8) 14.0 % 4.00 [ 1.91, 6.09 ]
Oerkild 2011 30 3.9 (11.4) 34 -2.1 (11.6) 6.3 % 6.00 [ 0.36, 11.64 ]
Varnfield 2014 46 71.6 (8.9) 26 76.2 (7.6) 9.5 % -4.60 [ -8.49, -0.71 ]
Total (95% CI) 600 546 100.0 % 0.74 [ -1.04, 2.53 ]
Heterogeneity: Tau2 = 4.77; Chi2 = 24.74, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 home-base vs centre-based, Outcome 11 Smoking 3 to 12 months.
Review: Home-based versus centre-based cardiac rehabilitation
Comparison: 1 home-base vs centre-based
Outcome: 11 Smoking 3 to 12 months
Study or subgroup home-based CR centre-based CR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bell 1998 8/70 15/68 14.7 % 0.52 [ 0.24, 1.14 ]
Dalal 2007 15/60 10/44 11.1 % 1.10 [ 0.55, 2.21 ]
Gordon 2002 Community 6/49 1/26 1.3 % 3.18 [ 0.40, 25.05 ]
Gordon 2002 Supervised 4/54 1/26 1.3 % 1.93 [ 0.23, 16.38 ]
Jolly 2007 49/263 45/262 43.5 % 1.08 [ 0.75, 1.57 ]
Oerkild 2011 28/30 31/34 28.1 % 1.02 [ 0.89, 1.18 ]
Total (95% CI) 526 460 100.0 % 1.02 [ 0.83, 1.27 ]
Total events: 110 (home-based CR), 103 (centre-based CR)
Heterogeneity: Chi2 = 4.48, df = 5 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Results of univariate meta-regression analysis for total mortality
Explanatory variable (n
trials)
Exp(slope)* 95%CI univariate P value Proportion of variation
explained
Interpretation
Case mix (% MI pa-
tients) (n = 6)
RR = 0.997 0.970 to 1.024
P = 0.743
Not calculable² No evidence that RR is as-
sociated with case mix
Dose of exercise
(number of weeks of ex-
ercise training x average
number of sessions/week
x average duration of ses-
sion in min) (n = )
Not calculable¹ Not calculable¹ Not calculable¹ No evidence that RR is as-
sociatedwith increased dose
of exercise
Type of cardiac rehabili-
tation (exercise only ver-
sus comprehensive car-
RR = 2.464 0.038 to 160.487
P = 0.603
Not calculable² No evidence that RR is as-
sociatedwith type of cardiac
rehabilitation
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Table 1. Results of univariate meta-regression analysis for total mortality (Continued)
diac rehabilitation) (n =
7)
Duration of follow-up
(months) (n = 7)
RR = 1.022 0.872 to 1.198
P = 0.737
Not calculable² No evidence thatRR is asso-
ciated with duration of fol-
low-up
Year of publication (n =
7)
RR = 0.988 0.851 to 1.147
P = 0.842
Not calculable² No evidence that RR is as-
sociated with year of publi-
cation
Risk of bias (low risk in
≥ 4 items versus < 4
items) (n = 7)
RR = 0.902 0.197 to 4.127
P = 0.868
Not calculable² No evidence that RR is as-
sociated with risk of bias
Study location (n = 7) RR = 0.846 0.398 to 1.822
P = 0.613
Not calculable² No evidence that RR is as-
sociatedwith study location
Sample size (n = 7) RR = 1.001 0.995 to 1.006
P = 0.726
Not calculable² No evidence that RR is as-
sociated with sample size
¹ Not calculable due to insufficient observations
² Not calculable; Tau² of all studies = 0
Abbreviations: MI, myocardial infarction; RR, risk ratio
Table 2. Results of univariate meta-regression analysis for exercise capacity
Explanatory variable (n
trials)
Exp(slope)* 95% CI
Univariate P value
Proportion of variation ex-
plained
Interpretation
Case mix (% MI pa-
tients) (n = 23)
RR = 0.003 -0.001 to 0.008
P = 0.119
11.69% No evidence that RR is asso-
ciated with case mix
Dose of exercise (num-
ber of weeks of exercise
training x average num-
ber of
sessions/week x average
duration of session in
min) (n = 10)
RR = -0.001 -0.003 to 0.001
P = 0.245
Not calculable¹ No evidence that RR is asso-
ciated with increased dose of
exercise
Type of cardiac rehabili-
tation (exercise only ver-
sus comprehensive
cardiac rehabilitation)
(n = 26)
RR = 0.210 -0.026 to 0.447
P = 0.079
18.73% No evidence that RR is as-
sociated with type of cardiac
rehabilitation
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Table 2. Results of univariate meta-regression analysis for exercise capacity (Continued)
Duration of follow-up
(months) (n = 25)
RR = 0.003 -0.007 to 0.013
P = 0.544
-5.17% No evidence that RR is asso-
ciated with duration of fol-
low-up
Year of publication (n =
25)
RR = -0.002 -0.024 to 0.020
P = 0.841
-5.52% No evidence that RR is asso-
ciated with year of publica-
tion
Risk of bias (low risk in
≥ 4 items versus < 4
items) (n = 25)
RR = 0.097 -0.118 to 0.311
P = 0.360
2.94% No evidence that RR is asso-
ciated with risk of bias
Study location (n = 26) RR = 0.195 -0.033 to 0.423
P = 0.090
15.80% No evidence that risk ratio
is associated with study loca-
tion
Sample size (n = 25) RR = 0.000 -0.001 to 0.002
P = 0.837
-7.78% No evidence that RR is asso-
ciated with sample size
¹ Not calculable; Tau² of all studies = 0
Abbreviations: MI, myocardial infarction; RR, risk ratio
Table 3. Summary of health-related quality of life (HRQoL) at follow up for home and centre-based cardiac rehabilitation
Study ID Follow up HRQoL measure Outcome values at fol-
low up
Mean (SD or range)
Home- versus centre-
based, between groupP
value
Between-group differ-
ence
Aamot 2014 Treadmill
Home versus treadmill
group
12 weeks MacNew
Emotional domain
Social domain
Physical domain
Global
6.1 (3.9-6.7) versus 6.0
(4.8-6.5) ns
6.8 (4.9-7.0) versus 6.7
(5.6-6.9) ns
6.4 (4.9-6.9) versus 6.6
(5.4-6.9) ns
6.4 (4.7-6.8) versus 6.3
(5.2-6.7) ns
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Aamot 2014 Treadmill
Home versus group exer-
cise
12 weeks MacNew
Emotional domain
Social domain
Physical domain
Global
6.1 (3.9-6.7) versus 6.2
(3.6-6.9) ns
6.8 (4.9-7.0) versus 6.5
(5.0-7.0) ns
6.4 (4.9-6.9) versus 6.4
(5.2-7.0) ns
6.4 (4.7-6.8) versus 6.3
Home = Centre
Home = Centre
Home = Centre
Home = Centre
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Table 3. Summary of health-related quality of life (HRQoL) at follow up for home and centre-based cardiac rehabilitation
(Continued)
(4.5-6.7) ns
Arthur 2002
/Smith 2004
6 months
18 months
SF-36 PCS
MCS
SF-36 PCS
MCS
51.2 (6.4) versus 48.6 (7.
1) P = 0.003*
53.5 (6.4 ) versus 52.0
(8.1) P = 0.13*
48.3 (11.7) versus 47.6
(11.7) P = 0.67*
53.0 (10.9) versus 50.2
(10.9) P = 0.07*
Home > Centre
Home = Centre
Home = Centre
Home = Centre
Bell 1998 10.5 months NottinghamHealth Pro-
file
Energy
Pain
Emotional reactions
Sleep
Social isolation
Physical mobility
18.6 (28.4) versus 17.3
(30.7) P = 0.78*
6.6 (15.3) versus 7.4 (15.
5) P = 0.74*
6.6 (15.3) versus 7.4 (15.
5) P = 0.74*
6.6 (15.3) versus 16.9
(22.8) P = 0.0007*
3.7 (13.6) versus 6.7 (15.
0) P = 0.18*
6.9 (13.5) versus 9.1 (15.
9) P =0.33*
Home = Centre
Home = Centre
Home = Centre
Home < Centre
Home = Centre
Home = Centre
Cowie 2012 3 months SF-36 PCS
MCS
MLWHF total
Physical
Emotional
34.01 (11.04) versus 31.
33 (7.97) P = 0.82
44.44 (12.23) versus 48.
25 (11.21) P = 0.04
37 (NR) vs 32 (NR) P =
0.18
21 (NR) vs 19 (NR) P =
0.31
7 (NR) vs 7 (NR) P = 0.
13
Home = Centre
Home < Centre
Home = Centre
Home = Centre
Home = Centre
Marchionni 2003 2 months
8 months
14 months
Sickness Impact Profile 2.83 (14.5) versus 4.71
(11.1) P = 0.09*
2.83 (14.5) versus 3.40
(11.1) P = 0.61*
2.00 (8.3) versus 3.70
(11.8) P = 0.06*
Home = Centre
Home = Centre
Home = Centre
Dalal 2007/Taylor 2007 9 months MacNew Global score
EQ-5D
5.61 (1.14) versus 5.54
(1.10) P = 0.71
0.74 (0.04) versus 0.78
(0.04) P = 0.57
Home = Centre
Home = Centre
120Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Summary of health-related quality of life (HRQoL) at follow up for home and centre-based cardiac rehabilitation
(Continued)
Hadadzadeh 2015 12 week SF 36
Physical Composite
Score
Mental Composite Score
51.6 (4.7) versus 52.2 (4.
7) P = 0.94
46.4 (4.9) versus 47.6 (6.
4) P = 0.10
Home = Centre
Home = Centre
Jolly 2007 6 months
12 months
24 months
EQ-5D
SF-12
PCS
MCS
EQ-5D
0.74 (0.26) versus 0.76
(0.23) P = 0.37
42.28 (10.9) 42.56 (10.
8) P = 0.8
49.19 (10.1) 50.33 (9.6)
P = 0.3
0.74 (0.27) versus 0.76
(0.23) P = 0.52*
0.73 (0.29) versus 0.75
(0.26) P = 0.39*
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Karapolat 2009 8 weeks SF-36
Physical function
Physical role
Bodily pain
General health
Vitality
Social function
Emotional role
Mental health
59.39 (25.35) versus 69.
57 (20.94),P = 0.08*
39.81 (41.75) versus 48.
21 (45.10) P = 0.43*
62.42 (30.45) versus 74.
23 (19.66) P = 0.07*
47.25 (23.42) versus 53.
98 (25.00) P =0.33*
66.67 (19.82) versus 69.
81 (17.41) P = 0.49*
65.33 (25.60) versus 69.
33 (25.14) P = 0.52*
44.74 (39.77) versus 37.
16 (39.24) P =0.44*
64.67 (19.04) versus 70.
52 (20.37) P = 0.22*
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Kraal 2014 12 weeks MacNew (Dutch trans-
lation)
Physical scale
Emotional scale
Social scale
Total score
6.1 (0.6) versus 5.7 (0.8)
P = 0.16
5.9 (0.8) versus 5.6 (0.9)
P = 0.88
6.4 (0.6) versus 6.1 (0.7)
P = 0.26
6.1 (0.5) versus 5.8 (0.7)
P = 0.50
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Moholdt 2012 6 months MacNew
Emotional domain
Physical domain
Social domain
1.2 (0.2) versus 1.4 (0.2)
P > 0.05
1.4 (0.7) versus 1.6 (1.1)
P > 0.05
4.3 (0.7) versus 4.3 (1.0)
P > 0.05
Home = Centre
Home = Centre
Home = Centre
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Table 3. Summary of health-related quality of life (HRQoL) at follow up for home and centre-based cardiac rehabilitation
(Continued)
Oerkild 2011 3 months
6 months
SF-36 PCS
SF-36 MCS
SF-36 PCS
SF-36 MCS
1.4 (-1.5 to 4.3) versus 0.
5 (-2.4 to 3.4) P > 0.05
0.8 (-2.6 to 4.3) versus -
0.2 (-3.6 to 3.4) P > 0.05
1.0 (-1.6 to 3.6) versus 1.
2 (-1.4 to 3.8) P > 0.05
2.3 (-1.1 to 5.7) versus 2.
6 (-0.9 to -6.0) P > 0.05
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Piotrowicz 2010/
Piotrowicz 2014
8 weeks SF-36
Physical function
Role limitation caused
by physical problems
Bodily pain
General health
Physical component
summary
Social function
Mental health
Role limitation caused
by physical problems
Vitality
Mental component sum-
mary
Total quality of life index
21.60 (9.65) versus 23.
20 (10.71) ns
12.74 (7.17) versus 11.
39 (8.43) ns
2.66 (2.22) versus 2.00
(2.07) ns
13.14 (3.80) versus 14.
59 (4.03) P < 0.05
50.27 (17.06) versus 51.
37 (19.60) ns
2.64 (2.84) versus 1.63
(1.54) P < 0.05
7.15 (4.00) versus 5.89
(3.58) ns
4.93 (6.15) versus 4.35
(6.07) ns
7.25 (3.78) versus 6.76
(3.17) ns
21.68 (12.46) versus 18.
56 (9.18) ns
70.50 (25.40) versus 69.
20 (26.40) ns
Home = Centre
Home = Centre
Home = Centre
Home < Centre
Home = Centre
Home > Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Varnfield 2014 6 weeks
6 months
EQ5D-Index 0.92 (0.9-1.0) versus 0.
82 (0.7-0.9)
“The HRQoL (EQ5D-
Index) improved signifi-
cantly in
CAP-CR participants
compared with TCR.”
0.85 (0.1) versus 0.86 (0.
2)
“Between-group differ-
ence for changes in
EQ5D-Index was
not significant at 6
months”
Home > Centre
Home = Centre
*P value calculated by authors of this report based on independent 2-group t-test
Home = Centre: no statistically significant difference (P > 0.05) in HRQoL between home and centre-based groups at follow up
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Home > Centre: statistically significant (P ≤ 0.05) higher HRQoL in home versus centre-based groups at follow up
Home < Centre: statistically significant (P ≤ 0.05) lower HRQoL in home versus centre-based groups at follow up
Abbreviations: HRQoL = health related quality of life; MCS: mental component score; MLWHF: Minnesota Living With Heart
Failure; PCS: physical component score; SF-12: 12-Item Short Form Health Survey; SF-36: Short Form (36) Health Survey
Table 4. Results of univariate meta-regression analysis for withdrawal (no of completers)
Explanatory variable (n
trials)
Exp(slope)* 95% CI univariate P value Proportion of variation ex-
plained
Interpretation
Case mix (% MI pa-
tients) (n = 21)
RR = 1.000 0.999 to 1.002
P = 0.949
-15.22% No evidence that RR is asso-
ciated with case mix
Dose of exercise
(number of weeks of ex-
ercise training x average
number of sessions/week
x average duration of ses-
sion in min) (n = 10)
RR = 0.999 0.998 to 1.000
P = 0.217
16.94% No evidence that RR is asso-
ciated with increased dose of
exercise
Type of cardiac rehabili-
tation
(exer-
cise only versus compre-
hensive cardiac rehabili-
tation) (n = 24)
RR = 1.041 0.975 to 1.111
P = 0.219
-1.56% No evidence that RR is as-
sociated with type of cardiac
rehabilitation
Duration of follow-up
(months) (n = 23)
RR = 1.000 0.997 to 1.003
P = 0.940
-21.09% No evidence that RR is asso-
ciated with duration of fol-
low-up
Year of publication (n =
23)
RR = 1.000 0.992 to 1.007
P = 0.930
-12.08% No evidence that RR is asso-
ciated with year of publica-
tion
Risk of bias (low risk in
≥ 4 items versus < 4
items) (n = 23)
RR = 0.949 0.880 to 1.023
P =0.160
32.50% No evidence that RR is asso-
ciated with risk of bias
Study location (n = 24) RR = 0.988 0.912 to 1.069
P = 0.747
-21.54% No evidence that RR is asso-
ciated with study location
Sample size (n = 23) RR = 1.000 1.000 to 1.000
P = 0.880
-20.04% No evidence that RR is asso-
ciated with sample size
Abbreviations: MI: myocardial infarction; RR: risk ratio
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Table 5. Results of univariate meta-regression analysis for total cholesterol
Explanatory variable (n
trials)
Exp(slope)* 95%CI univariate P value Proportion of variation
explained
Interpretation
Case mix (% MI pa-
tients) (n = 10)
RR = -0.007 -0.011 to -0.002
P = 0.014
88.71% Evidence that RR is associ-
ated with case mix
Dose of exercise
(number of weeks of ex-
ercise training x average
number of sessions/week
x average duration of ses-
sion in min) (n = )
Not calculable¹ Not calculable¹ Not calculable¹ No evidence that RR is as-
sociatedwith increased dose
of exercise
Type of cardiac rehabili-
tation
(exercise only vs compre-
hensive cardiac rehabili-
tation) (n = 10)
RR = -0.127 -0.822 to 0.567
P = 0.684
-17.11% No evidence that RR is as-
sociatedwith type of cardiac
rehabilitation
Duration of follow-up
(months) (n = 10)
RR = -0.007 -0.038 to 0.024
P = 0.594
-21.27% Noevidence thatRR is asso-
ciated with duration of fol-
low-up
Year of publication (n =
10)
RR = 0.027 -0.012 to 0.066
P = 0.154
31.00% No evidence that RR is as-
sociated with year of publi-
cation
Risk of bias (low risk in
≥ 4 items versus < 4
items) (n = 10)
RR = -0.077 -0.404 to 0.249
P = 0.600
-14.59% No evidence that RR is as-
sociated with risk of bias
Study location (n = 10) RR =0.015 -0.304 to 0.333
P = 0.919
-18.83% No evidence that RR is as-
sociatedwith study location
Sample size (n = 10) RR = -0.001 -0.002 to 0.001
P = 0.347
-7.77% No evidence that RR is as-
sociated with sample size
¹Not calculable due to insufficient observations
Abbreviations: MI: myocardial infarction; RR: risk ratio
Table 6. Results of univariate meta-regression analysis for systolic BP
Explanatory variable (n
trials)
Exp(slope)* 95% CI univariate P value Proportion of variation ex-
plained
Interpretation
Case mix (% MI pa-
tients) (n = 11)
RR = 0.026 -0.095 to 0.146
P = 0.642
-8.81% No evidence that RR is asso-
ciated with case mix
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Table 6. Results of univariate meta-regression analysis for systolic BP (Continued)
Dose of exercise
(number of weeks of ex-
ercise training x average
number of sessions/week
x average duration of ses-
sion in min) (n = 4)
RR = 0.001 -0.110 to 0.112
P = 0.971
Not calculable¹ No evidence that RR is asso-
ciated with increased dose of
exercise
Type of cardiac rehabili-
tation
(exer-
cise only versus compre-
hensive cardiac rehabili-
tation) (n = 12)
RR = 5.021 -0.929 to 10.971
P =0.089
51.60% No evidence that RR is as-
sociated with type of cardiac
rehabilitation
Duration of follow-up
(months) (n = 12)
RR = -0.053 -0.540 to 0.435
P = 0.815
-22.77% No evidence that RR is asso-
ciated with duration of fol-
low-up
Year of publication (n =
12)
RR = -0.008 -0.607 to 0.591
P =0.976
-15.85% No evidence that RR is asso-
ciated with year of publica-
tion
Risk of bias (low risk in
≥ 4 items versus < 4
items) (n = 12)
RR = 2.325 -1.376 to 6.026
P =0.192
37.06% No evidence that RR is asso-
ciated with risk of bias
Study location (n = 12) RR = 4.053 0.696 to 7.410
P = 0.023
71.21% Evidence that RR is associ-
ated with study location
Sample size (n = 12) RR = -0.005 -0.029 to 0.018
P = 0.623
-18.75% No evidence that RR is asso-
ciated with sample size
¹Not calculable; Tau² of all studies = 0
Abbreviations: MI: myocardial infarction; RR: risk ratio
Table 7. Results of univariate meta-regression analysis for diastolic blood pressure
Explanatory variable (n
trials)
Exp(slope)* 95% CI
univariate P value
Proportion of variation ex-
plained
Interpretation
Case mix (% MI pa-
tients) (n = 10)
RR = 0.025 -0.069 to 0.119
P = 0.561
-11.53% No evidence that risk RR is
associated with case mix
Dose of exercise
(number of weeks of ex-
ercise training x average
number of sessions/week
RR = -0.017 -0.085 to 0.051
P = 0.391
Not calculable¹ No evidence that RR is asso-
ciated with increased dose of
exercise
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Table 7. Results of univariate meta-regression analysis for diastolic blood pressure (Continued)
x average duration of ses-
sion in min) (n = 4)
Type of cardiac rehabili-
tation
(exer-
cise only versus compre-
hensive cardiac rehabili-
tation) (n = 11)
RR = 0.125 -4.719 to 4.970
P = 0.955
-20.57% No evidence that RR is as-
sociated with type of cardiac
rehabilitation
Duration of follow-up
(months) (n = 11)
RR = -0.051 -0.377 to 0.276
P = 0.734
-32.23% No evidence that RR is asso-
ciated with duration of fol-
low-up
Year of publication (n =
11)
RR = 0.234 -0.144 to 0.613
P = 0.195
40.22% No evidence that RR is asso-
ciated with year of publica-
tion
Risk of bias (low risk in
≥ 4 items versus < 4
items) (n = 11)
RR = 0.761 -2.082 to 3.605
P = 0.560
0.88% No evidence that RR is asso-
ciated with risk of bias
Study location (n = 11) RR = -0.034 -3.196 to 3.128
P = 0.981
-25.38% No evidence that RR is asso-
ciated with study location
Sample size (n = 11) RR = -0.001 -0.017 to 0.015
P = 0.907
-30.17% No evidence that risk ratio is
associated with sample size
¹Not calculable; Tau² of all studies = 0
Abbreviations: MI: myocardial infarction; RR: risk ratio
Table 8. Summary of adherence at follow up in home and centre-based cardiac rehabilitation
Trial Follow-up Method/definition of
adherence assessment
Findings Between-group differ-
ence
Aamot 2014 Treadmill
Home versus treadmill
group
12 weeks Comple-
tion of 70% of the exer-
cise sessions (considered
to be training per proto-
col)
Median (range) number
of exercise sessions com-
pleted
Home: 24/28
(86%) versus centre: 34/
34 (100%) P = 0.04
Home: 24 (10-24) versus
centre: 24 (7-24)
Home < Centre
Aamot 2014 Treadmill
Home versus group exer-
cise
12 weeks Comple-
tion of 70% of the exer-
cise sessions (considered
Home: 24/28
(86%) versus centre: 28/
28 (100%) P = 0.04
Home < Centre
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Table 8. Summary of adherence at follow up in home and centre-based cardiac rehabilitation (Continued)
to be training per proto-
col)
Median (range) number
of exercise sessions com-
pleted
Home: 24 (10-24) versus
centre: 23 (17-24)
Table 6
Arthur 2002
/Smith 2004
6 months
18 months
Number of exercise ses-
sion reported/week
Percentage of patients
seeking dietician consul-
tation
Percentage of
patients seeking psychol-
ogist consultation
Level of physical activity
- Physical Activity Scale
for the Elderly
Home: mean 6.5 (SD 4.
6)
Centre: mean 3.7 (SD 2.
6)
P < 0.0001†
Home 50% (mean 3.5,
SD 2.5 visits)
Centre: 53% (mean 3.6,
SD 2.3 visits)
Home: 42% (mean 2.6,
SD 2.4 visits)
Centre: 51% (mean 2.5,
SD 2.2 visits)
Home: mean 232.6 (SD
99.4)
Centre: mean 170.0 (SD
89.2)
P < 0.0001†
Home > Centre
?
Home = Centre**
Home > Centre
Carlson 2000 6 months Attendance at all 3 nutri-
tion/risk factor classes
Total exercise over follow
up - number of sessions
≥ 30 min
Home: 27/38 (71%)
Centre: 33/42 (79%)
P = 0.438*
Home: mean 111.8 (SD
29.1)
Centre: mean 98.1 (SD
33.4)
P = 0.06†
Home = Centre
Home = Centre
Cowie 2012 3 months Percentage completion
of 16 exercise sessions
Home: 77%
Centre: 86%
P = 0.32
Home = Centre
Dalal 2007 9 months Number who partici-
pated in intervention
Home: 40/60 (67%)
Centre: 32/44 (72%)
P = 0.51*
Home = Centre
Daskapan 2005 3 months Percentage of sessions at-
tended
Home: 97%
Centre: 81%
P value not calculable
?
Gordon 2002
Community
3 months Percentage of completed
scheduled appointments
(exercise sessions, of-
fice/on site visits, “tele-
Home (MD supervised)
: 83%
Home (community-
Home = Centre**
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Table 8. Summary of adherence at follow up in home and centre-based cardiac rehabilitation (Continued)
phone visits” in accor-
dance with intervention
protocol)
based): 86%
Centre: 81%
Grace
2016 Mixed Home ver-
sus mixed sex training
6 months Percentage of cardiac re-
habilitation sessions at-
tended
Home: 58.12% (SD 34.
68)
Centre: 51.33% (SD 35.
75)
P = 0.63
Home = Centre
Grace
2016 Mixed Home ver-
sus women only training
6 months Percentage of cardiac re-
habilitation sessions at-
tended
Home: 58.12% (SD 34.
68)
Centre: 54.4% (SD 34.
72)
P = 0.63
Home = Centre
Jolly 2007 3 months
6 months
12 months
24 months
Hours of self-reported
activity weighted for in-
tensity
Home: mean 23.2 (SD
22.1)
Centre: mean 18.7 (SD
19.3)
P = 0.06†
Home: mean 16.4 (SD
17.0)
Centre: mean 18.1 (SD
25.4)
P = 0.4†
Home: mean 19.2 (SD
20.8)
Centre: mean 15.9 (SD
16.7)
P = 0.06†
Home: mean 18.9 (SD
18.4)
Centre: mean 16.6 (SD
16.4)
P = 0.16†
Home = Centre
Home = Centre
Home = Centre
Home = Centre
Karapolat 2009 8 weeks Attendance at exercise
sessions
Home: (32/37) 87.5%
Centre: (33/37) 90%
P = 0.72*
Home = Centre
Kraal 2014 12 weeks Number of sessions at-
tended
Home: Mean = 24 (100
%; SD 7.2; range: 13 to
41)
Centre: Mean = 20.5
(86%; SD4.5 range: 6 to
25)
P = 0.049
Home > Centre
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Table 8. Summary of adherence at follow up in home and centre-based cardiac rehabilitation (Continued)
Marchionni 2003 4 months Number of exercise ses-
sions completed
Home: 37.3 (SD 3.4)
Centre: 34.3 (SD 4.4)
P < 0.0001†
Home > Centre
Miller 1984 Brief/
DeBusk 1985/
Taylor 1986
6 months Ratio of exercise ses-
sions completed versus
prescribed
Home: 50/70 (72%)
Centre: 28/40 (71%)
P value not calculable
Home = Centre**
Moholdt 2012 6 months Training diaries (only re-
ported for home group)
Home: 7/10
patients (with complete
diary data) reported ≥2
weekly interval sessions
over 6 months follow up
?
Piotrowicz 2010 8 weeks Percentage of patients
who carried out the pre-
scribed exercise train-
ing (home group: daily
telephone contacts with
monitoring centre; cen-
tre group: attendance at
supervised sessions)
Home: 77/77 (100%)
Centre: 59/75 (79%)
P < 0.0001†
Home > Centre
Sparks 1993 3 months Percentage of cardiac re-
habilitation sessions at-
tended
Home: 93%
Centre: 88%
P value not calculable
?
Varnfield 2014 6 weeks “Attended baseline as-
sessment and at least 4
weeks (8 of 12 sessions)
of centre-based gym ses-
sions/uploaded exercise
data to web portal for a
minimum of 4 weeks”
Home: 45/48 (94%)
Centre: 25/37 (68%)
P < 0.005
Home > Centre
*calculated by authors of this report based on Chi² test †calculated by authors of this report based on independent t-test
Home = Centre: no statistically significant difference (P > 0.05) in health-related quality of life (HRQoL) between home- and centre-
based groups at follow up
Home > Centre: statistically significant (P ≤ 0.05) higher HRQoL in home- versus centre-based groups at follow up
Home < Centre: statistically significant (P ≤ 0.05) lower HRQoL in home- versus centre-based groups at follow up
**Home- and centre-based groups at follow up appear to be similar but P value not reported or calculable
? Home- and centre-based groups at follow up appear different but P value not reported or calculable
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Table 9. Summary of costs in home- and centre-based settings
Study Curren-
cyYear of costs-
Follow up
Cardiac reha-
bilitation pro-
gramme cost
(per patient)
Programme
costs
considered
Total healthcare
cost(per
patient)
Additional
healthcare costs
considered
Comments
Carlson 2000 USD
Not reported
6 months
Home: mean
USD 1519
Centre: mean
USD 2349
Staff, ECG
monitoring
Not reported
Cowie 2012 GBP
2013 to 2014
60 months
Home: GBP
mean 197
Centre: GBP
mean 221
Staff, HR moni-
tors, DVD
Home: mean:
GBP 7932
Centre: mean:
GBP 7452
Hospitalisations,
emergency
admissions
Marchionni
2003
USD
2000
14 months
Home: mean
USD 1650
Centre: mean
USD 8841
Not reported Home: USD 21,
298
Centre: USD13,
246
Not reported
Dalal 2007 GBP
2002 to 2003
9 months
Home: mean
GBP 170 (SD 8)
Centre: mean
GBP 200 (SD 3)
Difference:
mean GBP 30
(95% CI -45 to -
12)
P < 0.0001
Staff, exercise,
equipment,
staff travel
Home:
mean GBP 3279
(SD 374)
Centre:
mean GBP 3201
(SD 443)
Difference:
mean GBP 78
(95% CI -1103
to 1191)
P = 0.894
Rehospitalisa-
tions,
revascularisa-
tions,
secondary
preventive
medication, in-
vestigations,
primary care
consultations
Jolly 2007 GBP
2003
24 months
Home: mean
GBP 198
(95% CI 189 to
209)
Centre: mean
GBP 157
(95% CI 139 to
175)
P < 0.05
Staff, tele-
phone, consulta-
tions, staff travel
Not reported With inclusion
of patient costs
(travel and time)
, the societal
costs of home-
and centre-bas
cardiac rehabili-
tation were not
significantly dif-
ferent
Varnfield 2014/
Whittaker 2014
AUD
Not reported
Based
on a 6 week pro-
gramme
Home: AUD
1633
Centre: AUD
1845
Education, as-
sessment, coach-
ing and mentor-
ing, gymnasium,
communication,
Patient travel:
Home: AUD 80
Centre: AUD
400
Re-admissions -
Estimated AUD
39,670
per re-admission
(Collins 2001)
Based on evi-
dence suggesting
that completing
a formal rehabil-
ita-
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Table 9. Summary of costs in home- and centre-based settings (Continued)
facility, technol-
ogy, administra-
tion
tion programme
significantly re-
duces the risk
of a secondary
event and
readmission, the
net-present value
was calculated at
AUD 4008 per
patient, equating
to a saving in
health care costs
of AUD 2375
per patient
Abbreviation: ECG = electrocardiogram
Table 10. Summary of healthcare utilisation in home- and centre-based settings
Study Dalal 2007 Gordon
2002
Commu-
nity
Bell 1998 Carlson
2000
Mar-
chionni
2003
Jolly 2007
Follow up 9 months 3 months 0 to 6
months
6 to 12
months
6 months 14 months 12 month 24 month
Rehospital-
isations
N patient
(%)
Mean (SD)
Home 9/60
(15%)
Centre 6/44
(14%)
P = 0.845
Home 2.2
(0.9)†
Centre 1.2
(0.6)
P = 0.383
Home 21/
90 (23%)
Centre 19/
88 (22%)
P = 0.78#
13/89
(15%)
12/84
(14%)
P = 0.95#
Home 0.46
(SE 0.1)
Centre 0.33
(SE 0.1)
P = 0.49
Home 0.08
(0.34)
Centre 0.12
(0.41)
P = 0.3
Home 0.20
(0.45)
Centre 0.26
(0.57)
P = 0.3
Primary
care consul-
tations
Mean (SD)
Home 6.3
(0.6)
Centre 7.0
(0.9)
P = 0.514
Home 6.6
(3.6)*
Centre 6.6
(4.1)
P = 1.00#
5.4 (4.1)
4.6 (3.7)
P = 0.19#
Home 0.65
(1.14)
Centre 0.72
(1.54)
P = 0.8
Home 0.53
(1.14)
Centre 0.66
(1.42)
P = 0.7
Secondary
prevention
medication
Home 31/
49 (63%)
Home 36/
97 (37%)
Home 19/
38
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Table 10. Summary of healthcare utilisation in home- and centre-based settings (Continued)
N patients
(%)
beta-
blockers
ACE
inhibitors
Statins
An-
tiplatelets
Centre 24/
34 (71%)
P = 0.49
Home 30/
49 (61%)
Centre 24/
33 (73%)
P = 0.28
Home 48/
49 (98%)*
Centre 30/
35 (88%)*
P = 0.18
Home 46/
49 (94%)
Centre 30/
35 (86%)
P = 0.21
Centre 17/
45 (38%)
NS
Home 25/
97 (26%)
Centre 8/45
(18%)
NS
Home 73/
97 (75%)
Centre 33/
45 (73%)
NS
Home 94/
97 (97%)*
Centre 45/
45 (100%)*
NS
Centre 18/
42
P = 0.52#
Home 4/38
Centre 4/42
P = 0.88#
Home 5/38
Centre 8/42
P = 0.47#
Home 15/
38
Centre 20/
42
P = 0.54#
Home 169
(72.2%)
Centre 171
(73.4%)
P = 0.8
Home 176
(75.2%)*
Centre 161
(69.1%)*
P = 0.1
Home 216
(92.3%)**
Centre 221
(94.8%)**
P = 0.3
Home 227
(97.0%)†
Centre 226
(97.0%)†
P = 1.0
Home 161
(71.6%)
Centre 164
(72.2%)
P = 0.9
Home 177
(78.7%)*
Centre 156
(68.7%)*
P = 0.02
Home 195
(86.7%)**
Centre 206
(90.7%)**
P = 0.2
Home 214
(95.1%)+
Centre 220
(96.9%)+
P = 0.3
Comments †number of
nights
*lipid lower-
ing drugs
*an-
tiplatelets &
anticoagu-
lants
*GP consul-
tations
*ACEi or
An-
giotensin II
receptor an-
tagonist
**choles-
terol-lower-
ing drugs
†Aspirin or
antiplatelet
drugs
#P value calculated by authors of the present report
NS: not statistically significant
SE: standard error
Table 11. Summary of healthcare in hospital- and centre-based settings, continued
Study Moholdt 2012 Oerkild 2011
Follow up 6 months 12 months
Rehospitalisations
N patient (%)
Number
Mean (SD)
Not reported Number and length of admissions same be-
tween groups
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Table 11. Summary of healthcare in hospital- and centre-based settings, continued (Continued)
Primary care
Consultations
Mean (SD)
Not reported Not reported
Secondary prevention medication
N patients (%)
beta-blockers
ACE inhibitors
Antihypertensives
Statins
Antiplatelets
Home: 8/14 (57%)
Centre: 15/16 (94%)
P = 0.02*
Home: 1/14 (7%)
Centre: 0/16 (0%)
P = 0.28*
Home: 6/14 (43%)
Centre: 2/16 (13%)
P = 0.07*
Home: 14/14 (100%)
Centre: 14/16 (100%)
P = 0.18*
Not reported
Comments
*P value calculated by review authors
ACE: angiotensin-converting-enzyme
A P P E N D I C E S
Appendix 1. Search strategies
September 2016 Strategies
CENTRAL
#1 MeSH descriptor: [Myocardial Ischemia] explode all trees
#2 (myocard* near isch*mi*)
#3 isch*mi* near heart
#4 MeSH descriptor: [Coronary Artery Bypass] explode all trees
#5 coronary
#6 MeSH descriptor: [Coronary Disease] explode all trees
#7 MeSH descriptor: [Myocardial Revascularization] explode all trees
#8 MeSH descriptor: [Myocardial Infarction] explode all trees
#9 myocard* near infarct*
#10 heart near infarct*
#11 MeSH descriptor: [Angina Pectoris] explode all trees
#12 angina
#13 MeSH descriptor: [Heart Failure] explode all trees
#14 heart and (failure or attack)
#15 MeSH descriptor: [Heart Diseases] explode all trees
#16 heart near disease*
#17 myocard*
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#18 cardiac*
#19 CABG
#20 PTCA
#21 stent* near (heart or cardiac*)
#22 MeSH descriptor: [Heart Bypass, Left] explode all trees
#23 MeSH descriptor: [Heart Bypass, Right] explode all trees
#24 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #
20 or #21 or #22 or #23
#25 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#26 (percutaneous coronary near/2 (interven* or revascular*))
#27 MeSH descriptor: [Angioplasty] explode all trees
#28 angioplast*
#29 ((coronary or arterial) near/4 dilat*)
#30 endoluminal repair*
#31 MeSH descriptor: [Stents] explode all trees
#32 stent*
#33 (pci or ptca)
#34 MeSH descriptor: [Atherectomy] explode all trees
#35 atherectom*
#36 acute coronary syndrom*
#37 #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36
#38 MeSH descriptor: [Rehabilitation Centers] explode all trees
#39 MeSH descriptor: [Exercise Therapy] explode all trees
#40 MeSH descriptor: [Sports] this term only
#41 MeSH descriptor: [Physical Exertion] explode all trees
#42 rehabilitat*
#43 (physical* near (fit* or train* or therap* or activit*))
#44 MeSH descriptor: [Exercise] explode all trees
#45 (train*) near (strength* or aerobic or exercise*)
#46 ((exercise* or fitness) near/3 (treatment or intervent* or program*))
#47 MeSH descriptor: [Rehabilitation] explode all trees
#48 MeSH descriptor: [Patient Education as Topic] explode all trees
#49 (patient* near/3 educat*)
#50 ((lifestyle or life-style) near/3 (intervent* or program* or treatment*))
#51 MeSH descriptor: [Self Care] explode all trees
#52 MeSH descriptor: [Ambulatory Care] explode all trees
#53 MeSH descriptor: [Psychotherapy] explode all trees
#54 psychotherap*
#55 psycholog* near intervent*
#56 relax*
#57 MeSH descriptor: [Relaxation Therapy] explode all trees
#58 MeSH descriptor: [Counseling] explode all trees
#59 counsel*ing
#60 MeSH descriptor: [Cognitive Therapy] explode all trees
#61 MeSH descriptor: [Behavior Therapy] explode all trees
#62 (behavio*r*) near/4 (modif* or therap* or rehab* or change)
#63 MeSH descriptor: [Stress, Psychological] explode all trees
#64 stress near manage*
#65 cognitive* near therap*
#66 MeSH descriptor: [Meditation] explode all trees
#67 meditat*
#68 MeSH descriptor: [Anxiety] this term only
#69 (manage*) near (anxiety or depres*)
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#70 CBT
#71 hypnotherap*
#72 goal near/3 setting
#73 (psycho-educat*) or (psychoeducat*)
#74 motivat* near interv*
#75 MeSH descriptor: [Psychopathology] explode all trees
#76 psychopathol*
#77 MeSH descriptor: [Autogenic Training] explode all trees
#78 autogenic*
#79 self near (manage* or care or motivat*)
#80 distress*
#81 psychosocial* or psycho-social
#82 MeSH descriptor: [Health Education] explode all trees
#83 ((nutrition or diet or health) near education)
#84 heart manual
#85 home-based
#86 #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55
or #56 or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73 or
#74 or #75 or #76 or #77 or #78 or #79 or #80 or #81 or #82 or #83 or #84 or #85
#87 #37 and #86
#88 #24 and #86 Publication Year from 2016 to 2016
#89 #87 or #88
MEDLINE
1. exp Myocardial Ischemia/
2. (myocard* adj3 isch?mi*).tw.
3. (isch?mi* adj3 heart).tw.
4. exp Coronary Artery Bypass/
5. coronary.tw.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. exp Myocardial Infarction/
9. (myocard* adj3 infarct*).tw.
10. (heart adj3 infarct*).tw.
11. exp Angina Pectoris/
12. angina.tw.
13. exp Heart Failure/
14. (heart adj3 (failure or attack)).tw.
15. exp Heart Diseases/
16. (heart adj3 disease*).tw.
17. myocard*.tw.
18. cardiac*.tw.
19. CABG.tw.
20. PTCA.tw.
21. (stent* adj3 (heart or cardiac*)).tw.
22. Heart Bypass, Left/
23. exp Heart Bypass, Right/
24. or/1-23
25. exp Percutaneous Coronary Intervention/
26. (percutaneous coronary adj2 (interven* or revascular*)).tw.
27. exp Angioplasty/
28. angioplast*.tw.
29. ((coronary or arterial) adj4 dilat*).tw.
30. endoluminal repair*.tw.
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31. exp Stents/
32. stent*.tw.
33. (pci or ptca).tw.
34. exp Atherectomy/
35. atherectom*.tw.
36. acute coronary syndrom*.tw.
37. or/25-36
38. Rehabilitation Centers/
39. exp Exercise Therapy/
40. Sports/
41. Physical Exertion/
42. rehabilitat*.tw.
43. (physical* adj3 (fit* or train* or therap* or activit*)).tw.
44. exp Exercise/
45. (train* adj3 (strength* or aerobic or exercise*)).tw.
46. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
47. exp Rehabilitation/
48. Patient Education as Topic/
49. (patient* adj3 educat*).tw.
50. ((lifestyle or life-style) adj3 (intervent* or program* or treatment*)).tw.
51. exp Self Care/
52. exp Ambulatory Care/
53. exp Psychotherapy/
54. psychotherap*.tw.
55. (psycholog* adj3 intervent*).tw.
56. relax*.tw.
57. Relaxation Therapy/
58. exp Counseling/
59. counsel?ing.tw.
60. exp Cognitive Therapy/
61. exp Behavior Therapy/
62. (behavio?r* adj4 (modif* or therap* or rehab* or change)).tw.
63. exp Stress, Psychological/
64. (stress adj3 manage*).tw.
65. (cognitive* adj3 therap*).tw.
66. exp Meditation/
67. meditat*.tw.
68. Anxiety/
69. (manage* adj3 (anxiety or depres*)).tw.
70. CBT.tw.
71. hypnotherap*.tw.
72. (goal adj3 setting).tw.
73. (psycho-educat* or psychoeducat*).tw.
74. (motivat* adj3 interv*).tw.
75. exp Psychopathology/
76. psychopathol*.tw.
77. exp Autogenic Training/
78. autogenic*.tw.
79. (self adj3 (manage* or care or motivat*)).tw.
80. distress*.tw.
81. (psychosocial* or psycho-social*).tw.
82. exp Health Education/
83. ((nutrition or diet or health) adj3 education).tw.
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84. heart manual.tw.
85. home based.tw.
86. or/38-85
87. randomized controlled trial.pt.
88. controlled clinical trial.pt.
89. randomized.ab.
90. placebo.ab.
91. drug therapy.fs.
92. randomly.ab.
93. trial.ab.
94. groups.ab.
95. 87 or 88 or 89 or 90 or 91 or 92 or 93 or 94
96. exp animals/ not humans.sh.
97. 95 not 96
98. 2016*.ed.
99. 37 and 86 and 97
100. 24 and 86 and 97 and 98
101. 99 or 100
Embase
1. exp Myocardial Ischemia/
2. (myocard* adj3 isch?mi*).tw.
3. (isch?mi* adj3 heart).tw.
4. exp Coronary Artery Bypass/
5. coronary.tw.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. exp Myocardial Infarction/
9. (myocard* adj3 infarct*).tw.
10. (heart adj3 infarct*).tw.
11. exp Angina Pectoris/
12. angina.tw.
13. exp Heart Failure/
14. (heart adj3 (failure or attack)).tw.
15. exp Heart Diseases/
16. (heart adj3 disease*).tw.
17. myocard*.tw.
18. cardiac*.tw.
19. CABG.tw.
20. PTCA.tw.
21. (stent* adj3 (heart or cardiac*)).tw.
22. Heart Bypass, Left/
23. exp Heart Bypass, Right/
24. or/1-23
25. exp percutaneous coronary intervention/
26. (percutaneous coronary adj2 (interven* or revascular*)).tw.
27. exp angioplasty/
28. angioplast*.tw.
29. ((coronary or arterial) adj4 dilat*).tw.
30. endoluminal repair*.tw.
31. exp stent/
32. stent*.tw.
33. (pci or ptca).tw.
34. exp atherectomy/
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35. atherectom*.tw.
36. acute coronary syndrom*.tw.
37. or/25-36
38. Rehabilitation Centers/
39. exp Exercise Therapy/
40. Sports/
41. Physical Exertion/
42. rehabilitat*.tw.
43. (physical* adj3 (fit* or train* or therap* or activit*)).tw.
44. exp Exercise/
45. (train* adj3 (strength* or aerobic or exercise*)).tw.
46. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
47. exp Rehabilitation/
48. Patient Education as Topic/
49. (patient* adj3 educat*).tw.
50. ((lifestyle or life-style) adj3 (intervent* or program* or treatment*)).tw.
51. exp Self Care/
52. exp Ambulatory Care/
53. exp Psychotherapy/
54. psychotherap*.tw.
55. (psycholog* adj3 intervent*).tw.
56. relax*.tw.
57. Relaxation Therapy/
58. exp Counseling/
59. counsel?ing.tw.
60. exp Cognitive Therapy/
61. exp Behavior Therapy/
62. (behavio?r* adj4 (modif* or therap* or rehab* or change)).tw.
63. exp Stress, Psychological/
64. (stress adj3 manage*).tw.
65. (cognitive* adj3 therap*).tw.
66. exp Meditation/
67. meditat*.tw.
68. Anxiety/
69. (manage* adj3 (anxiety or depres*)).tw.
70. CBT.tw.
71. hypnotherap*.tw.
72. (goal adj3 setting).tw.
73. (psycho-educat* or psychoeducat*).tw.
74. (motivat* adj3 interv*).tw.
75. exp Psychopathology/
76. psychopathol*.tw.
77. exp Autogenic Training/
78. autogenic*.tw.
79. (self adj3 (manage* or care or motivat*)).tw.
80. distress*.tw.
81. (psychosocial* or psycho-social*).tw.
82. exp Health Education/
83. ((nutrition or diet or health) adj3 education).tw.
84. heart manual.tw.
85. home based.tw.
86. or/38-85
87. random$.tw.
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88. factorial$.tw.
89. crossover$.tw.
90. cross over$.tw.
91. cross-over$.tw.
92. placebo$.tw.
93. (doubl$ adj blind$).tw.
94. (singl$ adj blind$).tw.
95. assign$.tw.
96. allocat$.tw.
97. volunteer$.tw.
98. crossover procedure/
99. double blind procedure/
100. randomized controlled trial/
101. single blind procedure/
102. 87 or 88 or 89 or 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97 or 98 or 99 or 100 or 101
103. (animal/ or nonhuman/) not human/
104. 102 not 103
105. 2016*.em.
106. 37 and 86 and 104
107. 24 and 86 and 104 and 105
108. 106 or 107
PsycINFO
1. (myocard* adj3 isch?mi*).tw.
2. (isch?mi* adj3 heart).tw.
3. coronary.tw.
4. exp Myocardial Infarction/
5. (myocard* adj3 infarct*).tw.
6. (heart adj3 infarct*).tw.
7. exp Angina Pectoris/
8. angina.tw.
9. (heart adj3 (failure or attack)).tw.
10. (heart adj3 disease*).tw.
11. myocard*.tw.
12. cardiac*.tw.
13. CABG.tw.
14. PTCA.tw.
15. (stent* adj3 (heart or cardiac*)).tw.
16. or/1-15
17. exp percutaneous coronary intervention/
18. (percutaneous coronary adj2 (interven* or revascular*)).tw.
19. exp angioplasty/
20. angioplast*.tw.
21. ((coronary or arterial) adj4 dilat*).tw.
22. endoluminal repair*.tw.
23. exp stent/
24. stent*.tw.
25. (pci or ptca).tw.
26. exp atherectomy/
27. atherectom*.tw.
28. acute coronary syndrom*.tw.
29. or/17-28
30. Rehabilitation Centers/
31. exp Exercise Therapy/
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32. Sports/
33. rehabilitat*.tw.
34. (physical* adj3 (fit* or train* or therap* or activit*)).tw.
35. exp Exercise/
36. (train* adj3 (strength* or aerobic or exercise*)).tw.
37. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
38. exp Rehabilitation/
39. (patient* adj3 educat*).tw.
40. ((lifestyle or life-style) adj3 (intervent* or program* or treatment*)).tw.
41. exp Self Care/
42. exp Ambulatory Care/
43. exp Psychotherapy/
44. psychotherap*.tw.
45. (psycholog* adj3 intervent*).tw.
46. relax*.tw.
47. Relaxation Therapy/
48. exp Counseling/
49. counsel?ing.tw.
50. exp Cognitive Therapy/
51. exp Behavior Therapy/
52. (behavio?r* adj4 (modif* or therap* or rehab* or change)).tw.
53. (stress adj3 manage*).tw.
54. (cognitive* adj3 therap*).tw.
55. exp Meditation/
56. meditat*.tw.
57. Anxiety/
58. (manage* adj3 (anxiety or depres*)).tw.
59. CBT.tw.
60. hypnotherap*.tw.
61. (goal adj3 setting).tw.
62. (psycho-educat* or psychoeducat*).tw.
63. (motivat* adj3 interv*).tw.
64. exp Psychopathology/
65. psychopathol*.tw.
66. exp Autogenic Training/
67. autogenic*.tw.
68. (self adj3 (manage* or care or motivat*)).tw.
69. distress*.tw.
70. (psychosocial* or psycho-social*).tw.
71. exp Health Education/
72. ((nutrition or diet or health) adj3 education).tw.
73. heart manual.tw.
74. home based.tw.
75. or/30-74
76. random$.tw.
77. factorial$.tw.
78. crossover$.tw.
79. cross-over$.tw.
80. placebo$.tw.
81. (doubl$ adj blind$).tw.
82. (singl$ adj blind$).tw.
83. assign$.tw.
84. allocat$.tw.
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85. volunteer$.tw.
86. control*.tw.
87. “2000”.md.
88. or/76-87
89. 2016*.up.
90. 29 and 75 and 88
91. 16 and 75 and 88 and 89
92. 90 or 91
CINAHL
S88 S86 OR S87
S87 S23 AND S82 AND S85 Limiters - Publication Year: 2016-2016
S86 S36 AND S82 AND S85
S85 S83 OR S84
S84 (MH “Clinical Trials+”)
S83 random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*
S82 S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51
OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 OR S65 OR S66
OR S67 OR S68 OR S69 OR S70 OR S71 OR S72 OR S73 OR S74 OR S75 OR S76 OR S77 OR S78 OR S79 OR S80 OR S81
S81 (heart manual) OR (home based)
S80 ((nutrition or diet or health) N3 education)
S79 (MH “Health Education+”)
S78 (psychosocial* or psycho-social)
S77 (distress*)
S76 (self N3 (manage* or care or motivat*))
S75 (autogenic*)
S74 (psychopathol*)
S73 (MH “Psychopathology”)
S72 (motivat* N3 interv*)
S71 (psycho-educat*) or (psychoeducat*)
S70 (goal N3 setting)
S69 (hypnotherap*)
S68 (CBT)
S67 (manage*) N3 (anxiety or depres*)
S66 (MH “Anxiety”)
S65 (meditat*)
S64 (MH “Meditation”)
S63 (cognitive* N3 therap*)
S62 (stress N3 manage*)
S61 (MH “Stress, Psychological+”)
S60 (behavio?r*) N4 (modif* or therap* or rehab* or change)
S59 (MH “Behavior Therapy+”)
S58 (MH “Cognitive Therapy”)
S57 (counsel?ing)
S56 (MH “Counseling+”)
S55 (relax*)
S54 (psycholog* N3 intervent*)
S53 (psychotherap*)
S52 (MH “Psychotherapy+”)
S51 (MH “Ambulatory Care”)
S50 (MH “Self Care+”)
S49 ((lifestyle or life-style) N3 (intervent* or program* or treatment*))
S48 (patient* N3 educat*)
S47 (MH “Patient Education+”)
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S46 (MH “Rehabilitation+”)
S45 ((exercise* or fitness) N3 (treatment or intervent* or program*))
S44 (train*) N3 (strength* or aerobic or exercise*)
S43 (MH “Exercise”)
S42 (physical* N3 (fit* or train* or therap* or activit*))
S41 (rehabilitat*)
S40 (MH “Exertion+”)
S39 (MH “Sports”)
S38 (MH “Therapeutic Exercise+”)
S37 (MH “Rehabilitation Centers+”)
S36 S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35
S35 acute coronary syndrom*
S34 atherectom*
S33 (MH “Atherectomy+”)
S32 (pci or ptca)
S31 stent*
S30 (MH “Stents+”)
S29 endoluminal repair*
S28 ((coronary or arterial) n4 dilat*)
S27 angioplast*
S26 (MH “Angioplasty+”)
S25 (percutaneous coronary n2 (interven* or revascular*))
S24 (MH “Angioplasty, Transluminal, Percutaneous Coronary”)
S23 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 OR S19 OR S20 OR S21 OR S22
S22 (MH “Cardiopulmonary Bypass”)
S21 (stent* N3 (heart or cardiac*))
S20 (PTCA)
S19 (CABG)
S18 (cardiac*)
S17 (myocard*)
S16 (heart N3 disease*)
S15 (MH “Heart Diseases+”)
S14 (heart N3 (failure or attack))
S13 (MH “Heart Failure+”)
S12 (angina)
S11 (MH “Angina Pectoris+”)
S10 (heart N3 infarct*)
S9 (myocard* N3 infarct*)
S8 (MH “Myocardial Infarction+”)
S7 (MH “Myocardial Revascularization+”)
S6 (MH “Coronary Disease+”)
S5 (coronary)
S4 (MH “Coronary Artery Bypass+”)
S3 (isch?mi* N3 heart)
S2 (myocard* N3 isch?mi*)
S1 (MH “Myocardial Ischemia+”)
August 2016 Strategies
CENTRAL
#1 MeSH descriptor: [Myocardial Ischemia] explode all trees
#2 (myocard* near isch*mi*)
#3 isch*mi* near heart
#4 MeSH descriptor: [Coronary Artery Bypass] explode all trees
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#5 coronary
#6 MeSH descriptor: [Coronary Disease] explode all trees
#7 MeSH descriptor: [Myocardial Revascularization] explode all trees
#8 MeSH descriptor: [Myocardial Infarction] explode all trees
#9 myocard* near infarct*
#10 heart near infarct*
#11 MeSH descriptor: [Angina Pectoris] explode all trees
#12 angina
#13 MeSH descriptor: [Heart Failure] explode all trees
#14 heart and (failure or attack)
#15 MeSH descriptor: [Heart Diseases] explode all trees
#16 heart near disease*
#17 myocard*
#18 cardiac*
#19 CABG
#20 PTCA
#21 stent* near (heart or cardiac*)
#22 MeSH descriptor: [Heart Bypass, Left] explode all trees
#23 MeSH descriptor: [Heart Bypass, Right] explode all trees
#24 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #
20 or #21 or #22 or #23
#25 MeSH descriptor: [Rehabilitation Centers] explode all trees
#26 MeSH descriptor: [Exercise Therapy] explode all trees
#27 MeSH descriptor: [Sports] this term only
#28 MeSH descriptor: [Physical Exertion] explode all trees
#29 rehabilitat*
#30 (physical* near (fit* or train* or therap* or activit*))
#31 MeSH descriptor: [Exercise] explode all trees
#32 (train*) near (strength* or aerobic or exercise*)
#33 ((exercise* or fitness) near/3 (treatment or intervent* or program*))
#34 MeSH descriptor: [Rehabilitation] explode all trees
#35 MeSH descriptor: [Patient Education as Topic] explode all trees
#36 (patient* near/3 educat*)
#37 ((lifestyle or life-style) near/3 (intervent* or program* or treatment*))
#38 MeSH descriptor: [Self Care] explode all trees
#39 MeSH descriptor: [Ambulatory Care] explode all trees
#40 MeSH descriptor: [Psychotherapy] explode all trees
#41 psychotherap*
#42 psycholog* near intervent*
#43 relax*
#44 MeSH descriptor: [Relaxation Therapy] explode all trees
#45 MeSH descriptor: [Counseling] explode all trees
#46 counsel*ing
#47 MeSH descriptor: [Cognitive Therapy] explode all trees
#48 MeSH descriptor: [Behavior Therapy] explode all trees
#49 (behavio*r*) near/4 (modif* or therap* or rehab* or change)
#50 MeSH descriptor: [Stress, Psychological] explode all trees
#51 stress near manage*
#52 cognitive* near therap*
#53 MeSH descriptor: [Meditation] explode all trees
#54 meditat*
#55 MeSH descriptor: [Anxiety] this term only
#56 (manage*) near (anxiety or depres*)
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#57 CBT
#58 hypnotherap*
#59 goal near/3 setting
#60 (psycho-educat*) or (psychoeducat*)
#61 motivat* near interv*
#62 MeSH descriptor: [Psychopathology] explode all trees
#63 psychopathol*
#64 MeSH descriptor: [Autogenic Training] explode all trees
#65 autogenic*
#66 self near (manage* or care or motivat*)
#67 distress*
#68 psychosocial* or psycho-social
#69 MeSH descriptor: [Health Education] explode all trees
#70 ((nutrition or diet or health) near education)
#71 heart manual
#72 home-based
#73 #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42
or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or #57 or #58 or #59 or #60 or
#61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72
#74 #24 and #73 from 2014 to 2016
MEDLINE
1. exp Myocardial Ischemia/
2. (myocard* adj3 isch?mi*).tw.
3. (isch?mi* adj3 heart).tw.
4. exp Coronary Artery Bypass/
5. coronary.tw.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. exp Myocardial Infarction/
9. (myocard* adj3 infarct*).tw.
10. (heart adj3 infarct*).tw.
11. exp Angina Pectoris/
12. angina.tw.
13. exp Heart Failure/
14. (heart adj3 (failure or attack)).tw.
15. exp Heart Diseases/
16. (heart adj3 disease*).tw.
17. myocard*.tw.
18. cardiac*.tw.
19. CABG.tw.
20. PTCA.tw.
21. (stent* adj3 (heart or cardiac*)).tw.
22. Heart Bypass, Left/
23. exp Heart Bypass, Right/
24. or/1-23
25. Rehabilitation Centers/
26. exp Exercise Therapy/
27. Sports/
28. Physical Exertion/
29. rehabilitat*.tw.
30. (physical* adj3 (fit* or train* or therap* or activit*)).tw.
31. exp Exercise/
32. (train* adj3 (strength* or aerobic or exercise*)).tw.
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33. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
34. exp Rehabilitation/
35. Patient Education as Topic/
36. (patient* adj3 educat*).tw.
37. ((lifestyle or life-style) adj3 (intervent* or program* or treatment*)).tw.
38. exp Self Care/
39. exp Ambulatory Care/
40. exp Psychotherapy/
41. psychotherap*.tw.
42. (psycholog* adj3 intervent*).tw.
43. relax*.tw.
44. Relaxation Therapy/
45. exp Counseling/
46. counsel?ing.tw.
47. exp Cognitive Therapy/
48. exp Behavior Therapy/
49. (behavio?r* adj4 (modif* or therap* or rehab* or change)).tw.
50. exp Stress, Psychological/
51. (stress adj3 manage*).tw.
52. (cognitive* adj3 therap*).tw.
53. exp Meditation/
54. meditat*.tw.
55. Anxiety/
56. (manage* adj3 (anxiety or depres*)).tw.
57. CBT.tw.
58. hypnotherap*.tw.
59. (goal adj3 setting).tw.
60. (psycho-educat* or psychoeducat*).tw.
61. (motivat* adj3 interv*).tw.
62. exp Psychopathology/
63. psychopathol*.tw.
64. exp Autogenic Training/
65. autogenic*.tw.
66. (self adj3 (manage* or care or motivat*)).tw.
67. distress*.tw.
68. (psychosocial* or psycho-social*).tw.
69. exp Health Education/
70. ((nutrition or diet or health) adj3 education).tw.
71. heart manual.tw.
72. home based.tw.
73. or/25-72
74. randomized controlled trial.pt.
75. controlled clinical trial.pt.
76. randomized.ab.
77. placebo.ab.
78. drug therapy.fs.
79. randomly.ab.
80. trial.ab.
81. groups.ab.
82. 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81
83. exp animals/ not humans.sh.
84. 82 not 83
85. 24 and 73 and 84
145Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
86. (2014* or 2015* or 2016*).ed.
87. 85 and 86
Embase
1. exp Myocardial Ischemia/
2. (myocard* adj3 isch?mi*).tw.
3. (isch?mi* adj3 heart).tw.
4. exp Coronary Artery Bypass/
5. coronary.tw.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. exp Myocardial Infarction/
9. (myocard* adj3 infarct*).tw.
10. (heart adj3 infarct*).tw.
11. exp Angina Pectoris/
12. angina.tw.
13. exp Heart Failure/
14. (heart adj3 (failure or attack)).tw.
15. exp Heart Diseases/
16. (heart adj3 disease*).tw.
17. myocard*.tw.
18. cardiac*.tw.
19. CABG.tw.
20. PTCA.tw.
21. (stent* adj3 (heart or cardiac*)).tw.
22. Heart Bypass, Left/
23. exp Heart Bypass, Right/
24. or/1-23
25. Rehabilitation Centers/
26. exp Exercise Therapy/
27. Sports/
28. Physical Exertion/
29. rehabilitat*.tw.
30. (physical* adj3 (fit* or train* or therap* or activit*)).tw.
31. exp Exercise/
32. (train* adj3 (strength* or aerobic or exercise*)).tw.
33. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
34. exp Rehabilitation/
35. Patient Education as Topic/
36. (patient* adj3 educat*).tw.
37. ((lifestyle or life-style) adj3 (intervent* or program* or treatment*)).tw.
38. exp Self Care/
39. exp Ambulatory Care/
40. exp Psychotherapy/
41. psychotherap*.tw.
42. (psycholog* adj3 intervent*).tw.
43. relax*.tw.
44. Relaxation Therapy/
45. exp Counseling/
46. counsel?ing.tw.
47. exp Cognitive Therapy/
48. exp Behavior Therapy/
49. (behavio?r* adj4 (modif* or therap* or rehab* or change)).tw.
50. exp Stress, Psychological/
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51. (stress adj3 manage*).tw.
52. (cognitive* adj3 therap*).tw.
53. exp Meditation/
54. meditat*.tw.
55. Anxiety/
56. (manage* adj3 (anxiety or depres*)).tw.
57. CBT.tw.
58. hypnotherap*.tw.
59. (goal adj3 setting).tw.
60. (psycho-educat* or psychoeducat*).tw.
61. (motivat* adj3 interv*).tw.
62. exp Psychopathology/
63. psychopathol*.tw.
64. exp Autogenic Training/
65. autogenic*.tw.
66. (self adj3 (manage* or care or motivat*)).tw.
67. distress*.tw.
68. (psychosocial* or psycho-social*).tw.
69. exp Health Education/
70. ((nutrition or diet or health) adj3 education).tw.
71. heart manual.tw.
72. home based.tw.
73. or/25-72
74. random$.tw.
75. factorial$.tw.
76. crossover$.tw.
77. cross over$.tw.
78. cross-over$.tw.
79. placebo$.tw.
80. (doubl$ adj blind$).tw.
81. (singl$ adj blind$).tw.
82. assign$.tw.
83. allocat$.tw.
84. volunteer$.tw.
85. crossover procedure/
86. double blind procedure/
87. randomized controlled trial/
88. single blind procedure/
89. 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82 or 83 or 84 or 85 or 86 or 87 or 88
90. (animal/ or nonhuman/) not human/
91. 89 not 90
92. 24 and 73 and 91
93. (2014* or 2015* or 2016*).em.
94. 92 and 93
95. limit 94 to embase
PsycINFO
1. (myocard* adj3 isch?mi*).tw.
2. (isch?mi* adj3 heart).tw.
3. coronary.tw.
4. exp Myocardial Infarction/
5. (myocard* adj3 infarct*).tw.
6. (heart adj3 infarct*).tw.
7. exp Angina Pectoris/
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8. angina.tw.
9. (heart adj3 (failure or attack)).tw.
10. (heart adj3 disease*).tw.
11. myocard*.tw.
12. cardiac*.tw.
13. CABG.tw.
14. PTCA.tw.
15. (stent* adj3 (heart or cardiac*)).tw.
16. Rehabilitation Centers/
17. exp Exercise Therapy/
18. Sports/
19. rehabilitat*.tw.
20. (physical* adj3 (fit* or train* or therap* or activit*)).tw.
21. exp Exercise/
22. (train* adj3 (strength* or aerobic or exercise*)).tw.
23. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
24. exp Rehabilitation/
25. (patient* adj3 educat*).tw.
26. ((lifestyle or life-style) adj3 (intervent* or program* or treatment*)).tw.
27. exp Self Care/
28. exp Ambulatory Care/
29. exp Psychotherapy/
30. psychotherap*.tw.
31. (psycholog* adj3 intervent*).tw.
32. relax*.tw.
33. Relaxation Therapy/
34. exp Counseling/
35. counsel?ing.tw.
36. exp Cognitive Therapy/
37. exp Behavior Therapy/
38. (behavio?r* adj4 (modif* or therap* or rehab* or change)).tw.
39. (stress adj3 manage*).tw.
40. (cognitive* adj3 therap*).tw.
41. exp Meditation/
42. meditat*.tw.
43. Anxiety/
44. (manage* adj3 (anxiety or depres*)).tw.
45. CBT.tw.
46. hypnotherap*.tw.
47. (goal adj3 setting).tw.
48. (psycho-educat* or psychoeducat*).tw.
49. (motivat* adj3 interv*).tw.
50. exp Psychopathology/
51. psychopathol*.tw.
52. exp Autogenic Training/
53. autogenic*.tw.
54. (self adj3 (manage* or care or motivat*)).tw.
55. distress*.tw.
56. (psychosocial* or psycho-social*).tw.
57. exp Health Education/
58. ((nutrition or diet or health) adj3 education).tw.
59. heart manual.tw.
60. home based.tw.
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61. or/1-15
62. or/16-60
63. 61 and 62
64. random$.tw.
65. factorial$.tw.
66. crossover$.tw.
67. cross-over$.tw.
68. placebo$.tw.
69. (doubl$ adj blind$).tw.
70. (singl$ adj blind$).tw.
71. assign$.tw.
72. allocat$.tw.
73. volunteer$.tw.
74. control*.tw.
75. “2000”.md.
76. or/64-75
77. 63 and 76
78. (2014* or 2015* or 2016*).up.
79. 77 and 78
CINAHL
S76 S74 and S75
S75 EM 20141013-20160803
S74 S70 and S73
S73 S71 or S72
S72 (MH “Clinical Trials+”)
S71 random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*
S70 S23 and S69
S69 S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41
or S42 or S43 or S44 or S45 or S46 or S47 or S48 or S49 or S50 or S51 or S52 or S53 or S54 or S55 or S56 or S57 or S58 or S59 or
S60 or S61 or S62 or S63 or S64 or S65 or S66 or S67 or S68
S68 (heart manual) OR (home based)
S67 ((nutrition or diet or health) N3 education)
S66 (MH “Health Education+”)
S65 (psychosocial* or psycho-social)
S64 (distress*)
S63 (self N3 (manage* or care or motivat*))
S62 (autogenic*)
S61 (psychopathol*)
S60 (MH “Psychopathology”)
S59 (motivat* N3 interv*)
S58 (psycho-educat*) or (psychoeducat*)
S57 (goal N3 setting)
S56 (hypnotherap*)
S55 (CBT)
S54 (manage*) N3 (anxiety or depres*)
S53 (MH “Anxiety”)
S52 (meditat*)
S51 (MH “Meditation”)
S50 (cognitive* N3 therap*)
S49 (stress N3 manage*)
S48 (MH “Stress, Psychological+”)
S47 (behavio?r*) N4 (modif* or therap* or rehab* or change)
S46 (MH “Behavior Therapy+”)
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S45 (MH “Cognitive Therapy”)
S44 (counsel?ing)
S43 (MH “Counseling+”)
S42 (relax*)
S41 (psycholog* N3 intervent*)
S40 (psychotherap*)
S39 (MH “Psychotherapy+”)
S38 (MH “Ambulatory Care”)
S37 (MH “Self Care+”)
S36 ((lifestyle or life-style) N3 (intervent* or program* or treatment*))
S35 (patient* N3 educat*)
S34 (MH “Patient Education+”)
S33 (MH “Rehabilitation+”)
S32 ((exercise* or fitness) N3 (treatment or intervent* or program*))
S31 (train*) N3 (strength* or aerobic or exercise*)
S30 (MH “Exercise”)
S29 (physical* N3 (fit* or train* or therap* or activit*))
S28 (rehabilitat*)
S27 (MH “Exertion+”)
S26 (MH “Sports”)
S25 (MH “Therapeutic Exercise+”)
S24 (MH “Rehabilitation Centers+”)
S23 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20
or S21 or S22
S22 (MH “Cardiopulmonary Bypass”)
S21 (stent* N3 (heart or cardiac*))
S20 (PTCA)
S19 (CABG)
S18 (cardiac*)
S17 (myocard*)
S16 (heart N3 disease*)
S15 (MH “Heart Diseases+”)
S14 (heart N3 (failure or attack))
S13 (MH “Heart Failure+”)
S12 (angina)
S11 (MH “Angina Pectoris+”)
S10 (heart N3 infarct*)
S9 (myocard* N3 infarct*)
S8 (MH “Myocardial Infarction+”)
S7 (MH “Myocardial Revascularization+”)
S6 (MH “Coronary Disease+”)
S5 (coronary)
S4 (MH “Coronary Artery Bypass+”)
S3 (isch?mi* N3 heart)
S2 (myocard* N3 isch?mi*)
S1 (MH “Myocardial Ischemia+”)
UK Clinical Trials Gateway (www.ukctg.nihr.ac.uk/)
“cardiac rehabilitation” AND “home”
WHO ICTRP
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“cardiac rehabilitation” AND “home”
Clinicaltrials.gov
“cardiac rehabilitation” AND “home”
WH A T ’ S N E W
Last assessed as up-to-date: 21 September 2016.
Date Event Description
20 January 2017 New citation required but conclusions have not
changed
Six new studies included. Conclusions not changed.
14 November 2016 New search has been performed The review was updated following a new search in
September 2016
H I S T O R Y
Protocol first published: Issue 2, 2008
Review first published: Issue 1, 2010
Date Event Description
14 October 2014 New search has been performed The review has been updated following a new search in
October 2014
9 October 2014 New citation required but conclusions have not
changed
Five new studies were found for inclusion but did not
change the conclusions of this review
19 April 2010 Amended Minor changes to the Background section.
10 February 2010 Amended Forest plots of ’Mortality’ and ’Completers’ have been
updated as home and hospital group headings were in-
advertently reversed in the original review
Added citation in ’Other published versions of this re-
view’.
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RST contributed to the original and previous versions of the review, led the analysis of this review and contributed to the editing of
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co-applicants on an ongoing National Institute for Health Research (NIHR) Programme Grants for Applied Research funded study
- Rehabilitation Enablement in Chronic Heart Failure (REACH-HF) - to develop and evaluate the costs and outcomes of a home-
based self help heart failure rehabilitation manual (RP-PG-1210-12004) http://medicine.exeter.ac.uk/research/healthserv/primarycare/
projects/reach-hf/.
SJD’s position at the University of Exeter Medical School is partially supported by the National Institute for Health Research (NIHR)
Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula. The views expressed in
this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health in England.
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KJ is part funded by NIHR CLAHRC-WM.
RJN, AZ and GAS declare that they have no conflicts of interest.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• NIHR Cochrane Heart Programme grant, UK.
• Transparency of the National Health System Drug Reimbursement Decisions, Poland.
co-financed by EU
152Home-based versus centre-based cardiac rehabilitation (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
To reflect current practice and terminology, “percutaneous transluminal coronary angioplasty” (PTCA) was replaced by “percutaneous
coronary intervention” (PCI), a term which encompasses the use of balloons, stents and atherectomy.
The order of primary and secondary outcomes has been updated, for clarity.
Due to the increase in the number of studies included in this review, we undertook meta-regression analysis to examine potential
treatment effect modifiers and the text has been updated to reflect this change.
Finally, we created a ’Summary of findings’ table using the following outcomes: total mortality, exercise capacity, withdrawal and health-
related quality of life.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Home Care Services; ∗Rehabilitation Centers; Heart Failure [∗rehabilitation]; Myocardial Infarction [∗rehabilitation]; Myocardial
Revascularization [∗rehabilitation]; Randomized Controlled Trials as Topic; Risk Factors
MeSH check words
Adult; Aged; Female; Humans; Male; Middle Aged
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